{"id":376800,"date":"2025-10-29T23:09:00","date_gmt":"2025-10-29T15:09:00","guid":{"rendered":"https:\/\/pingtungtimes.com.tw\/?p=376800"},"modified":"2025-10-29T23:09:00","modified_gmt":"2025-10-29T15:09:00","slug":"i-mab-nasdaq-imab%e6%ad%a3%e5%bc%8f%e6%9b%b4%e5%90%8d%e7%82%ba%e6%96%b0%e6%a9%8b%e7%94%9f%e7%89%a9%ef%bc%88novabridge-biosciences%ef%bc%9bnasdaq-nbp%ef%bc%89%ef%bc%8c%e8%82%a1%e7%a5%a8%e4%ba%a4","status":"publish","type":"post","link":"https:\/\/pingtungtimes.com.tw\/?p=376800","title":{"rendered":"I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002"},"content":{"rendered":"<div>\n<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<ul type=\"disc\">\n<li>\u5168\u65b0\u4f01\u696d\u54c1\u724c\u6a19\u8a8c\u8457\u516c\u53f8\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u7684\u6230\u7565\u8f49\u578b\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002<\/li>\n<li>\u516c\u53f8\u64ec\u5728\u9999\u6e2f\u9032\u884c\u9996\u6b21\u516c\u958b\u52df\u80a1\uff08IPO\uff09\uff0c\u4e26\u901a\u904e\u5728\u7f8e\u570b\u7d0d\u65af\u9054\u514b\uff08NASDAQ\uff09\u548c\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\uff0c\u64f4\u5927\u5c0d\u5168\u7403\u8cc7\u672c\u548c\u5275\u65b0\u8cc7\u6e90\u7684\u93c8\u63a5\u3002<\/li>\n<li>\u57fa\u65bc\u5168\u65b0\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u696d\u52d9\u6a21\u5f0f\uff0c\u516c\u53f8\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara Inc. (Visara)\uff0c\u4e26\u5df2\u6536\u8cfc\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50VIS-101\uff08\u9776\u5411 VEGF-A\/ANG2\uff09\u3002\u76f8\u8f03\u73fe\u884c\u6a19\u6e96\u7642\u6cd5\uff0cVIS-101\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u3001\u66f4\u6709\u6548\u7684\u6cbb\u7642\u9078\u64c7\u3002<\/li>\n<li>\u516c\u53f8\u6838\u5fc3\u8cc7\u7522givastomig\uff08\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff09\uff0c\u6b63\u6309\u7167\u6b64\u524d\u516c\u5e03\u7684\u6295\u8cc7\u8a08\u5283\u6301\u7e8c\u63a8\u9032\u7814\u767c\u3002<\/li>\n<\/ul>\n<p><span class=\"legendSpanClass\">\u99ac\u91cc\u862d\u5dde\u7f85\u514b\u7dad\u723e<\/span><span class=\"legendSpanClass\">2025\u5e7410\u670829\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; \u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff0c\u4e0b\u7a31\u300c\u65b0\u6a4b\u751f\u7269\u300d\u6216\u300c\u516c\u53f8\u300d\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u516c\u53f8\u5df2\u5b8c\u6210\u540d\u7a31\u8b8a\u66f4\uff0c\u7531\u300cI-Mab\u300d\u6b63\u5f0f\u66f4\u540d\u70ba\u300c\u65b0\u6a4b\u751f\u7269\u300d\u3002\u6b64\u9805\u66f4\u540d\u6c7a\u8b70\u5df2\u7372\u5f97\u516c\u53f8\u65bc2025\u5e7410\u670824\u65e5\u53ec\u958b\u7684\u7279\u5225\u80a1\u6771\u5927\u6703\u9ad8\u7968\u901a\u904e\uff0c\u4e26\u7372\u8463\u4e8b\u6703\u6279\u51c6\u3002\u81ea2025\u5e7410\u670830\u65e5\u958b\u76e4\u8d77\uff0c\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u5c07\u6b63\u5f0f\u555f\u7528\u65b0\u516c\u53f8\u540d\u7a31\u53ca\u65b0\u80a1\u7968\u4ee3\u78bc\u300cNBP\u300d\uff08Nasdaq: NBP\uff09\uff0c\u53d6\u4ee3\u73fe\u6709\u4ee3\u78bc\u300cIMAB\u300d\uff08Nasdaq: IMAB\uff09\u3002<\/p>\n<p>\u516c\u53f8\u540c\u6b65\u4e0a\u7dda\u5168\u65b0\u54c1\u724c\u53ca\u5b98\u7db2\uff08<a href=\"https:\/\/www.novabridge.com\/\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">www.novabridge.com<\/a>\uff09\uff0c\u6a19\u8a8c\u8457\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u6230\u7565\u8f49\u578b\u9081\u51fa\u95dc\u9375\u4e00\u6b65\uff0c\u6301\u7e8c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u7642\u6cd5\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002<\/p>\n<p>\u95dc\u65bc\u6b64\u6b21\u540d\u7a31\u53ca\u80a1\u7968\u4ee3\u78bc\u8b8a\u66f4\uff0c\u73fe\u6709\u80a1\u6771\u7121\u9700\u9032\u884c\u4efb\u4f55\u884c\u52d5\uff0c\u516c\u53f8CUSIP\u865f\u78bc\u5c07\u4fdd\u6301\u4e0d\u8b8a\u3002\u5728\u90e8\u5206\u7b2c\u4e09\u65b9\u7db2\u7ad9\u6216\u61c9\u7528\u7a0b\u5e8f\u4e0a\uff0c\u82e5\u641c\u7d22\u300cNovaBridge Biosciences\u300d\u6216\u300cNBP\u300d\u6642\uff0c\u53ef\u80fd\u66ab\u6642\u7121\u6cd5\u67e5\u8a62\u5230\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u57282025\u5e7410\u670830\u65e5\u4e4b\u524d\u7684\u6b77\u53f2\u4ea4\u6613\u6578\u64da\u3002\u5982\u9047\u6b64\u7a2e\u60c5\u6cc1\uff0c\u76f8\u95dc\u6578\u64da\u53ef\u66ab\u6642\u901a\u904e\u641c\u7d22\u300cI-MAB\u300d\u6216\u300cIMAB\u300d\u9032\u884c\u67e5\u8a62\u3002<\/p>\n<p><span id=\"spanHghlt7d9a\"><b><i>\u65b0\u6a4b\u751f\u7269<\/i><\/b><b><i>Logo &#8211; <\/i><\/b><i>\u76f8\u9023\u7684\u5206\u5b50\u7d50\u69cb\u7d44\u5408\u6210\u5b57\u6bcd\u300c<\/i><i>N\u300d\uff0c\u5bd3\u610f\u516c\u53f8\u8207\u5408\u4f5c\u4f19\u4f34\u651c\u624b\u5171\u5efa\u66f4\u5065\u5eb7\u672a\u4f86\uff1b\u958b\u653e\u7684\u5713\u74b0\u8c61\u5fb5\u6301\u7e8c\u5275\u65b0\u8207\u63a2\u7d22\u7cbe\u795e\u3002<\/i><\/span><\/p>\n<p>\u65b0\u6a4b\u751f\u7269\u57f7\u884c\u8463\u4e8b\u9577\u5085\u552f\u5148\u751f\u8868\u793a\uff1a\u300c\u5168\u65b0\u7684\u4f01\u696d\u54c1\u724c\u5f62\u8c61\u751f\u52d5\u9ad4\u73fe\u4e86\u6211\u5011\u65b0\u7684\u6230\u7565\u6838\u5fc3\u2014\u2014\u901a\u904e\u9ad8\u6548\u5354\u4f5c\u3001\u79d1\u5b78\u8f49\u5316\u8207\u5353\u8d8a\u57f7\u884c\uff0c\u52a0\u901f\u63a8\u9032\u8b8a\u9769\u6027\u7642\u6cd5\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u66f4\u5927\u50f9\u503c\u3002\u7f8e\u6e2f\u5169\u5730\u96d9\u91cd\u4e0a\u5e02\u662f\u516c\u53f8\u5168\u7403\u5316\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\uff0c\u9019\u5c07\u5e6b\u52a9\u6211\u5011\u62d3\u5bec\u6295\u8cc7\u8005\u7bc4\u570d\u3001\u63d0\u5347\u4ea4\u6613\u6d41\u52d5\u6027\u548c\u8cc7\u672c\u93c8\u63a5\u80fd\u529b\uff0c\u4e26\u5f37\u5316\u5728\u5feb\u901f\u589e\u9577\u7684\u4e9e\u6d32\u5e02\u5834\u7684\u5f71\u97ff\u529b\u3002\u300d<\/p>\n<p>\u65b0\u6a4b\u751f\u7269\u9996\u5e2d\u57f7\u884c\u5b98\u5085\u5e0c\u6e67\u535a\u58eb\u8868\u793a\uff1a\u300c\u65b0\u54c1\u724c\u5f62\u8c61\u8207\u6211\u5011\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u8f49\u578b\u7684\u6230\u7565\u9ad8\u5ea6\u4e00\u81f4\u3002\u8fd1\u671f\uff0c\u5728\u91dd\u5c0dgivastomig\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u80c3\u764c\u6cbb\u7642\u9818\u57df\u7684\u540c\u985e\u6700\u4f73 Claudin 18.2 \u9776\u5411\u7642\u6cd5\uff09\u7684\u300e\u4e09\u806f\u6703\u8b70\uff08Triple Meeting<sup>[1]<\/sup>\uff09\u300f\u4e0a\uff0c\u516c\u5e03\u4e86\u4ee4\u4eba\u632f\u596e\u7684I\u671f\u55ae\u85e5\u81e8\u5e8a\u6700\u65b0\u6578\u64da\uff1b\u540c\u6642\uff0c\u6211\u5011\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara \uff0c\u53ca\u5176\u8fd1\u671f\u6536\u8cfc\u7684 VIS\u2011101\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u4e0b\u4e00\u4ee3\u540c\u985e\u6700\u4f73\u7684\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff09\uff0c\u9032\u4e00\u6b65\u9a57\u8b49\u4e86\u65b0\u6230\u7565\u7684\u53ef\u884c\u6027\u3002\u6211\u5011\u6b63\u7a4d\u6975\u63a8\u9032 givastomig \u5168\u7403\u96a8\u6a5f\u5c0d\u7167 II \u671f\u7814\u7a76\uff0c\u9810\u8a08\u65bc\u202f2026\u202f\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5b8c\u6210\u9996\u4f8b\u60a3\u8005\u5165\u7d44\u3002\u6191\u501f\u65b0\u54c1\u724c\u5e36\u4f86\u7684\u7a4d\u6975\u52e2\u982d\uff0c\u5145\u5206\u91cb\u653e\u5275\u65b0\u85e5\u7269\u7684\u6f5b\u529b\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u50f9\u503c\u3002\u300d<\/p>\n<p><b>\u65b0\u6a4b\u751f\u7269\u7684\u5546\u696d\u6a21\u5f0f\u8207\u7522\u54c1\u7ba1\u7dda\u5e03\u5c40<\/b><\/p>\n<p>\u516c\u53f8\u5c07\u8207\u5168\u7403\u9818\u5148\u5275\u65b0\u8005\u5408\u4f5c\uff0c\u7504\u9078\u4e26\u52a0\u901f\u9ad8\u6f5b\u529b\u85e5\u7269\u8cc7\u7522\u3002\u8a72\u6a21\u5f0f\u878d\u5408\u56b4\u8b39\u7684\u8cc7\u7522\u7504\u9078\u3001\u5b9a\u5236\u5316\u7684\u8f49\u5316\u7b56\u7565\u53ca\u9ad8\u6548\u81e8\u5e8a\u57f7\u884c\uff0c\u4e26\u4f9d\u6258\u5eb7\u6a4b\u8cc7\u672c\u6df1\u539a\u8cc7\u6e90\u8207\u5168\u7403\u80fd\u529b\uff0c\u5728\u591a\u6cbb\u7642\u9818\u57df\u63a8\u9032\u6700\u5177\u6f5b\u529b\u7684\u5275\u65b0\u85e5\u3002<\/p>\n<p>\u516c\u53f8\u5c07\u63a1\u7528\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u6a21\u5f0f\uff0c\u901a\u904e\u8a2d\u7acb\u5c08\u6ce8\u7279\u5b9a\u6cbb\u7642\u9818\u57df\u6216\u8cc7\u7522\u7684\u885b\u661f\u5b50\u516c\u53f8\uff0c\u4fdd\u6301\u9ad8\u6548\u9748\u6d3b\u7684\u904b\u71df\u7d50\u69cb\uff0c\u5f9e\u800c\u5be6\u73fe\u98a8\u96aa\u53ef\u63a7\u8207\u50f9\u503c\u6700\u5927\u5316\u3002<\/p>\n<p><b>\u7ba1\u7dda\u6982\u89bd<\/b><\/p>\n<ul type=\"disc\">\n<li><b>Givastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c<\/b>\u76ee\u524d\u6b63\u5728\u958b\u5c551b\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u65e8\u5728\u7528\u65bc\u6cbb\u7642\u80c3\u764c\u53ca\u5176\u4ed6Claudin\u00a018.2\u967d\u6027\u7684\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u8a08\u5283\u555f\u52d5\u4e00\u9805\u5168\u7403\u96a8\u6a5f\u5c0d\u7167\u7684II\u671f\u7814\u7a76\uff0c\u76ee\u6a19\u65bc2026\u5e74\u7b2c\u4e00\u5b63\u5ea6\u62db\u52df\u9996\u4f4d\u60a3\u8005\u3002Givastomig\u6b63\u901a\u904e\u8207ABL\u00a0Bio\u7684\u5168\u7403\u5408\u4f5c\u9032\u884c\u806f\u5408\u958b\u767c\uff0c\u5176\u4e2d\u65b0\u6a4b\u751f\u7269\u4f5c\u70ba\u727d\u982d\u65b9\uff0c\u8207ABL\u00a0Bio\u5e73\u5206\u5168\u7403\u6b0a\u76ca\uff08\u5927\u4e2d\u83ef\u5340\u548c\u97d3\u570b\u9664\u5916\uff09\u3002<\/li>\n<li><b>Ragistomig<\/b><b>\u662f\u4e00\u6b3e\u6297<\/b><b>PD-L1\u00d74-1BB<\/b><b>\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\u3002<\/b>\u57fa\u65bc\u4e00\u671f\u81e8\u5e8a\u6578\u64da\uff0c\u76ee\u524d\u958b\u5c55\u76841b\u671f\u7814\u7a76\u65e8\u5728\u64f4\u5927\u6cbb\u7642\u7a97\u53e3\uff0c\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u7522\u751f\u7d50\u679c\u3002\u8a72\u9805\u76ee\u6b63\u8207ABL Bio\u806f\u5408\u958b\u767c\u3002<\/li>\n<li><b>Uliledlimab<\/b>\uff08\u6297CD73\u55ae\u6297\uff09\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\uff0cCD73\u662f\u817a\u7518\u4ecb\u5c0e\u514d\u75ab\u6291\u5236\u7684\u9650\u901f\u9176\u3002\u76ee\u524d\u6b63\u5728\u958b\u5c55\u7684\u96a8\u6a5fII\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\uff0c\u5c07uliledlimab\u806f\u5408\u7279\u745e\u666e\u5229\u55ae\u6297\uff08toripalimab\uff09\u7684\u65b9\u6848\u8207\u5e15\u535a\u5229\u73e0\u55ae\u6297\uff08Pembrolizumab\uff09\u55ae\u85e5\u6216\u7279\u745e\u666e\u5229\u55ae\u6297\u55ae\u85e5\u5728\u7d93CD73\u7be9\u9078\u7684\u60a3\u8005\u4eba\u7fa4\u4e2d\u9032\u884c\u5c0d\u6bd4\uff0c\u5176\u7121\u9032\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u6578\u64da\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u516c\u5e03\u3002\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u5927\u4e2d\u83ef\u5340\u4ee5\u5916\u7684\u5168\u7403\u6b0a\u76ca\u3002<\/li>\n<\/ul>\n<p><b>VIS-101\u7531\u65b0\u6a4b\u751f\u7269\u5728\u65b0\u5546\u696d\u6a21\u5f0f\u4e0b\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u6536\u8cfc\uff0c\u662f\u4e00\u6b3e\u9776\u5411VEGF-A\u548cANG2\u7684\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u76ee\u524d\u8655\u65bcII\u671f\u958b\u767c\u968e\u6bb5\u3002<\/b><\/p>\n<ul type=\"disc\">\n<li><b>VIS-101\u662f\u4e00\u6b3e\u65b0\u578b<\/b><b>\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c<\/b>\u9776\u5411VEGF-A\u548cANG2\uff0c\u4e14\u5206\u5b50\u6d3b\u6027\u66f4\u5f37\uff0c\u76f8\u8f03\u65bc\u73fe\u6709\u6a19\u6e96\u7642\u6cd5\uff0c\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u3001\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u548c\u8996\u7db2\u819c\u975c\u8108\u963b\u585e\uff08RVO\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5b8c\u6210\u4e86\u521d\u6b65\u7684\u5b89\u5168\u6027\u548c\u5291\u91cf\u905e\u589e\u7814\u7a76\uff0c\u76ee\u524d\u6b63\u5728\u4e2d\u570b\u5b8c\u6210\u4e00\u9805\u96a8\u6a5f\u5291\u91cf\u7bc4\u570d\u7684II\u671f\u7814\u7a76\u3002VIS-101\u9810\u8a08\u5c07\u65bc2026\u5e74\u5177\u5099\u958b\u5c55III\u671f\u8a66\u9a57\u7684\u689d\u4ef6\u3002<\/li>\n<li><b>\u6b64\u6b21\u6536\u8cfc\u5df2\u901a\u904e\u65b0\u6210\u7acb\u7684\u5b50\u516c\u53f8<\/b><b>Visara\u5b8c\u6210\u3002<\/b>Visara\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u5236\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u540c\u985e\u6700\u4f73\u7684\u773c\u79d1\u7642\u6cd5\uff0c\u5176\u4f9d\u6258\u65b0\u6a4b\u751f\u7269\u7d043700\u842c\u7f8e\u5143\u7684\u6ce8\u8cc7\uff0c\u4ee5\u53ca\u4e00\u5bb6\u6230\u7565\u5408\u4f5c\u4f19\u4f34\u6240\u8ca2\u737b\u7684\u90e8\u5206\u76f8\u95dc\u6b0a\u76ca\u800c\u6210\u7acb\u3002\u65b0\u6a4b\u751f\u7269\u6210\u70ba Visara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002<\/li>\n<li><b>Visara\u7531<\/b><b>\u5176\u806f\u5408\u5275\u59cb\u4eba\u517c<\/b><b>\u57f7\u884c\u8463\u4e8b\u9577Emmett\u00a0J.\u00a0Cunningham,\u00a0Jr.<\/b><b>\u535a\u58eb<\/b><b>\u9818\u5c0e\u3002<\/b>Cunningham\u535a\u58eb\u5728\u904e\u53bb25\u5e74\u4e2d\u4e00\u76f4\u662f\u4e00\u4f4d\u91ab\u751f\u3001\u5275\u65b0\u8005\u3001\u4f01\u696d\u5bb6\u548c\u6295\u8cc7\u4eba\uff0c\u66fe\u4efb\u9ed1\u77f3\u96c6\u5718\u9ad8\u7d1a\u8463\u4e8b\u7e3d\u7d93\u7406\u4ee5\u53caClarus\u00a0Ventures\u8463\u4e8b\u7e3d\u7d93\u7406\u3002Cunningham\u535a\u58eb\u4e5f\u662f\u570b\u969b\u516c\u8a8d\u7684\u611f\u67d3\u6027\u548c\u708e\u75c7\u6027\u773c\u75c5\u5c08\u5bb6\uff0c\u5408\u4f5c\u767c\u8868\u4e86\u903e450\u7bc7\u5b78\u8853\u8ad6\u6587\u3002<\/li>\n<\/ul>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tbody>\n<tr>\n<td class=\"prnpr2 prnpl2 prnsbtb1 prnrbrb1 prnsbbb1 prnsblb1\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">1\uff1a\u300cAACR\u2013NCI\u2013EORTC \u5206\u5b50\u9776\u9ede\u8207\u764c\u75c7\u6cbb\u7642\u570b\u969b\u6703\u8b70\u300d\uff08AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics\uff09\u4e5f\u88ab\u7a31\u70ba\u300c\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300d\uff0c\u65bc 2025 \u5e74 10 \u6708 22 \u65e5\u81f3 26 \u65e5\u5728\u7f8e\u570b\u99ac\u85a9\u8af8\u585e\u5dde\u6ce2\u58eb\u9813\u8209\u884c\u3002<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p><b>\u95dc\u65bc\u65b0\u6a4b\u751f\u7269<\/b><\/p>\n<p>\u65b0\u6a4b\u751f\u7269\uff08\u66f4\u540d\u524d\u70baI-MAB\uff1b\u7d0d\u65af\u9054\u514b\u4ee3\u78bc\uff1aIMAB\uff0c\u81ea2025\u5e7410\u670830\u65e5\u8d77\u5c07\u66f4\u6539\u70ba\u300cNBP\u300d\uff09\u662f\u4e00\u5bb6\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u7684\u53ef\u53ca\u6027\u3002\u6211\u5011\u5c07\u5c08\u696d\u7684\u696d\u52d9\u62d3\u5c55\u80fd\u529b\u8207\u654f\u6377\u7684\u8f49\u5316\u81e8\u5e8a\u958b\u767c\u76f8\u7d50\u5408\uff0c\u4ee5\u767c\u73fe\u3001\u52a0\u901f\u4e26\u63a8\u9032\u7a81\u7834\u6027\u8cc7\u7522\u3002\u901a\u904e\u929c\u63a5\u79d1\u5b78\u3001\u6230\u7565\u548c\u57f7\u884c\uff0c\u65b0\u6a4b\u751f\u7269\u4f7f\u8b8a\u9769\u6027\u7642\u6cd5\u80fd\u5920\u5f9e\u767c\u73fe\u968e\u6bb5\u5feb\u901f\u63a8\u9032\u81f3\u6709\u9700\u6c42\u7684\u60a3\u8005\u3002<\/p>\n<p>\u516c\u53f8\u7684\u5dee\u7570\u5316\u7ba1\u7dda\u4e3b\u8981\u7531givastomig\u548cVIS-101\u9818\u929c\u3002\u5176\u4e2d\uff0cgivastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff08Claudin 18.2\u00d74-1BB\uff09\uff1bVIS-101\u662f\u4e00\u6b3e\u540c\u985e\u7b2c\u4e8c\u4e14\u6709\u671b\u6210\u70ba\u540c\u985e\u6700\u4f73\u7684\u96d9\u529f\u80fd\u751f\u7269\u5236\u5291\uff0c\u9776\u5411VEGF-A\u548cANG2\u3002<\/p>\n<p>Givastomig\u901a\u904e4-1BB\u4fe1\u865f\u901a\u8def\uff0c\u5728\u8868\u9054Claudin 18.2\u7684\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u689d\u4ef6\u6027\u6fc0\u6d3bT\u7d30\u80de\u3002givastomig\u6b63\u958b\u767c\u7528\u65bc\u6cbb\u7642Claudin 18.2\u967d\u6027\u7684\u80c3\u764c\u53ca\u5176\u4ed6\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u65b0\u6a4b\u751f\u7269\u9084\u8207\u5408\u4f5c\u4f19\u4f34ABL Bio\u5408\u4f5c\u958b\u767cragistomig\uff0c\u9019\u662f\u4e00\u6b3e\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u5728\u5be6\u9ad4\u7624\u4e2d\u5c07PD-L1\u4f5c\u70ba\u816b\u7624\u7d50\u5408\u9776\u9ede\u30014-1BB\u4f5c\u70ba\u689d\u4ef6\u6027T\u7d30\u80de\u6fc0\u6d3b\u5291\u3002\u6b64\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u4e2d\u570b\u4ee5\u5916\u5730\u5340\u7684\u5168\u7403\u6b0a\u76ca\u3002Uliledlimab\u662f\u4e00\u6b3e\u6297CD73\u6297\u9ad4\uff0c\u9776\u5411\u816b\u7624\u4e2d\u7531\u817a\u7518\u4ecb\u5c0e\u7684\u514d\u75ab\u6291\u5236\u3002<\/p>\n<p>VIS-101\u9776\u5411VEGF-A\u548cANG2\uff0c\u53ef\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u5f37\u6709\u529b\u4e14\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u76ee\u524d\u6b63\u5728\u91dd\u5c0d\u6fd5\u6027AMD\u958b\u5c55\u4e00\u9805\u5927\u578b\u3001\u96a8\u6a5f\u3001\u5291\u91cf\u7bc4\u570d\u76842\u671f\u7814\u7a76\u3002\u65b0\u6a4b\u751f\u7269\u662fVisara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002<\/p>\n<p>\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f\uff1a<a href=\"https:\/\/www.novabridge.com\/\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">https:\/\/www.novabridge.com<\/a>\u00a0<\/p>\n<p><b>\u516c\u53f8\u64ec\u5728\u7d0d\u65af\u9054\u514b\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u96d9\u91cd\u4e0a\u5e02<\/b><\/p>\n<p>\u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u64ec\u8d74\u9999\u6e2fIPO\u4e26\u5728\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u4e0a\u5e02\u7684\u66f4\u591a\u4fe1\u606f\u5c07\u65bc\u65e5\u5f8c\u516c\u5e03\u3002<\/p>\n<p>\u64ec\u8b70\u767c\u884c\u7684\u6642\u9593\u3001\u898f\u6a21\u3001\u7d50\u69cb\u548c\u5177\u9ad4\u689d\u6b3e\u5c1a\u672a\u78ba\u5b9a\uff0c\u4ecd\u53d6\u6c7a\u65bc\u5e02\u5834\u72c0\u6cc1\u4ee5\u53ca\u5305\u62ec\u9999\u6e2f\u806f\u4ea4\u6240\uff08\u53ca\u5176\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5728\u5167\u7684\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\u7684\u5be9\u6279\u3002\u5c0d\u65bc\u64ec\u8b70\u7684\u9999\u6e2f\u4e0a\u5e02\u662f\u5426\u6703\u5b8c\u6210\u3001\u4f55\u6642\u5b8c\u6210\u6216\u5c07\u5728\u4f55\u7a2e\u689d\u6b3e\u4e0b\u5b8c\u6210\uff0c\u7121\u6cd5\u63d0\u4f9b\u4efb\u4f55\u4fdd\u8b49\u3002<\/p>\n<p>\u5728\u7372\u5f97\u76e3\u7ba1\u6a5f\u69cb\u548c\u516c\u53f8\u5fc5\u8981\u6279\u51c6\u7684\u524d\u63d0\u4e0b\uff0c\u516c\u53f8\u76ee\u524d\u9810\u8a08\u5c07\u7dad\u6301\u5176\u5728\u7d0d\u65af\u9054\u514b\u7684\u7f8e\u570b\u5b58\u6258\u80a1\uff08ADS\uff09\u4e0a\u5e02\u5730\u4f4d\uff0c\u4e26\u5c0b\u6c42\u5728\u7f8e\u570b\u548c\u9999\u6e2f\u5be6\u73fe\u96d9\u91cd\u4e0a\u5e02\u3002\u6700\u7d42\u6c7a\u5b9a\u5c07\u6839\u64da\u5e02\u5834\u72c0\u6cc1\u548c\u76e3\u7ba1\u53cd\u994b\u4f5c\u51fa\u3002<\/p>\n<p>\u672c\u516c\u544a\u50c5\u70ba\u4fe1\u606f\u62ab\u9732\u4e4b\u7528\uff0c\u4e14\u4e0d\u69cb\u6210\u5c0d\u516c\u53f8\u4efb\u4f55\u8b49\u5238\u7684\u8a8d\u8cfc\u3001\u8cfc\u8cb7\u6216\u6536\u8cfc\u8981\u7d04\u6216\u9080\u8acb\u3002\u516c\u53f8\u80a1\u6771\u53ca\u6f5b\u5728\u6295\u8cc7\u8005\u5728\u6d89\u53ca\u516c\u53f8\u8b49\u5238\u7684\u4ea4\u6613\u6642\uff0c\u61c9\u8b39\u614e\u8a55\u4f30\u76f8\u95dc\u98a8\u96aa\u3002<\/p>\n<p><b>\u524d\u77bb\u6027\u8072\u660e<\/b><\/p>\n<p>\u672c\u516c\u544a\u5305\u542b\u524d\u77bb\u6027\u8072\u660e\u3002\u9019\u4e9b\u8072\u660e\u4f9d\u64da1995\u5e74\u7f8e\u570b\u300a\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u7684\u300c\u5b89\u5168\u6e2f\u300d\u689d\u6b3e\u4f5c\u51fa\u3002\u53ef\u4ee5\u901a\u904e\u8853\u8a9e\u4f8b\u5982\u300c\u5c07\u300d\u3001\u300c\u9810\u8a08\u300d\u3001\u300c\u76f8\u4fe1\u300d\u3001\u300c\u65e8\u5728\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u3001\u300c\u6253\u7b97\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u4f30\u8a08\u300d\u3001\u300c\u6709\u4fe1\u5fc3\u300d\u7b49\u4ee5\u53ca\u985e\u4f3c\u8868\u8ff0\uff08\u6216\u5176\u53cd\u7fa9\u8868\u8ff0\uff09\u4f86\u8b58\u5225\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u3002\u65b0\u6a4b\u751f\u7269\u4e5f\u53ef\u80fd\u5728\u5176\u63d0\u4ea4\u7d66\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u7684\u5b9a\u671f\u5831\u544a\u3001\u5411\u80a1\u6771\u767c\u5e03\u7684\u5e74\u5ea6\u5831\u544a\u3001\u65b0\u805e\u7a3f\u53ca\u5176\u4ed6\u66f8\u9762\u6750\u6599\u4e2d\uff0c\u4ee5\u53ca\u516c\u53f8\u9ad8\u7ba1\u3001\u8463\u4e8b\u6216\u54e1\u5de5\u5411\u7b2c\u4e09\u65b9\u6240\u4f5c\u7684\u53e3\u982d\u9673\u8ff0\u4e2d\u4f5c\u51fa\u66f8\u9762\u6216\u53e3\u982d\u7684\u524d\u77bb\u6027\u8072\u660e\u3002\u51e1\u4e0d\u5c6c\u65bc\u6b77\u53f2\u4e8b\u5be6\u7684\u9673\u8ff0\uff08\u5305\u62ec\u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u7684\u4fe1\u5ff5\u548c\u9810\u671f\u7684\u9673\u8ff0\uff09\u5747\u70ba\u524d\u77bb\u6027\u8072\u660e\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u7684\u524d\u77bb\u6027\u8072\u660e\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u5167\u5bb9\uff1a\u65b0\u7684\u516c\u53f8\u6230\u7565\u53ef\u80fd\u5e36\u4f86\u7684\u6f5b\u5728\u76ca\u8655\uff1b\u516c\u53f8\u4ee5\u65b0\u540d\u7a31\u548c\u80a1\u7968\u4ee3\u78bc\u5728\u7d0d\u65af\u9054\u514b\u4ea4\u6613\u7684\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u64ec\u63a8\u9032\u9999\u6e2f IPO\uff0c\u9032\u800c\u5be6\u73fe\u64ec\u5728\u7d0d\u65af\u9054\u514b\u5168\u7403\u5e02\u5834\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\u7684\u8a08\u5283\uff1bgivastomig\u3001VIS-101\u53ca\u516c\u53f8\u5176\u4ed6\u5019\u9078\u85e5\u7269\u7684\u6230\u7565\u3001\u81e8\u5e8a\u958b\u767c\u3001\u8a08\u5283\u3001\u7d50\u679c\u3001\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\uff08\u5305\u62ec givastomig \u548c VIS-101\uff09\u7684\u6230\u7565\u8207\u81e8\u5e8a\u958b\u767c\uff1b\u9810\u671f\u7684\u81e8\u5e8a\u91cc\u7a0b\u7891\u548c\u7d50\u679c\u53ca\u76f8\u95dc\u6642\u9593\uff1b\u516c\u53f8\u7684\u9810\u671f\u8cc7\u91d1\u53ef\u7dad\u6301\u904b\u71df\u7684\u5468\u671f\u3002\u524d\u77bb\u6027\u8072\u660e\u6d89\u53ca\u7684\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u4e2d\u5305\u542b\u7684\u7d50\u679c\u5b58\u5728\u91cd\u5927\u5dee\u7570\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u56e0\u7d20\uff1a\u65b0\u6a4b\u751f\u7269\u8b49\u660e\u5176\u5019\u9078\u85e5\u7269\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7684\u80fd\u529b\uff1b\u516c\u53f8\u7372\u5f97\u8b49\u5238\u76e3\u7ba1\u6a5f\u69cb\u53ca\u4ea4\u6613\u6240\u5fc5\u8981\u6279\u51c6\u7684\u80fd\u529b\uff1b\u5019\u9078\u85e5\u7269\u7684\u81e8\u5e8a\u7d50\u679c\uff08\u53ef\u80fd\u652f\u6301\u4e5f\u53ef\u80fd\u4e0d\u652f\u6301\u9032\u4e00\u6b65\u958b\u767c\u6216\u65b0\u85e5\u7533\u8acb\/\u751f\u7269\u5236\u54c1\u8a31\u53ef\u7533\u8acb\uff08NDA\/BLA\uff09\u7684\u6279\u51c6\uff09\uff1b\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\uff08\u5305\u62ec\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\u4ee5\u53ca\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5c31\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\u76e3\u7ba1\u5be9\u6279\u6240\u4f5c\u6c7a\u5b9a\u7684\u5167\u5bb9\u548c\u6642\u9593\uff1b\u65b0\u6a4b\u751f\u7269\u5728\u5019\u9078\u85e5\u7269\u7372\u6279\u5f8c\u7684\u5546\u696d\u6210\u529f\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u4e26\u7dad\u8b77\u5176\u6280\u8853\u548c\u85e5\u7269\u77e5\u8b58\u7522\u6b0a\u4fdd\u8b77\u7684\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u5c0d\u7b2c\u4e09\u65b9\u958b\u5c55\u85e5\u7269\u958b\u767c\u3001\u751f\u7522\u5236\u9020\u53ca\u5176\u4ed6\u670d\u52d9\u7684\u4f9d\u8cf4\uff1b\u65b0\u6a4b\u751f\u7269\u6709\u9650\u7684\u904b\u71df\u6b77\u53f2\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u984d\u5916\u904b\u71df\u8cc7\u91d1\u4e26\u5b8c\u6210\u5176\u5019\u9078\u85e5\u7269\u958b\u767c\u548c\u5546\u696d\u5316\u7684\u80fd\u529b\uff1b\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u5df2\u65bc2025\u5e744\u67083\u65e5\u5411\u7f8e\u570bSEC\u63d0\u4ea4\u768420-F\u5e74\u5ea6\u5831\u544a\u4e2d\u300c\u98a8\u96aa\u56e0\u7d20\u300d\u90e8\u5206\u66f4\u5168\u9762\u8a0e\u8ad6\u7684\u98a8\u96aa\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u96a8\u5f8c\u5411SEC\u63d0\u4ea4\u7684\u6587\u4ef6\u4e2d\u8a0e\u8ad6\u7684\u6f5b\u5728\u98a8\u96aa\u3001\u4e0d\u78ba\u5b9a\u6027\u548c\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u3002\u6240\u6709\u524d\u77bb\u6027\u8072\u660e\u5747\u57fa\u65bc\u65b0\u6a4b\u751f\u7269\u7576\u524d\u53ef\u7372\u5f97\u7684\u4fe1\u606f\u3002\u9664\u6cd5\u5f8b\u8981\u6c42\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u4e0d\u627f\u64d4\u56e0\u7372\u5f97\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u6216\u4fee\u8a02\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u7684\u7fa9\u52d9\u3002<\/p>\n<p><b>\u65b0\u6a4b\u751f\u7269\u6295\u8cc7\u8005\u53ca\u5a92\u9ad4\u806f\u7e6b\u4eba<br \/><\/b>PJ Kelleher \u2013 LifeSci Advisors<br \/>+1-617-430-7579<br \/><a href=\"mailto:pkelleher@lifesciadvisors.com\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">pkelleher@lifesciadvisors.com<\/a><\/p>\n<p>\u96f7\u9cf4\uff08Kyler Lei\uff09\u2013 \u65b0\u6a4b\u751f\u7269<br \/>+1-240-745-6330<br \/><a href=\"mailto:kyler.lei@imabbio.com\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">kyler.lei@imabbio.com<\/a><br \/><a href=\"mailto:IR@imabbio.com\" target=\"_blank\" rel=\"nofollow\" style=\"color: #0000FF\">IR@imabbio.com<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\">  <\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u5168\u65b0\u4f01\u696d\u54c1\u724c\u6a19\u8a8c\u8457\u516c\u53f8\u5411\u5168\u7403\u751f&#8230;<\/p>\n","protected":false},"author":16,"featured_media":376801,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[40567],"tags":[],"class_list":["post-376800","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-40567"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831<\/title>\n<meta name=\"description\" content=\"\u5168\u65b0\u4f01\u696d\u54c1\u724c\u6a19\u8a8c\u8457\u516c\u53f8\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u7684\u6230\u7565\u8f49\u578b\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002  \u516c\u53f8\u64ec\u5728\u9999\u6e2f\u9032\u884c\u9996\u6b21\u516c\u958b\u52df\u80a1\uff08IPO\uff09\uff0c\u4e26\u901a\u904e\u5728\u7f8e\u570b\u7d0d\u65af\u9054\u514b\uff08NASDAQ\uff09\u548c\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\uff0c\u64f4\u5927\u5c0d\u5168\u7403\u8cc7\u672c\u548c\u5275\u65b0\u8cc7\u6e90\u7684\u93c8\u63a5\u3002  \u57fa\u65bc\u5168\u65b0\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u696d\u52d9\u6a21\u5f0f\uff0c\u516c\u53f8\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara Inc. (Visara)\uff0c\u4e26\u5df2\u6536\u8cfc\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50VIS-101\uff08\u9776\u5411 VEGF-A\/ANG2\uff09\u3002\u76f8\u8f03\u73fe\u884c\u6a19\u6e96\u7642\u6cd5\uff0cVIS-101\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u3001\u66f4\u6709\u6548\u7684\u6cbb\u7642\u9078\u64c7\u3002  \u516c\u53f8\u6838\u5fc3\u8cc7\u7522givastomig\uff08\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff09\uff0c\u6b63\u6309\u7167\u6b64\u524d\u516c\u5e03\u7684\u6295\u8cc7\u8a08\u5283\u6301\u7e8c\u63a8\u9032\u7814\u767c\u3002  \u99ac\u91cc\u862d\u5dde\u7f85\u514b\u7dad\u723e2025\u5e7410\u670829\u65e5 \/\u7f8e\u901a\u793e\/ -- \u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff0c\u4e0b\u7a31\u300c\u65b0\u6a4b\u751f\u7269\u300d\u6216\u300c\u516c\u53f8\u300d\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u516c\u53f8\u5df2\u5b8c\u6210\u540d\u7a31\u8b8a\u66f4\uff0c\u7531\u300cI-Mab\u300d\u6b63\u5f0f\u66f4\u540d\u70ba\u300c\u65b0\u6a4b\u751f\u7269\u300d\u3002\u6b64\u9805\u66f4\u540d\u6c7a\u8b70\u5df2\u7372\u5f97\u516c\u53f8\u65bc2025\u5e7410\u670824\u65e5\u53ec\u958b\u7684\u7279\u5225\u80a1\u6771\u5927\u6703\u9ad8\u7968\u901a\u904e\uff0c\u4e26\u7372\u8463\u4e8b\u6703\u6279\u51c6\u3002\u81ea2025\u5e7410\u670830\u65e5\u958b\u76e4\u8d77\uff0c\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u5c07\u6b63\u5f0f\u555f\u7528\u65b0\u516c\u53f8\u540d\u7a31\u53ca\u65b0\u80a1\u7968\u4ee3\u78bc\u300cNBP\u300d\uff08Nasdaq: NBP\uff09\uff0c\u53d6\u4ee3\u73fe\u6709\u4ee3\u78bc\u300cIMAB\u300d\uff08Nasdaq: IMAB\uff09\u3002 \u516c\u53f8\u540c\u6b65\u4e0a\u7dda\u5168\u65b0\u54c1\u724c\u53ca\u5b98\u7db2\uff08www.novabridge.com\uff09\uff0c\u6a19\u8a8c\u8457\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u6230\u7565\u8f49\u578b\u9081\u51fa\u95dc\u9375\u4e00\u6b65\uff0c\u6301\u7e8c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u7642\u6cd5\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002 \u95dc\u65bc\u6b64\u6b21\u540d\u7a31\u53ca\u80a1\u7968\u4ee3\u78bc\u8b8a\u66f4\uff0c\u73fe\u6709\u80a1\u6771\u7121\u9700\u9032\u884c\u4efb\u4f55\u884c\u52d5\uff0c\u516c\u53f8CUSIP\u865f\u78bc\u5c07\u4fdd\u6301\u4e0d\u8b8a\u3002\u5728\u90e8\u5206\u7b2c\u4e09\u65b9\u7db2\u7ad9\u6216\u61c9\u7528\u7a0b\u5e8f\u4e0a\uff0c\u82e5\u641c\u7d22\u300cNovaBridge Biosciences\u300d\u6216\u300cNBP\u300d\u6642\uff0c\u53ef\u80fd\u66ab\u6642\u7121\u6cd5\u67e5\u8a62\u5230\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u57282025\u5e7410\u670830\u65e5\u4e4b\u524d\u7684\u6b77\u53f2\u4ea4\u6613\u6578\u64da\u3002\u5982\u9047\u6b64\u7a2e\u60c5\u6cc1\uff0c\u76f8\u95dc\u6578\u64da\u53ef\u66ab\u6642\u901a\u904e\u641c\u7d22\u300cI-MAB\u300d\u6216\u300cIMAB\u300d\u9032\u884c\u67e5\u8a62\u3002 \u65b0\u6a4b\u751f\u7269Logo - \u76f8\u9023\u7684\u5206\u5b50\u7d50\u69cb\u7d44\u5408\u6210\u5b57\u6bcd\u300cN\u300d\uff0c\u5bd3\u610f\u516c\u53f8\u8207\u5408\u4f5c\u4f19\u4f34\u651c\u624b\u5171\u5efa\u66f4\u5065\u5eb7\u672a\u4f86\uff1b\u958b\u653e\u7684\u5713\u74b0\u8c61\u5fb5\u6301\u7e8c\u5275\u65b0\u8207\u63a2\u7d22\u7cbe\u795e\u3002 \u65b0\u6a4b\u751f\u7269\u57f7\u884c\u8463\u4e8b\u9577\u5085\u552f\u5148\u751f\u8868\u793a\uff1a\u300c\u5168\u65b0\u7684\u4f01\u696d\u54c1\u724c\u5f62\u8c61\u751f\u52d5\u9ad4\u73fe\u4e86\u6211\u5011\u65b0\u7684\u6230\u7565\u6838\u5fc3\u2014\u2014\u901a\u904e\u9ad8\u6548\u5354\u4f5c\u3001\u79d1\u5b78\u8f49\u5316\u8207\u5353\u8d8a\u57f7\u884c\uff0c\u52a0\u901f\u63a8\u9032\u8b8a\u9769\u6027\u7642\u6cd5\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u66f4\u5927\u50f9\u503c\u3002\u7f8e\u6e2f\u5169\u5730\u96d9\u91cd\u4e0a\u5e02\u662f\u516c\u53f8\u5168\u7403\u5316\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\uff0c\u9019\u5c07\u5e6b\u52a9\u6211\u5011\u62d3\u5bec\u6295\u8cc7\u8005\u7bc4\u570d\u3001\u63d0\u5347\u4ea4\u6613\u6d41\u52d5\u6027\u548c\u8cc7\u672c\u93c8\u63a5\u80fd\u529b\uff0c\u4e26\u5f37\u5316\u5728\u5feb\u901f\u589e\u9577\u7684\u4e9e\u6d32\u5e02\u5834\u7684\u5f71\u97ff\u529b\u3002\u300d \u65b0\u6a4b\u751f\u7269\u9996\u5e2d\u57f7\u884c\u5b98\u5085\u5e0c\u6e67\u535a\u58eb\u8868\u793a\uff1a\u300c\u65b0\u54c1\u724c\u5f62\u8c61\u8207\u6211\u5011\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u8f49\u578b\u7684\u6230\u7565\u9ad8\u5ea6\u4e00\u81f4\u3002\u8fd1\u671f\uff0c\u5728\u91dd\u5c0dgivastomig\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u80c3\u764c\u6cbb\u7642\u9818\u57df\u7684\u540c\u985e\u6700\u4f73 Claudin 18.2 \u9776\u5411\u7642\u6cd5\uff09\u7684\u300e\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300f\u4e0a\uff0c\u516c\u5e03\u4e86\u4ee4\u4eba\u632f\u596e\u7684I\u671f\u55ae\u85e5\u81e8\u5e8a\u6700\u65b0\u6578\u64da\uff1b\u540c\u6642\uff0c\u6211\u5011\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara \uff0c\u53ca\u5176\u8fd1\u671f\u6536\u8cfc\u7684 VIS\u2011101\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u4e0b\u4e00\u4ee3\u540c\u985e\u6700\u4f73\u7684\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff09\uff0c\u9032\u4e00\u6b65\u9a57\u8b49\u4e86\u65b0\u6230\u7565\u7684\u53ef\u884c\u6027\u3002\u6211\u5011\u6b63\u7a4d\u6975\u63a8\u9032 givastomig \u5168\u7403\u96a8\u6a5f\u5c0d\u7167 II \u671f\u7814\u7a76\uff0c\u9810\u8a08\u65bc\u202f2026\u202f\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5b8c\u6210\u9996\u4f8b\u60a3\u8005\u5165\u7d44\u3002\u6191\u501f\u65b0\u54c1\u724c\u5e36\u4f86\u7684\u7a4d\u6975\u52e2\u982d\uff0c\u5145\u5206\u91cb\u653e\u5275\u65b0\u85e5\u7269\u7684\u6f5b\u529b\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u50f9\u503c\u3002\u300d \u65b0\u6a4b\u751f\u7269\u7684\u5546\u696d\u6a21\u5f0f\u8207\u7522\u54c1\u7ba1\u7dda\u5e03\u5c40 \u516c\u53f8\u5c07\u8207\u5168\u7403\u9818\u5148\u5275\u65b0\u8005\u5408\u4f5c\uff0c\u7504\u9078\u4e26\u52a0\u901f\u9ad8\u6f5b\u529b\u85e5\u7269\u8cc7\u7522\u3002\u8a72\u6a21\u5f0f\u878d\u5408\u56b4\u8b39\u7684\u8cc7\u7522\u7504\u9078\u3001\u5b9a\u5236\u5316\u7684\u8f49\u5316\u7b56\u7565\u53ca\u9ad8\u6548\u81e8\u5e8a\u57f7\u884c\uff0c\u4e26\u4f9d\u6258\u5eb7\u6a4b\u8cc7\u672c\u6df1\u539a\u8cc7\u6e90\u8207\u5168\u7403\u80fd\u529b\uff0c\u5728\u591a\u6cbb\u7642\u9818\u57df\u63a8\u9032\u6700\u5177\u6f5b\u529b\u7684\u5275\u65b0\u85e5\u3002 \u516c\u53f8\u5c07\u63a1\u7528\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u6a21\u5f0f\uff0c\u901a\u904e\u8a2d\u7acb\u5c08\u6ce8\u7279\u5b9a\u6cbb\u7642\u9818\u57df\u6216\u8cc7\u7522\u7684\u885b\u661f\u5b50\u516c\u53f8\uff0c\u4fdd\u6301\u9ad8\u6548\u9748\u6d3b\u7684\u904b\u71df\u7d50\u69cb\uff0c\u5f9e\u800c\u5be6\u73fe\u98a8\u96aa\u53ef\u63a7\u8207\u50f9\u503c\u6700\u5927\u5316\u3002 \u7ba1\u7dda\u6982\u89bd   Givastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u76ee\u524d\u6b63\u5728\u958b\u5c551b\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u65e8\u5728\u7528\u65bc\u6cbb\u7642\u80c3\u764c\u53ca\u5176\u4ed6Claudin\u00a018.2\u967d\u6027\u7684\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u8a08\u5283\u555f\u52d5\u4e00\u9805\u5168\u7403\u96a8\u6a5f\u5c0d\u7167\u7684II\u671f\u7814\u7a76\uff0c\u76ee\u6a19\u65bc2026\u5e74\u7b2c\u4e00\u5b63\u5ea6\u62db\u52df\u9996\u4f4d\u60a3\u8005\u3002Givastomig\u6b63\u901a\u904e\u8207ABL\u00a0Bio\u7684\u5168\u7403\u5408\u4f5c\u9032\u884c\u806f\u5408\u958b\u767c\uff0c\u5176\u4e2d\u65b0\u6a4b\u751f\u7269\u4f5c\u70ba\u727d\u982d\u65b9\uff0c\u8207ABL\u00a0Bio\u5e73\u5206\u5168\u7403\u6b0a\u76ca\uff08\u5927\u4e2d\u83ef\u5340\u548c\u97d3\u570b\u9664\u5916\uff09\u3002  Ragistomig\u662f\u4e00\u6b3e\u6297PD-L1\u00d74-1BB\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\u3002\u57fa\u65bc\u4e00\u671f\u81e8\u5e8a\u6578\u64da\uff0c\u76ee\u524d\u958b\u5c55\u76841b\u671f\u7814\u7a76\u65e8\u5728\u64f4\u5927\u6cbb\u7642\u7a97\u53e3\uff0c\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u7522\u751f\u7d50\u679c\u3002\u8a72\u9805\u76ee\u6b63\u8207ABL Bio\u806f\u5408\u958b\u767c\u3002  Uliledlimab\uff08\u6297CD73\u55ae\u6297\uff09\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\uff0cCD73\u662f\u817a\u7518\u4ecb\u5c0e\u514d\u75ab\u6291\u5236\u7684\u9650\u901f\u9176\u3002\u76ee\u524d\u6b63\u5728\u958b\u5c55\u7684\u96a8\u6a5fII\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\uff0c\u5c07uliledlimab\u806f\u5408\u7279\u745e\u666e\u5229\u55ae\u6297\uff08toripalimab\uff09\u7684\u65b9\u6848\u8207\u5e15\u535a\u5229\u73e0\u55ae\u6297\uff08Pembrolizumab\uff09\u55ae\u85e5\u6216\u7279\u745e\u666e\u5229\u55ae\u6297\u55ae\u85e5\u5728\u7d93CD73\u7be9\u9078\u7684\u60a3\u8005\u4eba\u7fa4\u4e2d\u9032\u884c\u5c0d\u6bd4\uff0c\u5176\u7121\u9032\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u6578\u64da\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u516c\u5e03\u3002\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u5927\u4e2d\u83ef\u5340\u4ee5\u5916\u7684\u5168\u7403\u6b0a\u76ca\u3002  VIS-101\u7531\u65b0\u6a4b\u751f\u7269\u5728\u65b0\u5546\u696d\u6a21\u5f0f\u4e0b\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u6536\u8cfc\uff0c\u662f\u4e00\u6b3e\u9776\u5411VEGF-A\u548cANG2\u7684\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u76ee\u524d\u8655\u65bcII\u671f\u958b\u767c\u968e\u6bb5\u3002   VIS-101\u662f\u4e00\u6b3e\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff0c\u4e14\u5206\u5b50\u6d3b\u6027\u66f4\u5f37\uff0c\u76f8\u8f03\u65bc\u73fe\u6709\u6a19\u6e96\u7642\u6cd5\uff0c\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u3001\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u548c\u8996\u7db2\u819c\u975c\u8108\u963b\u585e\uff08RVO\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5b8c\u6210\u4e86\u521d\u6b65\u7684\u5b89\u5168\u6027\u548c\u5291\u91cf\u905e\u589e\u7814\u7a76\uff0c\u76ee\u524d\u6b63\u5728\u4e2d\u570b\u5b8c\u6210\u4e00\u9805\u96a8\u6a5f\u5291\u91cf\u7bc4\u570d\u7684II\u671f\u7814\u7a76\u3002VIS-101\u9810\u8a08\u5c07\u65bc2026\u5e74\u5177\u5099\u958b\u5c55III\u671f\u8a66\u9a57\u7684\u689d\u4ef6\u3002  \u6b64\u6b21\u6536\u8cfc\u5df2\u901a\u904e\u65b0\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u5b8c\u6210\u3002Visara\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u5236\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u540c\u985e\u6700\u4f73\u7684\u773c\u79d1\u7642\u6cd5\uff0c\u5176\u4f9d\u6258\u65b0\u6a4b\u751f\u7269\u7d043700\u842c\u7f8e\u5143\u7684\u6ce8\u8cc7\uff0c\u4ee5\u53ca\u4e00\u5bb6\u6230\u7565\u5408\u4f5c\u4f19\u4f34\u6240\u8ca2\u737b\u7684\u90e8\u5206\u76f8\u95dc\u6b0a\u76ca\u800c\u6210\u7acb\u3002\u65b0\u6a4b\u751f\u7269\u6210\u70ba Visara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002  Visara\u7531\u5176\u806f\u5408\u5275\u59cb\u4eba\u517c\u57f7\u884c\u8463\u4e8b\u9577Emmett\u00a0J.\u00a0Cunningham,\u00a0Jr.\u535a\u58eb\u9818\u5c0e\u3002Cunningham\u535a\u58eb\u5728\u904e\u53bb25\u5e74\u4e2d\u4e00\u76f4\u662f\u4e00\u4f4d\u91ab\u751f\u3001\u5275\u65b0\u8005\u3001\u4f01\u696d\u5bb6\u548c\u6295\u8cc7\u4eba\uff0c\u66fe\u4efb\u9ed1\u77f3\u96c6\u5718\u9ad8\u7d1a\u8463\u4e8b\u7e3d\u7d93\u7406\u4ee5\u53caClarus\u00a0Ventures\u8463\u4e8b\u7e3d\u7d93\u7406\u3002Cunningham\u535a\u58eb\u4e5f\u662f\u570b\u969b\u516c\u8a8d\u7684\u611f\u67d3\u6027\u548c\u708e\u75c7\u6027\u773c\u75c5\u5c08\u5bb6\uff0c\u5408\u4f5c\u767c\u8868\u4e86\u903e450\u7bc7\u5b78\u8853\u8ad6\u6587\u3002           1\uff1a\u300cAACR\u2013NCI\u2013EORTC \u5206\u5b50\u9776\u9ede\u8207\u764c\u75c7\u6cbb\u7642\u570b\u969b\u6703\u8b70\u300d\uff08AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics\uff09\u4e5f\u88ab\u7a31\u70ba\u300c\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300d\uff0c\u65bc 2025 \u5e74 10 \u6708 22 \u65e5\u81f3 26 \u65e5\u5728\u7f8e\u570b\u99ac\u85a9\u8af8\u585e\u5dde\u6ce2\u58eb\u9813\u8209\u884c\u3002         \u95dc\u65bc\u65b0\u6a4b\u751f\u7269 \u65b0\u6a4b\u751f\u7269\uff08\u66f4\u540d\u524d\u70baI-MAB\uff1b\u7d0d\u65af\u9054\u514b\u4ee3\u78bc\uff1aIMAB\uff0c\u81ea2025\u5e7410\u670830\u65e5\u8d77\u5c07\u66f4\u6539\u70ba\u300cNBP\u300d\uff09\u662f\u4e00\u5bb6\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u7684\u53ef\u53ca\u6027\u3002\u6211\u5011\u5c07\u5c08\u696d\u7684\u696d\u52d9\u62d3\u5c55\u80fd\u529b\u8207\u654f\u6377\u7684\u8f49\u5316\u81e8\u5e8a\u958b\u767c\u76f8\u7d50\u5408\uff0c\u4ee5\u767c\u73fe\u3001\u52a0\u901f\u4e26\u63a8\u9032\u7a81\u7834\u6027\u8cc7\u7522\u3002\u901a\u904e\u929c\u63a5\u79d1\u5b78\u3001\u6230\u7565\u548c\u57f7\u884c\uff0c\u65b0\u6a4b\u751f\u7269\u4f7f\u8b8a\u9769\u6027\u7642\u6cd5\u80fd\u5920\u5f9e\u767c\u73fe\u968e\u6bb5\u5feb\u901f\u63a8\u9032\u81f3\u6709\u9700\u6c42\u7684\u60a3\u8005\u3002 \u516c\u53f8\u7684\u5dee\u7570\u5316\u7ba1\u7dda\u4e3b\u8981\u7531givastomig\u548cVIS-101\u9818\u929c\u3002\u5176\u4e2d\uff0cgivastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff08Claudin 18.2\u00d74-1BB\uff09\uff1bVIS-101\u662f\u4e00\u6b3e\u540c\u985e\u7b2c\u4e8c\u4e14\u6709\u671b\u6210\u70ba\u540c\u985e\u6700\u4f73\u7684\u96d9\u529f\u80fd\u751f\u7269\u5236\u5291\uff0c\u9776\u5411VEGF-A\u548cANG2\u3002 Givastomig\u901a\u904e4-1BB\u4fe1\u865f\u901a\u8def\uff0c\u5728\u8868\u9054Claudin 18.2\u7684\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u689d\u4ef6\u6027\u6fc0\u6d3bT\u7d30\u80de\u3002givastomig\u6b63\u958b\u767c\u7528\u65bc\u6cbb\u7642Claudin 18.2\u967d\u6027\u7684\u80c3\u764c\u53ca\u5176\u4ed6\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u65b0\u6a4b\u751f\u7269\u9084\u8207\u5408\u4f5c\u4f19\u4f34ABL Bio\u5408\u4f5c\u958b\u767cragistomig\uff0c\u9019\u662f\u4e00\u6b3e\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u5728\u5be6\u9ad4\u7624\u4e2d\u5c07PD-L1\u4f5c\u70ba\u816b\u7624\u7d50\u5408\u9776\u9ede\u30014-1BB\u4f5c\u70ba\u689d\u4ef6\u6027T\u7d30\u80de\u6fc0\u6d3b\u5291\u3002\u6b64\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u4e2d\u570b\u4ee5\u5916\u5730\u5340\u7684\u5168\u7403\u6b0a\u76ca\u3002Uliledlimab\u662f\u4e00\u6b3e\u6297CD73\u6297\u9ad4\uff0c\u9776\u5411\u816b\u7624\u4e2d\u7531\u817a\u7518\u4ecb\u5c0e\u7684\u514d\u75ab\u6291\u5236\u3002 VIS-101\u9776\u5411VEGF-A\u548cANG2\uff0c\u53ef\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u5f37\u6709\u529b\u4e14\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u76ee\u524d\u6b63\u5728\u91dd\u5c0d\u6fd5\u6027AMD\u958b\u5c55\u4e00\u9805\u5927\u578b\u3001\u96a8\u6a5f\u3001\u5291\u91cf\u7bc4\u570d\u76842\u671f\u7814\u7a76\u3002\u65b0\u6a4b\u751f\u7269\u662fVisara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002 \u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f\uff1ahttps:\/\/www.novabridge.com\u00a0 \u516c\u53f8\u64ec\u5728\u7d0d\u65af\u9054\u514b\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u96d9\u91cd\u4e0a\u5e02 \u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u64ec\u8d74\u9999\u6e2fIPO\u4e26\u5728\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u4e0a\u5e02\u7684\u66f4\u591a\u4fe1\u606f\u5c07\u65bc\u65e5\u5f8c\u516c\u5e03\u3002 \u64ec\u8b70\u767c\u884c\u7684\u6642\u9593\u3001\u898f\u6a21\u3001\u7d50\u69cb\u548c\u5177\u9ad4\u689d\u6b3e\u5c1a\u672a\u78ba\u5b9a\uff0c\u4ecd\u53d6\u6c7a\u65bc\u5e02\u5834\u72c0\u6cc1\u4ee5\u53ca\u5305\u62ec\u9999\u6e2f\u806f\u4ea4\u6240\uff08\u53ca\u5176\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5728\u5167\u7684\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\u7684\u5be9\u6279\u3002\u5c0d\u65bc\u64ec\u8b70\u7684\u9999\u6e2f\u4e0a\u5e02\u662f\u5426\u6703\u5b8c\u6210\u3001\u4f55\u6642\u5b8c\u6210\u6216\u5c07\u5728\u4f55\u7a2e\u689d\u6b3e\u4e0b\u5b8c\u6210\uff0c\u7121\u6cd5\u63d0\u4f9b\u4efb\u4f55\u4fdd\u8b49\u3002 \u5728\u7372\u5f97\u76e3\u7ba1\u6a5f\u69cb\u548c\u516c\u53f8\u5fc5\u8981\u6279\u51c6\u7684\u524d\u63d0\u4e0b\uff0c\u516c\u53f8\u76ee\u524d\u9810\u8a08\u5c07\u7dad\u6301\u5176\u5728\u7d0d\u65af\u9054\u514b\u7684\u7f8e\u570b\u5b58\u6258\u80a1\uff08ADS\uff09\u4e0a\u5e02\u5730\u4f4d\uff0c\u4e26\u5c0b\u6c42\u5728\u7f8e\u570b\u548c\u9999\u6e2f\u5be6\u73fe\u96d9\u91cd\u4e0a\u5e02\u3002\u6700\u7d42\u6c7a\u5b9a\u5c07\u6839\u64da\u5e02\u5834\u72c0\u6cc1\u548c\u76e3\u7ba1\u53cd\u994b\u4f5c\u51fa\u3002 \u672c\u516c\u544a\u50c5\u70ba\u4fe1\u606f\u62ab\u9732\u4e4b\u7528\uff0c\u4e14\u4e0d\u69cb\u6210\u5c0d\u516c\u53f8\u4efb\u4f55\u8b49\u5238\u7684\u8a8d\u8cfc\u3001\u8cfc\u8cb7\u6216\u6536\u8cfc\u8981\u7d04\u6216\u9080\u8acb\u3002\u516c\u53f8\u80a1\u6771\u53ca\u6f5b\u5728\u6295\u8cc7\u8005\u5728\u6d89\u53ca\u516c\u53f8\u8b49\u5238\u7684\u4ea4\u6613\u6642\uff0c\u61c9\u8b39\u614e\u8a55\u4f30\u76f8\u95dc\u98a8\u96aa\u3002 \u524d\u77bb\u6027\u8072\u660e \u672c\u516c\u544a\u5305\u542b\u524d\u77bb\u6027\u8072\u660e\u3002\u9019\u4e9b\u8072\u660e\u4f9d\u64da1995\u5e74\u7f8e\u570b\u300a\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u7684\u300c\u5b89\u5168\u6e2f\u300d\u689d\u6b3e\u4f5c\u51fa\u3002\u53ef\u4ee5\u901a\u904e\u8853\u8a9e\u4f8b\u5982\u300c\u5c07\u300d\u3001\u300c\u9810\u8a08\u300d\u3001\u300c\u76f8\u4fe1\u300d\u3001\u300c\u65e8\u5728\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u3001\u300c\u6253\u7b97\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u4f30\u8a08\u300d\u3001\u300c\u6709\u4fe1\u5fc3\u300d\u7b49\u4ee5\u53ca\u985e\u4f3c\u8868\u8ff0\uff08\u6216\u5176\u53cd\u7fa9\u8868\u8ff0\uff09\u4f86\u8b58\u5225\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u3002\u65b0\u6a4b\u751f\u7269\u4e5f\u53ef\u80fd\u5728\u5176\u63d0\u4ea4\u7d66\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u7684\u5b9a\u671f\u5831\u544a\u3001\u5411\u80a1\u6771\u767c\u5e03\u7684\u5e74\u5ea6\u5831\u544a\u3001\u65b0\u805e\u7a3f\u53ca\u5176\u4ed6\u66f8\u9762\u6750\u6599\u4e2d\uff0c\u4ee5\u53ca\u516c\u53f8\u9ad8\u7ba1\u3001\u8463\u4e8b\u6216\u54e1\u5de5\u5411\u7b2c\u4e09\u65b9\u6240\u4f5c\u7684\u53e3\u982d\u9673\u8ff0\u4e2d\u4f5c\u51fa\u66f8\u9762\u6216\u53e3\u982d\u7684\u524d\u77bb\u6027\u8072\u660e\u3002\u51e1\u4e0d\u5c6c\u65bc\u6b77\u53f2\u4e8b\u5be6\u7684\u9673\u8ff0\uff08\u5305\u62ec\u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u7684\u4fe1\u5ff5\u548c\u9810\u671f\u7684\u9673\u8ff0\uff09\u5747\u70ba\u524d\u77bb\u6027\u8072\u660e\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u7684\u524d\u77bb\u6027\u8072\u660e\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u5167\u5bb9\uff1a\u65b0\u7684\u516c\u53f8\u6230\u7565\u53ef\u80fd\u5e36\u4f86\u7684\u6f5b\u5728\u76ca\u8655\uff1b\u516c\u53f8\u4ee5\u65b0\u540d\u7a31\u548c\u80a1\u7968\u4ee3\u78bc\u5728\u7d0d\u65af\u9054\u514b\u4ea4\u6613\u7684\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u64ec\u63a8\u9032\u9999\u6e2f IPO\uff0c\u9032\u800c\u5be6\u73fe\u64ec\u5728\u7d0d\u65af\u9054\u514b\u5168\u7403\u5e02\u5834\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\u7684\u8a08\u5283\uff1bgivastomig\u3001VIS-101\u53ca\u516c\u53f8\u5176\u4ed6\u5019\u9078\u85e5\u7269\u7684\u6230\u7565\u3001\u81e8\u5e8a\u958b\u767c\u3001\u8a08\u5283\u3001\u7d50\u679c\u3001\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\uff08\u5305\u62ec givastomig \u548c VIS-101\uff09\u7684\u6230\u7565\u8207\u81e8\u5e8a\u958b\u767c\uff1b\u9810\u671f\u7684\u81e8\u5e8a\u91cc\u7a0b\u7891\u548c\u7d50\u679c\u53ca\u76f8\u95dc\u6642\u9593\uff1b\u516c\u53f8\u7684\u9810\u671f\u8cc7\u91d1\u53ef\u7dad\u6301\u904b\u71df\u7684\u5468\u671f\u3002\u524d\u77bb\u6027\u8072\u660e\u6d89\u53ca\u7684\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u4e2d\u5305\u542b\u7684\u7d50\u679c\u5b58\u5728\u91cd\u5927\u5dee\u7570\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u56e0\u7d20\uff1a\u65b0\u6a4b\u751f\u7269\u8b49\u660e\u5176\u5019\u9078\u85e5\u7269\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7684\u80fd\u529b\uff1b\u516c\u53f8\u7372\u5f97\u8b49\u5238\u76e3\u7ba1\u6a5f\u69cb\u53ca\u4ea4\u6613\u6240\u5fc5\u8981\u6279\u51c6\u7684\u80fd\u529b\uff1b\u5019\u9078\u85e5\u7269\u7684\u81e8\u5e8a\u7d50\u679c\uff08\u53ef\u80fd\u652f\u6301\u4e5f\u53ef\u80fd\u4e0d\u652f\u6301\u9032\u4e00\u6b65\u958b\u767c\u6216\u65b0\u85e5\u7533\u8acb\/\u751f\u7269\u5236\u54c1\u8a31\u53ef\u7533\u8acb\uff08NDA\/BLA\uff09\u7684\u6279\u51c6\uff09\uff1b\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\uff08\u5305\u62ec\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\u4ee5\u53ca\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5c31\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\u76e3\u7ba1\u5be9\u6279\u6240\u4f5c\u6c7a\u5b9a\u7684\u5167\u5bb9\u548c\u6642\u9593\uff1b\u65b0\u6a4b\u751f\u7269\u5728\u5019\u9078\u85e5\u7269\u7372\u6279\u5f8c\u7684\u5546\u696d\u6210\u529f\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u4e26\u7dad\u8b77\u5176\u6280\u8853\u548c\u85e5\u7269\u77e5\u8b58\u7522\u6b0a\u4fdd\u8b77\u7684\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u5c0d\u7b2c\u4e09\u65b9\u958b\u5c55\u85e5\u7269\u958b\u767c\u3001\u751f\u7522\u5236\u9020\u53ca\u5176\u4ed6\u670d\u52d9\u7684\u4f9d\u8cf4\uff1b\u65b0\u6a4b\u751f\u7269\u6709\u9650\u7684\u904b\u71df\u6b77\u53f2\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u984d\u5916\u904b\u71df\u8cc7\u91d1\u4e26\u5b8c\u6210\u5176\u5019\u9078\u85e5\u7269\u958b\u767c\u548c\u5546\u696d\u5316\u7684\u80fd\u529b\uff1b\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u5df2\u65bc2025\u5e744\u67083\u65e5\u5411\u7f8e\u570bSEC\u63d0\u4ea4\u768420-F\u5e74\u5ea6\u5831\u544a\u4e2d\u300c\u98a8\u96aa\u56e0\u7d20\u300d\u90e8\u5206\u66f4\u5168\u9762\u8a0e\u8ad6\u7684\u98a8\u96aa\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u96a8\u5f8c\u5411SEC\u63d0\u4ea4\u7684\u6587\u4ef6\u4e2d\u8a0e\u8ad6\u7684\u6f5b\u5728\u98a8\u96aa\u3001\u4e0d\u78ba\u5b9a\u6027\u548c\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u3002\u6240\u6709\u524d\u77bb\u6027\u8072\u660e\u5747\u57fa\u65bc\u65b0\u6a4b\u751f\u7269\u7576\u524d\u53ef\u7372\u5f97\u7684\u4fe1\u606f\u3002\u9664\u6cd5\u5f8b\u8981\u6c42\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u4e0d\u627f\u64d4\u56e0\u7372\u5f97\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u6216\u4fee\u8a02\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u7684\u7fa9\u52d9\u3002 \u65b0\u6a4b\u751f\u7269\u6295\u8cc7\u8005\u53ca\u5a92\u9ad4\u806f\u7e6b\u4ebaPJ Kelleher \u2013 LifeSci Advisors+1-617-430-7579pkelleher@lifesciadvisors.com \u96f7\u9cf4\uff08Kyler Lei\uff09\u2013 \u65b0\u6a4b\u751f\u7269+1-240-745-6330kyler.lei@imabbio.comIR@imabbio.com\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pingtungtimes.com.tw\/?p=376800\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"og:description\" content=\"\u5168\u65b0\u4f01\u696d\u54c1\u724c\u6a19\u8a8c\u8457\u516c\u53f8\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u7684\u6230\u7565\u8f49\u578b\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002  \u516c\u53f8\u64ec\u5728\u9999\u6e2f\u9032\u884c\u9996\u6b21\u516c\u958b\u52df\u80a1\uff08IPO\uff09\uff0c\u4e26\u901a\u904e\u5728\u7f8e\u570b\u7d0d\u65af\u9054\u514b\uff08NASDAQ\uff09\u548c\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\uff0c\u64f4\u5927\u5c0d\u5168\u7403\u8cc7\u672c\u548c\u5275\u65b0\u8cc7\u6e90\u7684\u93c8\u63a5\u3002  \u57fa\u65bc\u5168\u65b0\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u696d\u52d9\u6a21\u5f0f\uff0c\u516c\u53f8\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara Inc. (Visara)\uff0c\u4e26\u5df2\u6536\u8cfc\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50VIS-101\uff08\u9776\u5411 VEGF-A\/ANG2\uff09\u3002\u76f8\u8f03\u73fe\u884c\u6a19\u6e96\u7642\u6cd5\uff0cVIS-101\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u3001\u66f4\u6709\u6548\u7684\u6cbb\u7642\u9078\u64c7\u3002  \u516c\u53f8\u6838\u5fc3\u8cc7\u7522givastomig\uff08\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff09\uff0c\u6b63\u6309\u7167\u6b64\u524d\u516c\u5e03\u7684\u6295\u8cc7\u8a08\u5283\u6301\u7e8c\u63a8\u9032\u7814\u767c\u3002  \u99ac\u91cc\u862d\u5dde\u7f85\u514b\u7dad\u723e2025\u5e7410\u670829\u65e5 \/\u7f8e\u901a\u793e\/ -- \u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff0c\u4e0b\u7a31\u300c\u65b0\u6a4b\u751f\u7269\u300d\u6216\u300c\u516c\u53f8\u300d\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u516c\u53f8\u5df2\u5b8c\u6210\u540d\u7a31\u8b8a\u66f4\uff0c\u7531\u300cI-Mab\u300d\u6b63\u5f0f\u66f4\u540d\u70ba\u300c\u65b0\u6a4b\u751f\u7269\u300d\u3002\u6b64\u9805\u66f4\u540d\u6c7a\u8b70\u5df2\u7372\u5f97\u516c\u53f8\u65bc2025\u5e7410\u670824\u65e5\u53ec\u958b\u7684\u7279\u5225\u80a1\u6771\u5927\u6703\u9ad8\u7968\u901a\u904e\uff0c\u4e26\u7372\u8463\u4e8b\u6703\u6279\u51c6\u3002\u81ea2025\u5e7410\u670830\u65e5\u958b\u76e4\u8d77\uff0c\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u5c07\u6b63\u5f0f\u555f\u7528\u65b0\u516c\u53f8\u540d\u7a31\u53ca\u65b0\u80a1\u7968\u4ee3\u78bc\u300cNBP\u300d\uff08Nasdaq: NBP\uff09\uff0c\u53d6\u4ee3\u73fe\u6709\u4ee3\u78bc\u300cIMAB\u300d\uff08Nasdaq: IMAB\uff09\u3002 \u516c\u53f8\u540c\u6b65\u4e0a\u7dda\u5168\u65b0\u54c1\u724c\u53ca\u5b98\u7db2\uff08www.novabridge.com\uff09\uff0c\u6a19\u8a8c\u8457\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u6230\u7565\u8f49\u578b\u9081\u51fa\u95dc\u9375\u4e00\u6b65\uff0c\u6301\u7e8c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u7642\u6cd5\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002 \u95dc\u65bc\u6b64\u6b21\u540d\u7a31\u53ca\u80a1\u7968\u4ee3\u78bc\u8b8a\u66f4\uff0c\u73fe\u6709\u80a1\u6771\u7121\u9700\u9032\u884c\u4efb\u4f55\u884c\u52d5\uff0c\u516c\u53f8CUSIP\u865f\u78bc\u5c07\u4fdd\u6301\u4e0d\u8b8a\u3002\u5728\u90e8\u5206\u7b2c\u4e09\u65b9\u7db2\u7ad9\u6216\u61c9\u7528\u7a0b\u5e8f\u4e0a\uff0c\u82e5\u641c\u7d22\u300cNovaBridge Biosciences\u300d\u6216\u300cNBP\u300d\u6642\uff0c\u53ef\u80fd\u66ab\u6642\u7121\u6cd5\u67e5\u8a62\u5230\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u57282025\u5e7410\u670830\u65e5\u4e4b\u524d\u7684\u6b77\u53f2\u4ea4\u6613\u6578\u64da\u3002\u5982\u9047\u6b64\u7a2e\u60c5\u6cc1\uff0c\u76f8\u95dc\u6578\u64da\u53ef\u66ab\u6642\u901a\u904e\u641c\u7d22\u300cI-MAB\u300d\u6216\u300cIMAB\u300d\u9032\u884c\u67e5\u8a62\u3002 \u65b0\u6a4b\u751f\u7269Logo - \u76f8\u9023\u7684\u5206\u5b50\u7d50\u69cb\u7d44\u5408\u6210\u5b57\u6bcd\u300cN\u300d\uff0c\u5bd3\u610f\u516c\u53f8\u8207\u5408\u4f5c\u4f19\u4f34\u651c\u624b\u5171\u5efa\u66f4\u5065\u5eb7\u672a\u4f86\uff1b\u958b\u653e\u7684\u5713\u74b0\u8c61\u5fb5\u6301\u7e8c\u5275\u65b0\u8207\u63a2\u7d22\u7cbe\u795e\u3002 \u65b0\u6a4b\u751f\u7269\u57f7\u884c\u8463\u4e8b\u9577\u5085\u552f\u5148\u751f\u8868\u793a\uff1a\u300c\u5168\u65b0\u7684\u4f01\u696d\u54c1\u724c\u5f62\u8c61\u751f\u52d5\u9ad4\u73fe\u4e86\u6211\u5011\u65b0\u7684\u6230\u7565\u6838\u5fc3\u2014\u2014\u901a\u904e\u9ad8\u6548\u5354\u4f5c\u3001\u79d1\u5b78\u8f49\u5316\u8207\u5353\u8d8a\u57f7\u884c\uff0c\u52a0\u901f\u63a8\u9032\u8b8a\u9769\u6027\u7642\u6cd5\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u66f4\u5927\u50f9\u503c\u3002\u7f8e\u6e2f\u5169\u5730\u96d9\u91cd\u4e0a\u5e02\u662f\u516c\u53f8\u5168\u7403\u5316\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\uff0c\u9019\u5c07\u5e6b\u52a9\u6211\u5011\u62d3\u5bec\u6295\u8cc7\u8005\u7bc4\u570d\u3001\u63d0\u5347\u4ea4\u6613\u6d41\u52d5\u6027\u548c\u8cc7\u672c\u93c8\u63a5\u80fd\u529b\uff0c\u4e26\u5f37\u5316\u5728\u5feb\u901f\u589e\u9577\u7684\u4e9e\u6d32\u5e02\u5834\u7684\u5f71\u97ff\u529b\u3002\u300d \u65b0\u6a4b\u751f\u7269\u9996\u5e2d\u57f7\u884c\u5b98\u5085\u5e0c\u6e67\u535a\u58eb\u8868\u793a\uff1a\u300c\u65b0\u54c1\u724c\u5f62\u8c61\u8207\u6211\u5011\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u8f49\u578b\u7684\u6230\u7565\u9ad8\u5ea6\u4e00\u81f4\u3002\u8fd1\u671f\uff0c\u5728\u91dd\u5c0dgivastomig\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u80c3\u764c\u6cbb\u7642\u9818\u57df\u7684\u540c\u985e\u6700\u4f73 Claudin 18.2 \u9776\u5411\u7642\u6cd5\uff09\u7684\u300e\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300f\u4e0a\uff0c\u516c\u5e03\u4e86\u4ee4\u4eba\u632f\u596e\u7684I\u671f\u55ae\u85e5\u81e8\u5e8a\u6700\u65b0\u6578\u64da\uff1b\u540c\u6642\uff0c\u6211\u5011\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara \uff0c\u53ca\u5176\u8fd1\u671f\u6536\u8cfc\u7684 VIS\u2011101\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u4e0b\u4e00\u4ee3\u540c\u985e\u6700\u4f73\u7684\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff09\uff0c\u9032\u4e00\u6b65\u9a57\u8b49\u4e86\u65b0\u6230\u7565\u7684\u53ef\u884c\u6027\u3002\u6211\u5011\u6b63\u7a4d\u6975\u63a8\u9032 givastomig \u5168\u7403\u96a8\u6a5f\u5c0d\u7167 II \u671f\u7814\u7a76\uff0c\u9810\u8a08\u65bc\u202f2026\u202f\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5b8c\u6210\u9996\u4f8b\u60a3\u8005\u5165\u7d44\u3002\u6191\u501f\u65b0\u54c1\u724c\u5e36\u4f86\u7684\u7a4d\u6975\u52e2\u982d\uff0c\u5145\u5206\u91cb\u653e\u5275\u65b0\u85e5\u7269\u7684\u6f5b\u529b\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u50f9\u503c\u3002\u300d \u65b0\u6a4b\u751f\u7269\u7684\u5546\u696d\u6a21\u5f0f\u8207\u7522\u54c1\u7ba1\u7dda\u5e03\u5c40 \u516c\u53f8\u5c07\u8207\u5168\u7403\u9818\u5148\u5275\u65b0\u8005\u5408\u4f5c\uff0c\u7504\u9078\u4e26\u52a0\u901f\u9ad8\u6f5b\u529b\u85e5\u7269\u8cc7\u7522\u3002\u8a72\u6a21\u5f0f\u878d\u5408\u56b4\u8b39\u7684\u8cc7\u7522\u7504\u9078\u3001\u5b9a\u5236\u5316\u7684\u8f49\u5316\u7b56\u7565\u53ca\u9ad8\u6548\u81e8\u5e8a\u57f7\u884c\uff0c\u4e26\u4f9d\u6258\u5eb7\u6a4b\u8cc7\u672c\u6df1\u539a\u8cc7\u6e90\u8207\u5168\u7403\u80fd\u529b\uff0c\u5728\u591a\u6cbb\u7642\u9818\u57df\u63a8\u9032\u6700\u5177\u6f5b\u529b\u7684\u5275\u65b0\u85e5\u3002 \u516c\u53f8\u5c07\u63a1\u7528\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u6a21\u5f0f\uff0c\u901a\u904e\u8a2d\u7acb\u5c08\u6ce8\u7279\u5b9a\u6cbb\u7642\u9818\u57df\u6216\u8cc7\u7522\u7684\u885b\u661f\u5b50\u516c\u53f8\uff0c\u4fdd\u6301\u9ad8\u6548\u9748\u6d3b\u7684\u904b\u71df\u7d50\u69cb\uff0c\u5f9e\u800c\u5be6\u73fe\u98a8\u96aa\u53ef\u63a7\u8207\u50f9\u503c\u6700\u5927\u5316\u3002 \u7ba1\u7dda\u6982\u89bd   Givastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u76ee\u524d\u6b63\u5728\u958b\u5c551b\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u65e8\u5728\u7528\u65bc\u6cbb\u7642\u80c3\u764c\u53ca\u5176\u4ed6Claudin\u00a018.2\u967d\u6027\u7684\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u8a08\u5283\u555f\u52d5\u4e00\u9805\u5168\u7403\u96a8\u6a5f\u5c0d\u7167\u7684II\u671f\u7814\u7a76\uff0c\u76ee\u6a19\u65bc2026\u5e74\u7b2c\u4e00\u5b63\u5ea6\u62db\u52df\u9996\u4f4d\u60a3\u8005\u3002Givastomig\u6b63\u901a\u904e\u8207ABL\u00a0Bio\u7684\u5168\u7403\u5408\u4f5c\u9032\u884c\u806f\u5408\u958b\u767c\uff0c\u5176\u4e2d\u65b0\u6a4b\u751f\u7269\u4f5c\u70ba\u727d\u982d\u65b9\uff0c\u8207ABL\u00a0Bio\u5e73\u5206\u5168\u7403\u6b0a\u76ca\uff08\u5927\u4e2d\u83ef\u5340\u548c\u97d3\u570b\u9664\u5916\uff09\u3002  Ragistomig\u662f\u4e00\u6b3e\u6297PD-L1\u00d74-1BB\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\u3002\u57fa\u65bc\u4e00\u671f\u81e8\u5e8a\u6578\u64da\uff0c\u76ee\u524d\u958b\u5c55\u76841b\u671f\u7814\u7a76\u65e8\u5728\u64f4\u5927\u6cbb\u7642\u7a97\u53e3\uff0c\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u7522\u751f\u7d50\u679c\u3002\u8a72\u9805\u76ee\u6b63\u8207ABL Bio\u806f\u5408\u958b\u767c\u3002  Uliledlimab\uff08\u6297CD73\u55ae\u6297\uff09\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\uff0cCD73\u662f\u817a\u7518\u4ecb\u5c0e\u514d\u75ab\u6291\u5236\u7684\u9650\u901f\u9176\u3002\u76ee\u524d\u6b63\u5728\u958b\u5c55\u7684\u96a8\u6a5fII\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\uff0c\u5c07uliledlimab\u806f\u5408\u7279\u745e\u666e\u5229\u55ae\u6297\uff08toripalimab\uff09\u7684\u65b9\u6848\u8207\u5e15\u535a\u5229\u73e0\u55ae\u6297\uff08Pembrolizumab\uff09\u55ae\u85e5\u6216\u7279\u745e\u666e\u5229\u55ae\u6297\u55ae\u85e5\u5728\u7d93CD73\u7be9\u9078\u7684\u60a3\u8005\u4eba\u7fa4\u4e2d\u9032\u884c\u5c0d\u6bd4\uff0c\u5176\u7121\u9032\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u6578\u64da\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u516c\u5e03\u3002\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u5927\u4e2d\u83ef\u5340\u4ee5\u5916\u7684\u5168\u7403\u6b0a\u76ca\u3002  VIS-101\u7531\u65b0\u6a4b\u751f\u7269\u5728\u65b0\u5546\u696d\u6a21\u5f0f\u4e0b\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u6536\u8cfc\uff0c\u662f\u4e00\u6b3e\u9776\u5411VEGF-A\u548cANG2\u7684\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u76ee\u524d\u8655\u65bcII\u671f\u958b\u767c\u968e\u6bb5\u3002   VIS-101\u662f\u4e00\u6b3e\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff0c\u4e14\u5206\u5b50\u6d3b\u6027\u66f4\u5f37\uff0c\u76f8\u8f03\u65bc\u73fe\u6709\u6a19\u6e96\u7642\u6cd5\uff0c\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u3001\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u548c\u8996\u7db2\u819c\u975c\u8108\u963b\u585e\uff08RVO\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5b8c\u6210\u4e86\u521d\u6b65\u7684\u5b89\u5168\u6027\u548c\u5291\u91cf\u905e\u589e\u7814\u7a76\uff0c\u76ee\u524d\u6b63\u5728\u4e2d\u570b\u5b8c\u6210\u4e00\u9805\u96a8\u6a5f\u5291\u91cf\u7bc4\u570d\u7684II\u671f\u7814\u7a76\u3002VIS-101\u9810\u8a08\u5c07\u65bc2026\u5e74\u5177\u5099\u958b\u5c55III\u671f\u8a66\u9a57\u7684\u689d\u4ef6\u3002  \u6b64\u6b21\u6536\u8cfc\u5df2\u901a\u904e\u65b0\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u5b8c\u6210\u3002Visara\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u5236\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u540c\u985e\u6700\u4f73\u7684\u773c\u79d1\u7642\u6cd5\uff0c\u5176\u4f9d\u6258\u65b0\u6a4b\u751f\u7269\u7d043700\u842c\u7f8e\u5143\u7684\u6ce8\u8cc7\uff0c\u4ee5\u53ca\u4e00\u5bb6\u6230\u7565\u5408\u4f5c\u4f19\u4f34\u6240\u8ca2\u737b\u7684\u90e8\u5206\u76f8\u95dc\u6b0a\u76ca\u800c\u6210\u7acb\u3002\u65b0\u6a4b\u751f\u7269\u6210\u70ba Visara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002  Visara\u7531\u5176\u806f\u5408\u5275\u59cb\u4eba\u517c\u57f7\u884c\u8463\u4e8b\u9577Emmett\u00a0J.\u00a0Cunningham,\u00a0Jr.\u535a\u58eb\u9818\u5c0e\u3002Cunningham\u535a\u58eb\u5728\u904e\u53bb25\u5e74\u4e2d\u4e00\u76f4\u662f\u4e00\u4f4d\u91ab\u751f\u3001\u5275\u65b0\u8005\u3001\u4f01\u696d\u5bb6\u548c\u6295\u8cc7\u4eba\uff0c\u66fe\u4efb\u9ed1\u77f3\u96c6\u5718\u9ad8\u7d1a\u8463\u4e8b\u7e3d\u7d93\u7406\u4ee5\u53caClarus\u00a0Ventures\u8463\u4e8b\u7e3d\u7d93\u7406\u3002Cunningham\u535a\u58eb\u4e5f\u662f\u570b\u969b\u516c\u8a8d\u7684\u611f\u67d3\u6027\u548c\u708e\u75c7\u6027\u773c\u75c5\u5c08\u5bb6\uff0c\u5408\u4f5c\u767c\u8868\u4e86\u903e450\u7bc7\u5b78\u8853\u8ad6\u6587\u3002           1\uff1a\u300cAACR\u2013NCI\u2013EORTC \u5206\u5b50\u9776\u9ede\u8207\u764c\u75c7\u6cbb\u7642\u570b\u969b\u6703\u8b70\u300d\uff08AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics\uff09\u4e5f\u88ab\u7a31\u70ba\u300c\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300d\uff0c\u65bc 2025 \u5e74 10 \u6708 22 \u65e5\u81f3 26 \u65e5\u5728\u7f8e\u570b\u99ac\u85a9\u8af8\u585e\u5dde\u6ce2\u58eb\u9813\u8209\u884c\u3002         \u95dc\u65bc\u65b0\u6a4b\u751f\u7269 \u65b0\u6a4b\u751f\u7269\uff08\u66f4\u540d\u524d\u70baI-MAB\uff1b\u7d0d\u65af\u9054\u514b\u4ee3\u78bc\uff1aIMAB\uff0c\u81ea2025\u5e7410\u670830\u65e5\u8d77\u5c07\u66f4\u6539\u70ba\u300cNBP\u300d\uff09\u662f\u4e00\u5bb6\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u7684\u53ef\u53ca\u6027\u3002\u6211\u5011\u5c07\u5c08\u696d\u7684\u696d\u52d9\u62d3\u5c55\u80fd\u529b\u8207\u654f\u6377\u7684\u8f49\u5316\u81e8\u5e8a\u958b\u767c\u76f8\u7d50\u5408\uff0c\u4ee5\u767c\u73fe\u3001\u52a0\u901f\u4e26\u63a8\u9032\u7a81\u7834\u6027\u8cc7\u7522\u3002\u901a\u904e\u929c\u63a5\u79d1\u5b78\u3001\u6230\u7565\u548c\u57f7\u884c\uff0c\u65b0\u6a4b\u751f\u7269\u4f7f\u8b8a\u9769\u6027\u7642\u6cd5\u80fd\u5920\u5f9e\u767c\u73fe\u968e\u6bb5\u5feb\u901f\u63a8\u9032\u81f3\u6709\u9700\u6c42\u7684\u60a3\u8005\u3002 \u516c\u53f8\u7684\u5dee\u7570\u5316\u7ba1\u7dda\u4e3b\u8981\u7531givastomig\u548cVIS-101\u9818\u929c\u3002\u5176\u4e2d\uff0cgivastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff08Claudin 18.2\u00d74-1BB\uff09\uff1bVIS-101\u662f\u4e00\u6b3e\u540c\u985e\u7b2c\u4e8c\u4e14\u6709\u671b\u6210\u70ba\u540c\u985e\u6700\u4f73\u7684\u96d9\u529f\u80fd\u751f\u7269\u5236\u5291\uff0c\u9776\u5411VEGF-A\u548cANG2\u3002 Givastomig\u901a\u904e4-1BB\u4fe1\u865f\u901a\u8def\uff0c\u5728\u8868\u9054Claudin 18.2\u7684\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u689d\u4ef6\u6027\u6fc0\u6d3bT\u7d30\u80de\u3002givastomig\u6b63\u958b\u767c\u7528\u65bc\u6cbb\u7642Claudin 18.2\u967d\u6027\u7684\u80c3\u764c\u53ca\u5176\u4ed6\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u65b0\u6a4b\u751f\u7269\u9084\u8207\u5408\u4f5c\u4f19\u4f34ABL Bio\u5408\u4f5c\u958b\u767cragistomig\uff0c\u9019\u662f\u4e00\u6b3e\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u5728\u5be6\u9ad4\u7624\u4e2d\u5c07PD-L1\u4f5c\u70ba\u816b\u7624\u7d50\u5408\u9776\u9ede\u30014-1BB\u4f5c\u70ba\u689d\u4ef6\u6027T\u7d30\u80de\u6fc0\u6d3b\u5291\u3002\u6b64\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u4e2d\u570b\u4ee5\u5916\u5730\u5340\u7684\u5168\u7403\u6b0a\u76ca\u3002Uliledlimab\u662f\u4e00\u6b3e\u6297CD73\u6297\u9ad4\uff0c\u9776\u5411\u816b\u7624\u4e2d\u7531\u817a\u7518\u4ecb\u5c0e\u7684\u514d\u75ab\u6291\u5236\u3002 VIS-101\u9776\u5411VEGF-A\u548cANG2\uff0c\u53ef\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u5f37\u6709\u529b\u4e14\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u76ee\u524d\u6b63\u5728\u91dd\u5c0d\u6fd5\u6027AMD\u958b\u5c55\u4e00\u9805\u5927\u578b\u3001\u96a8\u6a5f\u3001\u5291\u91cf\u7bc4\u570d\u76842\u671f\u7814\u7a76\u3002\u65b0\u6a4b\u751f\u7269\u662fVisara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002 \u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f\uff1ahttps:\/\/www.novabridge.com\u00a0 \u516c\u53f8\u64ec\u5728\u7d0d\u65af\u9054\u514b\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u96d9\u91cd\u4e0a\u5e02 \u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u64ec\u8d74\u9999\u6e2fIPO\u4e26\u5728\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u4e0a\u5e02\u7684\u66f4\u591a\u4fe1\u606f\u5c07\u65bc\u65e5\u5f8c\u516c\u5e03\u3002 \u64ec\u8b70\u767c\u884c\u7684\u6642\u9593\u3001\u898f\u6a21\u3001\u7d50\u69cb\u548c\u5177\u9ad4\u689d\u6b3e\u5c1a\u672a\u78ba\u5b9a\uff0c\u4ecd\u53d6\u6c7a\u65bc\u5e02\u5834\u72c0\u6cc1\u4ee5\u53ca\u5305\u62ec\u9999\u6e2f\u806f\u4ea4\u6240\uff08\u53ca\u5176\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5728\u5167\u7684\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\u7684\u5be9\u6279\u3002\u5c0d\u65bc\u64ec\u8b70\u7684\u9999\u6e2f\u4e0a\u5e02\u662f\u5426\u6703\u5b8c\u6210\u3001\u4f55\u6642\u5b8c\u6210\u6216\u5c07\u5728\u4f55\u7a2e\u689d\u6b3e\u4e0b\u5b8c\u6210\uff0c\u7121\u6cd5\u63d0\u4f9b\u4efb\u4f55\u4fdd\u8b49\u3002 \u5728\u7372\u5f97\u76e3\u7ba1\u6a5f\u69cb\u548c\u516c\u53f8\u5fc5\u8981\u6279\u51c6\u7684\u524d\u63d0\u4e0b\uff0c\u516c\u53f8\u76ee\u524d\u9810\u8a08\u5c07\u7dad\u6301\u5176\u5728\u7d0d\u65af\u9054\u514b\u7684\u7f8e\u570b\u5b58\u6258\u80a1\uff08ADS\uff09\u4e0a\u5e02\u5730\u4f4d\uff0c\u4e26\u5c0b\u6c42\u5728\u7f8e\u570b\u548c\u9999\u6e2f\u5be6\u73fe\u96d9\u91cd\u4e0a\u5e02\u3002\u6700\u7d42\u6c7a\u5b9a\u5c07\u6839\u64da\u5e02\u5834\u72c0\u6cc1\u548c\u76e3\u7ba1\u53cd\u994b\u4f5c\u51fa\u3002 \u672c\u516c\u544a\u50c5\u70ba\u4fe1\u606f\u62ab\u9732\u4e4b\u7528\uff0c\u4e14\u4e0d\u69cb\u6210\u5c0d\u516c\u53f8\u4efb\u4f55\u8b49\u5238\u7684\u8a8d\u8cfc\u3001\u8cfc\u8cb7\u6216\u6536\u8cfc\u8981\u7d04\u6216\u9080\u8acb\u3002\u516c\u53f8\u80a1\u6771\u53ca\u6f5b\u5728\u6295\u8cc7\u8005\u5728\u6d89\u53ca\u516c\u53f8\u8b49\u5238\u7684\u4ea4\u6613\u6642\uff0c\u61c9\u8b39\u614e\u8a55\u4f30\u76f8\u95dc\u98a8\u96aa\u3002 \u524d\u77bb\u6027\u8072\u660e \u672c\u516c\u544a\u5305\u542b\u524d\u77bb\u6027\u8072\u660e\u3002\u9019\u4e9b\u8072\u660e\u4f9d\u64da1995\u5e74\u7f8e\u570b\u300a\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u7684\u300c\u5b89\u5168\u6e2f\u300d\u689d\u6b3e\u4f5c\u51fa\u3002\u53ef\u4ee5\u901a\u904e\u8853\u8a9e\u4f8b\u5982\u300c\u5c07\u300d\u3001\u300c\u9810\u8a08\u300d\u3001\u300c\u76f8\u4fe1\u300d\u3001\u300c\u65e8\u5728\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u3001\u300c\u6253\u7b97\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u4f30\u8a08\u300d\u3001\u300c\u6709\u4fe1\u5fc3\u300d\u7b49\u4ee5\u53ca\u985e\u4f3c\u8868\u8ff0\uff08\u6216\u5176\u53cd\u7fa9\u8868\u8ff0\uff09\u4f86\u8b58\u5225\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u3002\u65b0\u6a4b\u751f\u7269\u4e5f\u53ef\u80fd\u5728\u5176\u63d0\u4ea4\u7d66\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u7684\u5b9a\u671f\u5831\u544a\u3001\u5411\u80a1\u6771\u767c\u5e03\u7684\u5e74\u5ea6\u5831\u544a\u3001\u65b0\u805e\u7a3f\u53ca\u5176\u4ed6\u66f8\u9762\u6750\u6599\u4e2d\uff0c\u4ee5\u53ca\u516c\u53f8\u9ad8\u7ba1\u3001\u8463\u4e8b\u6216\u54e1\u5de5\u5411\u7b2c\u4e09\u65b9\u6240\u4f5c\u7684\u53e3\u982d\u9673\u8ff0\u4e2d\u4f5c\u51fa\u66f8\u9762\u6216\u53e3\u982d\u7684\u524d\u77bb\u6027\u8072\u660e\u3002\u51e1\u4e0d\u5c6c\u65bc\u6b77\u53f2\u4e8b\u5be6\u7684\u9673\u8ff0\uff08\u5305\u62ec\u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u7684\u4fe1\u5ff5\u548c\u9810\u671f\u7684\u9673\u8ff0\uff09\u5747\u70ba\u524d\u77bb\u6027\u8072\u660e\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u7684\u524d\u77bb\u6027\u8072\u660e\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u5167\u5bb9\uff1a\u65b0\u7684\u516c\u53f8\u6230\u7565\u53ef\u80fd\u5e36\u4f86\u7684\u6f5b\u5728\u76ca\u8655\uff1b\u516c\u53f8\u4ee5\u65b0\u540d\u7a31\u548c\u80a1\u7968\u4ee3\u78bc\u5728\u7d0d\u65af\u9054\u514b\u4ea4\u6613\u7684\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u64ec\u63a8\u9032\u9999\u6e2f IPO\uff0c\u9032\u800c\u5be6\u73fe\u64ec\u5728\u7d0d\u65af\u9054\u514b\u5168\u7403\u5e02\u5834\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\u7684\u8a08\u5283\uff1bgivastomig\u3001VIS-101\u53ca\u516c\u53f8\u5176\u4ed6\u5019\u9078\u85e5\u7269\u7684\u6230\u7565\u3001\u81e8\u5e8a\u958b\u767c\u3001\u8a08\u5283\u3001\u7d50\u679c\u3001\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\uff08\u5305\u62ec givastomig \u548c VIS-101\uff09\u7684\u6230\u7565\u8207\u81e8\u5e8a\u958b\u767c\uff1b\u9810\u671f\u7684\u81e8\u5e8a\u91cc\u7a0b\u7891\u548c\u7d50\u679c\u53ca\u76f8\u95dc\u6642\u9593\uff1b\u516c\u53f8\u7684\u9810\u671f\u8cc7\u91d1\u53ef\u7dad\u6301\u904b\u71df\u7684\u5468\u671f\u3002\u524d\u77bb\u6027\u8072\u660e\u6d89\u53ca\u7684\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u4e2d\u5305\u542b\u7684\u7d50\u679c\u5b58\u5728\u91cd\u5927\u5dee\u7570\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u56e0\u7d20\uff1a\u65b0\u6a4b\u751f\u7269\u8b49\u660e\u5176\u5019\u9078\u85e5\u7269\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7684\u80fd\u529b\uff1b\u516c\u53f8\u7372\u5f97\u8b49\u5238\u76e3\u7ba1\u6a5f\u69cb\u53ca\u4ea4\u6613\u6240\u5fc5\u8981\u6279\u51c6\u7684\u80fd\u529b\uff1b\u5019\u9078\u85e5\u7269\u7684\u81e8\u5e8a\u7d50\u679c\uff08\u53ef\u80fd\u652f\u6301\u4e5f\u53ef\u80fd\u4e0d\u652f\u6301\u9032\u4e00\u6b65\u958b\u767c\u6216\u65b0\u85e5\u7533\u8acb\/\u751f\u7269\u5236\u54c1\u8a31\u53ef\u7533\u8acb\uff08NDA\/BLA\uff09\u7684\u6279\u51c6\uff09\uff1b\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\uff08\u5305\u62ec\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\u4ee5\u53ca\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5c31\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\u76e3\u7ba1\u5be9\u6279\u6240\u4f5c\u6c7a\u5b9a\u7684\u5167\u5bb9\u548c\u6642\u9593\uff1b\u65b0\u6a4b\u751f\u7269\u5728\u5019\u9078\u85e5\u7269\u7372\u6279\u5f8c\u7684\u5546\u696d\u6210\u529f\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u4e26\u7dad\u8b77\u5176\u6280\u8853\u548c\u85e5\u7269\u77e5\u8b58\u7522\u6b0a\u4fdd\u8b77\u7684\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u5c0d\u7b2c\u4e09\u65b9\u958b\u5c55\u85e5\u7269\u958b\u767c\u3001\u751f\u7522\u5236\u9020\u53ca\u5176\u4ed6\u670d\u52d9\u7684\u4f9d\u8cf4\uff1b\u65b0\u6a4b\u751f\u7269\u6709\u9650\u7684\u904b\u71df\u6b77\u53f2\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u984d\u5916\u904b\u71df\u8cc7\u91d1\u4e26\u5b8c\u6210\u5176\u5019\u9078\u85e5\u7269\u958b\u767c\u548c\u5546\u696d\u5316\u7684\u80fd\u529b\uff1b\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u5df2\u65bc2025\u5e744\u67083\u65e5\u5411\u7f8e\u570bSEC\u63d0\u4ea4\u768420-F\u5e74\u5ea6\u5831\u544a\u4e2d\u300c\u98a8\u96aa\u56e0\u7d20\u300d\u90e8\u5206\u66f4\u5168\u9762\u8a0e\u8ad6\u7684\u98a8\u96aa\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u96a8\u5f8c\u5411SEC\u63d0\u4ea4\u7684\u6587\u4ef6\u4e2d\u8a0e\u8ad6\u7684\u6f5b\u5728\u98a8\u96aa\u3001\u4e0d\u78ba\u5b9a\u6027\u548c\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u3002\u6240\u6709\u524d\u77bb\u6027\u8072\u660e\u5747\u57fa\u65bc\u65b0\u6a4b\u751f\u7269\u7576\u524d\u53ef\u7372\u5f97\u7684\u4fe1\u606f\u3002\u9664\u6cd5\u5f8b\u8981\u6c42\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u4e0d\u627f\u64d4\u56e0\u7372\u5f97\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u6216\u4fee\u8a02\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u7684\u7fa9\u52d9\u3002 \u65b0\u6a4b\u751f\u7269\u6295\u8cc7\u8005\u53ca\u5a92\u9ad4\u806f\u7e6b\u4ebaPJ Kelleher \u2013 LifeSci Advisors+1-617-430-7579pkelleher@lifesciadvisors.com \u96f7\u9cf4\uff08Kyler Lei\uff09\u2013 \u65b0\u6a4b\u751f\u7269+1-240-745-6330kyler.lei@imabbio.comIR@imabbio.com\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pingtungtimes.com.tw\/?p=376800\" \/>\n<meta property=\"og:site_name\" content=\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pingtungnews\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-29T15:09:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1706\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u7f8e\u901a\u793e\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005:\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u7f8e\u901a\u793e\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u4f30\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800\"},\"author\":{\"name\":\"\u7f8e\u901a\u793e\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\"},\"headline\":\"I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002\",\"datePublished\":\"2025-10-29T15:09:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800\"},\"wordCount\":215,\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/image_5053990_46034728.jpg\",\"articleSection\":[\"\u7f8e\u901a\u793e\"],\"inLanguage\":\"zh-TW\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800\",\"name\":\"I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/image_5053990_46034728.jpg\",\"datePublished\":\"2025-10-29T15:09:00+00:00\",\"description\":\"\u5168\u65b0\u4f01\u696d\u54c1\u724c\u6a19\u8a8c\u8457\u516c\u53f8\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u7684\u6230\u7565\u8f49\u578b\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002 \u516c\u53f8\u64ec\u5728\u9999\u6e2f\u9032\u884c\u9996\u6b21\u516c\u958b\u52df\u80a1\uff08IPO\uff09\uff0c\u4e26\u901a\u904e\u5728\u7f8e\u570b\u7d0d\u65af\u9054\u514b\uff08NASDAQ\uff09\u548c\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\uff0c\u64f4\u5927\u5c0d\u5168\u7403\u8cc7\u672c\u548c\u5275\u65b0\u8cc7\u6e90\u7684\u93c8\u63a5\u3002 \u57fa\u65bc\u5168\u65b0\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u696d\u52d9\u6a21\u5f0f\uff0c\u516c\u53f8\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara Inc. (Visara)\uff0c\u4e26\u5df2\u6536\u8cfc\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50VIS-101\uff08\u9776\u5411 VEGF-A\\\/ANG2\uff09\u3002\u76f8\u8f03\u73fe\u884c\u6a19\u6e96\u7642\u6cd5\uff0cVIS-101\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u3001\u66f4\u6709\u6548\u7684\u6cbb\u7642\u9078\u64c7\u3002 \u516c\u53f8\u6838\u5fc3\u8cc7\u7522givastomig\uff08\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff09\uff0c\u6b63\u6309\u7167\u6b64\u524d\u516c\u5e03\u7684\u6295\u8cc7\u8a08\u5283\u6301\u7e8c\u63a8\u9032\u7814\u767c\u3002 \u99ac\u91cc\u862d\u5dde\u7f85\u514b\u7dad\u723e2025\u5e7410\u670829\u65e5 \\\/\u7f8e\u901a\u793e\\\/ -- \u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff0c\u4e0b\u7a31\u300c\u65b0\u6a4b\u751f\u7269\u300d\u6216\u300c\u516c\u53f8\u300d\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u516c\u53f8\u5df2\u5b8c\u6210\u540d\u7a31\u8b8a\u66f4\uff0c\u7531\u300cI-Mab\u300d\u6b63\u5f0f\u66f4\u540d\u70ba\u300c\u65b0\u6a4b\u751f\u7269\u300d\u3002\u6b64\u9805\u66f4\u540d\u6c7a\u8b70\u5df2\u7372\u5f97\u516c\u53f8\u65bc2025\u5e7410\u670824\u65e5\u53ec\u958b\u7684\u7279\u5225\u80a1\u6771\u5927\u6703\u9ad8\u7968\u901a\u904e\uff0c\u4e26\u7372\u8463\u4e8b\u6703\u6279\u51c6\u3002\u81ea2025\u5e7410\u670830\u65e5\u958b\u76e4\u8d77\uff0c\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u5c07\u6b63\u5f0f\u555f\u7528\u65b0\u516c\u53f8\u540d\u7a31\u53ca\u65b0\u80a1\u7968\u4ee3\u78bc\u300cNBP\u300d\uff08Nasdaq: NBP\uff09\uff0c\u53d6\u4ee3\u73fe\u6709\u4ee3\u78bc\u300cIMAB\u300d\uff08Nasdaq: IMAB\uff09\u3002 \u516c\u53f8\u540c\u6b65\u4e0a\u7dda\u5168\u65b0\u54c1\u724c\u53ca\u5b98\u7db2\uff08www.novabridge.com\uff09\uff0c\u6a19\u8a8c\u8457\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u6230\u7565\u8f49\u578b\u9081\u51fa\u95dc\u9375\u4e00\u6b65\uff0c\u6301\u7e8c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u7642\u6cd5\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002 \u95dc\u65bc\u6b64\u6b21\u540d\u7a31\u53ca\u80a1\u7968\u4ee3\u78bc\u8b8a\u66f4\uff0c\u73fe\u6709\u80a1\u6771\u7121\u9700\u9032\u884c\u4efb\u4f55\u884c\u52d5\uff0c\u516c\u53f8CUSIP\u865f\u78bc\u5c07\u4fdd\u6301\u4e0d\u8b8a\u3002\u5728\u90e8\u5206\u7b2c\u4e09\u65b9\u7db2\u7ad9\u6216\u61c9\u7528\u7a0b\u5e8f\u4e0a\uff0c\u82e5\u641c\u7d22\u300cNovaBridge Biosciences\u300d\u6216\u300cNBP\u300d\u6642\uff0c\u53ef\u80fd\u66ab\u6642\u7121\u6cd5\u67e5\u8a62\u5230\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u57282025\u5e7410\u670830\u65e5\u4e4b\u524d\u7684\u6b77\u53f2\u4ea4\u6613\u6578\u64da\u3002\u5982\u9047\u6b64\u7a2e\u60c5\u6cc1\uff0c\u76f8\u95dc\u6578\u64da\u53ef\u66ab\u6642\u901a\u904e\u641c\u7d22\u300cI-MAB\u300d\u6216\u300cIMAB\u300d\u9032\u884c\u67e5\u8a62\u3002 \u65b0\u6a4b\u751f\u7269Logo - \u76f8\u9023\u7684\u5206\u5b50\u7d50\u69cb\u7d44\u5408\u6210\u5b57\u6bcd\u300cN\u300d\uff0c\u5bd3\u610f\u516c\u53f8\u8207\u5408\u4f5c\u4f19\u4f34\u651c\u624b\u5171\u5efa\u66f4\u5065\u5eb7\u672a\u4f86\uff1b\u958b\u653e\u7684\u5713\u74b0\u8c61\u5fb5\u6301\u7e8c\u5275\u65b0\u8207\u63a2\u7d22\u7cbe\u795e\u3002 \u65b0\u6a4b\u751f\u7269\u57f7\u884c\u8463\u4e8b\u9577\u5085\u552f\u5148\u751f\u8868\u793a\uff1a\u300c\u5168\u65b0\u7684\u4f01\u696d\u54c1\u724c\u5f62\u8c61\u751f\u52d5\u9ad4\u73fe\u4e86\u6211\u5011\u65b0\u7684\u6230\u7565\u6838\u5fc3\u2014\u2014\u901a\u904e\u9ad8\u6548\u5354\u4f5c\u3001\u79d1\u5b78\u8f49\u5316\u8207\u5353\u8d8a\u57f7\u884c\uff0c\u52a0\u901f\u63a8\u9032\u8b8a\u9769\u6027\u7642\u6cd5\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u66f4\u5927\u50f9\u503c\u3002\u7f8e\u6e2f\u5169\u5730\u96d9\u91cd\u4e0a\u5e02\u662f\u516c\u53f8\u5168\u7403\u5316\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\uff0c\u9019\u5c07\u5e6b\u52a9\u6211\u5011\u62d3\u5bec\u6295\u8cc7\u8005\u7bc4\u570d\u3001\u63d0\u5347\u4ea4\u6613\u6d41\u52d5\u6027\u548c\u8cc7\u672c\u93c8\u63a5\u80fd\u529b\uff0c\u4e26\u5f37\u5316\u5728\u5feb\u901f\u589e\u9577\u7684\u4e9e\u6d32\u5e02\u5834\u7684\u5f71\u97ff\u529b\u3002\u300d \u65b0\u6a4b\u751f\u7269\u9996\u5e2d\u57f7\u884c\u5b98\u5085\u5e0c\u6e67\u535a\u58eb\u8868\u793a\uff1a\u300c\u65b0\u54c1\u724c\u5f62\u8c61\u8207\u6211\u5011\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u8f49\u578b\u7684\u6230\u7565\u9ad8\u5ea6\u4e00\u81f4\u3002\u8fd1\u671f\uff0c\u5728\u91dd\u5c0dgivastomig\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u80c3\u764c\u6cbb\u7642\u9818\u57df\u7684\u540c\u985e\u6700\u4f73 Claudin 18.2 \u9776\u5411\u7642\u6cd5\uff09\u7684\u300e\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300f\u4e0a\uff0c\u516c\u5e03\u4e86\u4ee4\u4eba\u632f\u596e\u7684I\u671f\u55ae\u85e5\u81e8\u5e8a\u6700\u65b0\u6578\u64da\uff1b\u540c\u6642\uff0c\u6211\u5011\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara \uff0c\u53ca\u5176\u8fd1\u671f\u6536\u8cfc\u7684 VIS\u2011101\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u4e0b\u4e00\u4ee3\u540c\u985e\u6700\u4f73\u7684\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff09\uff0c\u9032\u4e00\u6b65\u9a57\u8b49\u4e86\u65b0\u6230\u7565\u7684\u53ef\u884c\u6027\u3002\u6211\u5011\u6b63\u7a4d\u6975\u63a8\u9032 givastomig \u5168\u7403\u96a8\u6a5f\u5c0d\u7167 II \u671f\u7814\u7a76\uff0c\u9810\u8a08\u65bc\u202f2026\u202f\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5b8c\u6210\u9996\u4f8b\u60a3\u8005\u5165\u7d44\u3002\u6191\u501f\u65b0\u54c1\u724c\u5e36\u4f86\u7684\u7a4d\u6975\u52e2\u982d\uff0c\u5145\u5206\u91cb\u653e\u5275\u65b0\u85e5\u7269\u7684\u6f5b\u529b\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u50f9\u503c\u3002\u300d \u65b0\u6a4b\u751f\u7269\u7684\u5546\u696d\u6a21\u5f0f\u8207\u7522\u54c1\u7ba1\u7dda\u5e03\u5c40 \u516c\u53f8\u5c07\u8207\u5168\u7403\u9818\u5148\u5275\u65b0\u8005\u5408\u4f5c\uff0c\u7504\u9078\u4e26\u52a0\u901f\u9ad8\u6f5b\u529b\u85e5\u7269\u8cc7\u7522\u3002\u8a72\u6a21\u5f0f\u878d\u5408\u56b4\u8b39\u7684\u8cc7\u7522\u7504\u9078\u3001\u5b9a\u5236\u5316\u7684\u8f49\u5316\u7b56\u7565\u53ca\u9ad8\u6548\u81e8\u5e8a\u57f7\u884c\uff0c\u4e26\u4f9d\u6258\u5eb7\u6a4b\u8cc7\u672c\u6df1\u539a\u8cc7\u6e90\u8207\u5168\u7403\u80fd\u529b\uff0c\u5728\u591a\u6cbb\u7642\u9818\u57df\u63a8\u9032\u6700\u5177\u6f5b\u529b\u7684\u5275\u65b0\u85e5\u3002 \u516c\u53f8\u5c07\u63a1\u7528\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u6a21\u5f0f\uff0c\u901a\u904e\u8a2d\u7acb\u5c08\u6ce8\u7279\u5b9a\u6cbb\u7642\u9818\u57df\u6216\u8cc7\u7522\u7684\u885b\u661f\u5b50\u516c\u53f8\uff0c\u4fdd\u6301\u9ad8\u6548\u9748\u6d3b\u7684\u904b\u71df\u7d50\u69cb\uff0c\u5f9e\u800c\u5be6\u73fe\u98a8\u96aa\u53ef\u63a7\u8207\u50f9\u503c\u6700\u5927\u5316\u3002 \u7ba1\u7dda\u6982\u89bd Givastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u76ee\u524d\u6b63\u5728\u958b\u5c551b\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u65e8\u5728\u7528\u65bc\u6cbb\u7642\u80c3\u764c\u53ca\u5176\u4ed6Claudin\u00a018.2\u967d\u6027\u7684\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u8a08\u5283\u555f\u52d5\u4e00\u9805\u5168\u7403\u96a8\u6a5f\u5c0d\u7167\u7684II\u671f\u7814\u7a76\uff0c\u76ee\u6a19\u65bc2026\u5e74\u7b2c\u4e00\u5b63\u5ea6\u62db\u52df\u9996\u4f4d\u60a3\u8005\u3002Givastomig\u6b63\u901a\u904e\u8207ABL\u00a0Bio\u7684\u5168\u7403\u5408\u4f5c\u9032\u884c\u806f\u5408\u958b\u767c\uff0c\u5176\u4e2d\u65b0\u6a4b\u751f\u7269\u4f5c\u70ba\u727d\u982d\u65b9\uff0c\u8207ABL\u00a0Bio\u5e73\u5206\u5168\u7403\u6b0a\u76ca\uff08\u5927\u4e2d\u83ef\u5340\u548c\u97d3\u570b\u9664\u5916\uff09\u3002 Ragistomig\u662f\u4e00\u6b3e\u6297PD-L1\u00d74-1BB\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\u3002\u57fa\u65bc\u4e00\u671f\u81e8\u5e8a\u6578\u64da\uff0c\u76ee\u524d\u958b\u5c55\u76841b\u671f\u7814\u7a76\u65e8\u5728\u64f4\u5927\u6cbb\u7642\u7a97\u53e3\uff0c\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u7522\u751f\u7d50\u679c\u3002\u8a72\u9805\u76ee\u6b63\u8207ABL Bio\u806f\u5408\u958b\u767c\u3002 Uliledlimab\uff08\u6297CD73\u55ae\u6297\uff09\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\uff0cCD73\u662f\u817a\u7518\u4ecb\u5c0e\u514d\u75ab\u6291\u5236\u7684\u9650\u901f\u9176\u3002\u76ee\u524d\u6b63\u5728\u958b\u5c55\u7684\u96a8\u6a5fII\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\uff0c\u5c07uliledlimab\u806f\u5408\u7279\u745e\u666e\u5229\u55ae\u6297\uff08toripalimab\uff09\u7684\u65b9\u6848\u8207\u5e15\u535a\u5229\u73e0\u55ae\u6297\uff08Pembrolizumab\uff09\u55ae\u85e5\u6216\u7279\u745e\u666e\u5229\u55ae\u6297\u55ae\u85e5\u5728\u7d93CD73\u7be9\u9078\u7684\u60a3\u8005\u4eba\u7fa4\u4e2d\u9032\u884c\u5c0d\u6bd4\uff0c\u5176\u7121\u9032\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u6578\u64da\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u516c\u5e03\u3002\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u5927\u4e2d\u83ef\u5340\u4ee5\u5916\u7684\u5168\u7403\u6b0a\u76ca\u3002 VIS-101\u7531\u65b0\u6a4b\u751f\u7269\u5728\u65b0\u5546\u696d\u6a21\u5f0f\u4e0b\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u6536\u8cfc\uff0c\u662f\u4e00\u6b3e\u9776\u5411VEGF-A\u548cANG2\u7684\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u76ee\u524d\u8655\u65bcII\u671f\u958b\u767c\u968e\u6bb5\u3002 VIS-101\u662f\u4e00\u6b3e\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff0c\u4e14\u5206\u5b50\u6d3b\u6027\u66f4\u5f37\uff0c\u76f8\u8f03\u65bc\u73fe\u6709\u6a19\u6e96\u7642\u6cd5\uff0c\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u3001\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u548c\u8996\u7db2\u819c\u975c\u8108\u963b\u585e\uff08RVO\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5b8c\u6210\u4e86\u521d\u6b65\u7684\u5b89\u5168\u6027\u548c\u5291\u91cf\u905e\u589e\u7814\u7a76\uff0c\u76ee\u524d\u6b63\u5728\u4e2d\u570b\u5b8c\u6210\u4e00\u9805\u96a8\u6a5f\u5291\u91cf\u7bc4\u570d\u7684II\u671f\u7814\u7a76\u3002VIS-101\u9810\u8a08\u5c07\u65bc2026\u5e74\u5177\u5099\u958b\u5c55III\u671f\u8a66\u9a57\u7684\u689d\u4ef6\u3002 \u6b64\u6b21\u6536\u8cfc\u5df2\u901a\u904e\u65b0\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u5b8c\u6210\u3002Visara\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u5236\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u540c\u985e\u6700\u4f73\u7684\u773c\u79d1\u7642\u6cd5\uff0c\u5176\u4f9d\u6258\u65b0\u6a4b\u751f\u7269\u7d043700\u842c\u7f8e\u5143\u7684\u6ce8\u8cc7\uff0c\u4ee5\u53ca\u4e00\u5bb6\u6230\u7565\u5408\u4f5c\u4f19\u4f34\u6240\u8ca2\u737b\u7684\u90e8\u5206\u76f8\u95dc\u6b0a\u76ca\u800c\u6210\u7acb\u3002\u65b0\u6a4b\u751f\u7269\u6210\u70ba Visara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002 Visara\u7531\u5176\u806f\u5408\u5275\u59cb\u4eba\u517c\u57f7\u884c\u8463\u4e8b\u9577Emmett\u00a0J.\u00a0Cunningham,\u00a0Jr.\u535a\u58eb\u9818\u5c0e\u3002Cunningham\u535a\u58eb\u5728\u904e\u53bb25\u5e74\u4e2d\u4e00\u76f4\u662f\u4e00\u4f4d\u91ab\u751f\u3001\u5275\u65b0\u8005\u3001\u4f01\u696d\u5bb6\u548c\u6295\u8cc7\u4eba\uff0c\u66fe\u4efb\u9ed1\u77f3\u96c6\u5718\u9ad8\u7d1a\u8463\u4e8b\u7e3d\u7d93\u7406\u4ee5\u53caClarus\u00a0Ventures\u8463\u4e8b\u7e3d\u7d93\u7406\u3002Cunningham\u535a\u58eb\u4e5f\u662f\u570b\u969b\u516c\u8a8d\u7684\u611f\u67d3\u6027\u548c\u708e\u75c7\u6027\u773c\u75c5\u5c08\u5bb6\uff0c\u5408\u4f5c\u767c\u8868\u4e86\u903e450\u7bc7\u5b78\u8853\u8ad6\u6587\u3002 1\uff1a\u300cAACR\u2013NCI\u2013EORTC \u5206\u5b50\u9776\u9ede\u8207\u764c\u75c7\u6cbb\u7642\u570b\u969b\u6703\u8b70\u300d\uff08AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics\uff09\u4e5f\u88ab\u7a31\u70ba\u300c\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300d\uff0c\u65bc 2025 \u5e74 10 \u6708 22 \u65e5\u81f3 26 \u65e5\u5728\u7f8e\u570b\u99ac\u85a9\u8af8\u585e\u5dde\u6ce2\u58eb\u9813\u8209\u884c\u3002 \u95dc\u65bc\u65b0\u6a4b\u751f\u7269 \u65b0\u6a4b\u751f\u7269\uff08\u66f4\u540d\u524d\u70baI-MAB\uff1b\u7d0d\u65af\u9054\u514b\u4ee3\u78bc\uff1aIMAB\uff0c\u81ea2025\u5e7410\u670830\u65e5\u8d77\u5c07\u66f4\u6539\u70ba\u300cNBP\u300d\uff09\u662f\u4e00\u5bb6\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u7684\u53ef\u53ca\u6027\u3002\u6211\u5011\u5c07\u5c08\u696d\u7684\u696d\u52d9\u62d3\u5c55\u80fd\u529b\u8207\u654f\u6377\u7684\u8f49\u5316\u81e8\u5e8a\u958b\u767c\u76f8\u7d50\u5408\uff0c\u4ee5\u767c\u73fe\u3001\u52a0\u901f\u4e26\u63a8\u9032\u7a81\u7834\u6027\u8cc7\u7522\u3002\u901a\u904e\u929c\u63a5\u79d1\u5b78\u3001\u6230\u7565\u548c\u57f7\u884c\uff0c\u65b0\u6a4b\u751f\u7269\u4f7f\u8b8a\u9769\u6027\u7642\u6cd5\u80fd\u5920\u5f9e\u767c\u73fe\u968e\u6bb5\u5feb\u901f\u63a8\u9032\u81f3\u6709\u9700\u6c42\u7684\u60a3\u8005\u3002 \u516c\u53f8\u7684\u5dee\u7570\u5316\u7ba1\u7dda\u4e3b\u8981\u7531givastomig\u548cVIS-101\u9818\u929c\u3002\u5176\u4e2d\uff0cgivastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff08Claudin 18.2\u00d74-1BB\uff09\uff1bVIS-101\u662f\u4e00\u6b3e\u540c\u985e\u7b2c\u4e8c\u4e14\u6709\u671b\u6210\u70ba\u540c\u985e\u6700\u4f73\u7684\u96d9\u529f\u80fd\u751f\u7269\u5236\u5291\uff0c\u9776\u5411VEGF-A\u548cANG2\u3002 Givastomig\u901a\u904e4-1BB\u4fe1\u865f\u901a\u8def\uff0c\u5728\u8868\u9054Claudin 18.2\u7684\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u689d\u4ef6\u6027\u6fc0\u6d3bT\u7d30\u80de\u3002givastomig\u6b63\u958b\u767c\u7528\u65bc\u6cbb\u7642Claudin 18.2\u967d\u6027\u7684\u80c3\u764c\u53ca\u5176\u4ed6\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u65b0\u6a4b\u751f\u7269\u9084\u8207\u5408\u4f5c\u4f19\u4f34ABL Bio\u5408\u4f5c\u958b\u767cragistomig\uff0c\u9019\u662f\u4e00\u6b3e\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u5728\u5be6\u9ad4\u7624\u4e2d\u5c07PD-L1\u4f5c\u70ba\u816b\u7624\u7d50\u5408\u9776\u9ede\u30014-1BB\u4f5c\u70ba\u689d\u4ef6\u6027T\u7d30\u80de\u6fc0\u6d3b\u5291\u3002\u6b64\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u4e2d\u570b\u4ee5\u5916\u5730\u5340\u7684\u5168\u7403\u6b0a\u76ca\u3002Uliledlimab\u662f\u4e00\u6b3e\u6297CD73\u6297\u9ad4\uff0c\u9776\u5411\u816b\u7624\u4e2d\u7531\u817a\u7518\u4ecb\u5c0e\u7684\u514d\u75ab\u6291\u5236\u3002 VIS-101\u9776\u5411VEGF-A\u548cANG2\uff0c\u53ef\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u5f37\u6709\u529b\u4e14\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u76ee\u524d\u6b63\u5728\u91dd\u5c0d\u6fd5\u6027AMD\u958b\u5c55\u4e00\u9805\u5927\u578b\u3001\u96a8\u6a5f\u3001\u5291\u91cf\u7bc4\u570d\u76842\u671f\u7814\u7a76\u3002\u65b0\u6a4b\u751f\u7269\u662fVisara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002 \u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f\uff1ahttps:\\\/\\\/www.novabridge.com\u00a0 \u516c\u53f8\u64ec\u5728\u7d0d\u65af\u9054\u514b\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u96d9\u91cd\u4e0a\u5e02 \u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u64ec\u8d74\u9999\u6e2fIPO\u4e26\u5728\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u4e0a\u5e02\u7684\u66f4\u591a\u4fe1\u606f\u5c07\u65bc\u65e5\u5f8c\u516c\u5e03\u3002 \u64ec\u8b70\u767c\u884c\u7684\u6642\u9593\u3001\u898f\u6a21\u3001\u7d50\u69cb\u548c\u5177\u9ad4\u689d\u6b3e\u5c1a\u672a\u78ba\u5b9a\uff0c\u4ecd\u53d6\u6c7a\u65bc\u5e02\u5834\u72c0\u6cc1\u4ee5\u53ca\u5305\u62ec\u9999\u6e2f\u806f\u4ea4\u6240\uff08\u53ca\u5176\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5728\u5167\u7684\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\u7684\u5be9\u6279\u3002\u5c0d\u65bc\u64ec\u8b70\u7684\u9999\u6e2f\u4e0a\u5e02\u662f\u5426\u6703\u5b8c\u6210\u3001\u4f55\u6642\u5b8c\u6210\u6216\u5c07\u5728\u4f55\u7a2e\u689d\u6b3e\u4e0b\u5b8c\u6210\uff0c\u7121\u6cd5\u63d0\u4f9b\u4efb\u4f55\u4fdd\u8b49\u3002 \u5728\u7372\u5f97\u76e3\u7ba1\u6a5f\u69cb\u548c\u516c\u53f8\u5fc5\u8981\u6279\u51c6\u7684\u524d\u63d0\u4e0b\uff0c\u516c\u53f8\u76ee\u524d\u9810\u8a08\u5c07\u7dad\u6301\u5176\u5728\u7d0d\u65af\u9054\u514b\u7684\u7f8e\u570b\u5b58\u6258\u80a1\uff08ADS\uff09\u4e0a\u5e02\u5730\u4f4d\uff0c\u4e26\u5c0b\u6c42\u5728\u7f8e\u570b\u548c\u9999\u6e2f\u5be6\u73fe\u96d9\u91cd\u4e0a\u5e02\u3002\u6700\u7d42\u6c7a\u5b9a\u5c07\u6839\u64da\u5e02\u5834\u72c0\u6cc1\u548c\u76e3\u7ba1\u53cd\u994b\u4f5c\u51fa\u3002 \u672c\u516c\u544a\u50c5\u70ba\u4fe1\u606f\u62ab\u9732\u4e4b\u7528\uff0c\u4e14\u4e0d\u69cb\u6210\u5c0d\u516c\u53f8\u4efb\u4f55\u8b49\u5238\u7684\u8a8d\u8cfc\u3001\u8cfc\u8cb7\u6216\u6536\u8cfc\u8981\u7d04\u6216\u9080\u8acb\u3002\u516c\u53f8\u80a1\u6771\u53ca\u6f5b\u5728\u6295\u8cc7\u8005\u5728\u6d89\u53ca\u516c\u53f8\u8b49\u5238\u7684\u4ea4\u6613\u6642\uff0c\u61c9\u8b39\u614e\u8a55\u4f30\u76f8\u95dc\u98a8\u96aa\u3002 \u524d\u77bb\u6027\u8072\u660e \u672c\u516c\u544a\u5305\u542b\u524d\u77bb\u6027\u8072\u660e\u3002\u9019\u4e9b\u8072\u660e\u4f9d\u64da1995\u5e74\u7f8e\u570b\u300a\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u7684\u300c\u5b89\u5168\u6e2f\u300d\u689d\u6b3e\u4f5c\u51fa\u3002\u53ef\u4ee5\u901a\u904e\u8853\u8a9e\u4f8b\u5982\u300c\u5c07\u300d\u3001\u300c\u9810\u8a08\u300d\u3001\u300c\u76f8\u4fe1\u300d\u3001\u300c\u65e8\u5728\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u3001\u300c\u6253\u7b97\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u4f30\u8a08\u300d\u3001\u300c\u6709\u4fe1\u5fc3\u300d\u7b49\u4ee5\u53ca\u985e\u4f3c\u8868\u8ff0\uff08\u6216\u5176\u53cd\u7fa9\u8868\u8ff0\uff09\u4f86\u8b58\u5225\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u3002\u65b0\u6a4b\u751f\u7269\u4e5f\u53ef\u80fd\u5728\u5176\u63d0\u4ea4\u7d66\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u7684\u5b9a\u671f\u5831\u544a\u3001\u5411\u80a1\u6771\u767c\u5e03\u7684\u5e74\u5ea6\u5831\u544a\u3001\u65b0\u805e\u7a3f\u53ca\u5176\u4ed6\u66f8\u9762\u6750\u6599\u4e2d\uff0c\u4ee5\u53ca\u516c\u53f8\u9ad8\u7ba1\u3001\u8463\u4e8b\u6216\u54e1\u5de5\u5411\u7b2c\u4e09\u65b9\u6240\u4f5c\u7684\u53e3\u982d\u9673\u8ff0\u4e2d\u4f5c\u51fa\u66f8\u9762\u6216\u53e3\u982d\u7684\u524d\u77bb\u6027\u8072\u660e\u3002\u51e1\u4e0d\u5c6c\u65bc\u6b77\u53f2\u4e8b\u5be6\u7684\u9673\u8ff0\uff08\u5305\u62ec\u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u7684\u4fe1\u5ff5\u548c\u9810\u671f\u7684\u9673\u8ff0\uff09\u5747\u70ba\u524d\u77bb\u6027\u8072\u660e\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u7684\u524d\u77bb\u6027\u8072\u660e\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u5167\u5bb9\uff1a\u65b0\u7684\u516c\u53f8\u6230\u7565\u53ef\u80fd\u5e36\u4f86\u7684\u6f5b\u5728\u76ca\u8655\uff1b\u516c\u53f8\u4ee5\u65b0\u540d\u7a31\u548c\u80a1\u7968\u4ee3\u78bc\u5728\u7d0d\u65af\u9054\u514b\u4ea4\u6613\u7684\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u64ec\u63a8\u9032\u9999\u6e2f IPO\uff0c\u9032\u800c\u5be6\u73fe\u64ec\u5728\u7d0d\u65af\u9054\u514b\u5168\u7403\u5e02\u5834\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\u7684\u8a08\u5283\uff1bgivastomig\u3001VIS-101\u53ca\u516c\u53f8\u5176\u4ed6\u5019\u9078\u85e5\u7269\u7684\u6230\u7565\u3001\u81e8\u5e8a\u958b\u767c\u3001\u8a08\u5283\u3001\u7d50\u679c\u3001\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\uff08\u5305\u62ec givastomig \u548c VIS-101\uff09\u7684\u6230\u7565\u8207\u81e8\u5e8a\u958b\u767c\uff1b\u9810\u671f\u7684\u81e8\u5e8a\u91cc\u7a0b\u7891\u548c\u7d50\u679c\u53ca\u76f8\u95dc\u6642\u9593\uff1b\u516c\u53f8\u7684\u9810\u671f\u8cc7\u91d1\u53ef\u7dad\u6301\u904b\u71df\u7684\u5468\u671f\u3002\u524d\u77bb\u6027\u8072\u660e\u6d89\u53ca\u7684\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u4e2d\u5305\u542b\u7684\u7d50\u679c\u5b58\u5728\u91cd\u5927\u5dee\u7570\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u56e0\u7d20\uff1a\u65b0\u6a4b\u751f\u7269\u8b49\u660e\u5176\u5019\u9078\u85e5\u7269\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7684\u80fd\u529b\uff1b\u516c\u53f8\u7372\u5f97\u8b49\u5238\u76e3\u7ba1\u6a5f\u69cb\u53ca\u4ea4\u6613\u6240\u5fc5\u8981\u6279\u51c6\u7684\u80fd\u529b\uff1b\u5019\u9078\u85e5\u7269\u7684\u81e8\u5e8a\u7d50\u679c\uff08\u53ef\u80fd\u652f\u6301\u4e5f\u53ef\u80fd\u4e0d\u652f\u6301\u9032\u4e00\u6b65\u958b\u767c\u6216\u65b0\u85e5\u7533\u8acb\\\/\u751f\u7269\u5236\u54c1\u8a31\u53ef\u7533\u8acb\uff08NDA\\\/BLA\uff09\u7684\u6279\u51c6\uff09\uff1b\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\uff08\u5305\u62ec\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\u4ee5\u53ca\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5c31\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\u76e3\u7ba1\u5be9\u6279\u6240\u4f5c\u6c7a\u5b9a\u7684\u5167\u5bb9\u548c\u6642\u9593\uff1b\u65b0\u6a4b\u751f\u7269\u5728\u5019\u9078\u85e5\u7269\u7372\u6279\u5f8c\u7684\u5546\u696d\u6210\u529f\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u4e26\u7dad\u8b77\u5176\u6280\u8853\u548c\u85e5\u7269\u77e5\u8b58\u7522\u6b0a\u4fdd\u8b77\u7684\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u5c0d\u7b2c\u4e09\u65b9\u958b\u5c55\u85e5\u7269\u958b\u767c\u3001\u751f\u7522\u5236\u9020\u53ca\u5176\u4ed6\u670d\u52d9\u7684\u4f9d\u8cf4\uff1b\u65b0\u6a4b\u751f\u7269\u6709\u9650\u7684\u904b\u71df\u6b77\u53f2\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u984d\u5916\u904b\u71df\u8cc7\u91d1\u4e26\u5b8c\u6210\u5176\u5019\u9078\u85e5\u7269\u958b\u767c\u548c\u5546\u696d\u5316\u7684\u80fd\u529b\uff1b\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u5df2\u65bc2025\u5e744\u67083\u65e5\u5411\u7f8e\u570bSEC\u63d0\u4ea4\u768420-F\u5e74\u5ea6\u5831\u544a\u4e2d\u300c\u98a8\u96aa\u56e0\u7d20\u300d\u90e8\u5206\u66f4\u5168\u9762\u8a0e\u8ad6\u7684\u98a8\u96aa\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u96a8\u5f8c\u5411SEC\u63d0\u4ea4\u7684\u6587\u4ef6\u4e2d\u8a0e\u8ad6\u7684\u6f5b\u5728\u98a8\u96aa\u3001\u4e0d\u78ba\u5b9a\u6027\u548c\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u3002\u6240\u6709\u524d\u77bb\u6027\u8072\u660e\u5747\u57fa\u65bc\u65b0\u6a4b\u751f\u7269\u7576\u524d\u53ef\u7372\u5f97\u7684\u4fe1\u606f\u3002\u9664\u6cd5\u5f8b\u8981\u6c42\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u4e0d\u627f\u64d4\u56e0\u7372\u5f97\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u6216\u4fee\u8a02\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u7684\u7fa9\u52d9\u3002 \u65b0\u6a4b\u751f\u7269\u6295\u8cc7\u8005\u53ca\u5a92\u9ad4\u806f\u7e6b\u4ebaPJ Kelleher \u2013 LifeSci Advisors+1-617-430-7579pkelleher@lifesciadvisors.com \u96f7\u9cf4\uff08Kyler Lei\uff09\u2013 \u65b0\u6a4b\u751f\u7269+1-240-745-6330kyler.lei@imabbio.comIR@imabbio.com\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800#primaryimage\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/image_5053990_46034728.jpg\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/image_5053990_46034728.jpg\",\"width\":400,\"height\":282},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=376800#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"description\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4\",\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"width\":150,\"height\":150,\"caption\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pingtungnews\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\",\"name\":\"\u7f8e\u901a\u793e\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"caption\":\"\u7f8e\u901a\u793e\"},\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?author=16\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u5168\u65b0\u4f01\u696d\u54c1\u724c\u6a19\u8a8c\u8457\u516c\u53f8\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u7684\u6230\u7565\u8f49\u578b\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002  \u516c\u53f8\u64ec\u5728\u9999\u6e2f\u9032\u884c\u9996\u6b21\u516c\u958b\u52df\u80a1\uff08IPO\uff09\uff0c\u4e26\u901a\u904e\u5728\u7f8e\u570b\u7d0d\u65af\u9054\u514b\uff08NASDAQ\uff09\u548c\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\uff0c\u64f4\u5927\u5c0d\u5168\u7403\u8cc7\u672c\u548c\u5275\u65b0\u8cc7\u6e90\u7684\u93c8\u63a5\u3002  \u57fa\u65bc\u5168\u65b0\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u696d\u52d9\u6a21\u5f0f\uff0c\u516c\u53f8\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara Inc. (Visara)\uff0c\u4e26\u5df2\u6536\u8cfc\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50VIS-101\uff08\u9776\u5411 VEGF-A\/ANG2\uff09\u3002\u76f8\u8f03\u73fe\u884c\u6a19\u6e96\u7642\u6cd5\uff0cVIS-101\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u3001\u66f4\u6709\u6548\u7684\u6cbb\u7642\u9078\u64c7\u3002  \u516c\u53f8\u6838\u5fc3\u8cc7\u7522givastomig\uff08\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff09\uff0c\u6b63\u6309\u7167\u6b64\u524d\u516c\u5e03\u7684\u6295\u8cc7\u8a08\u5283\u6301\u7e8c\u63a8\u9032\u7814\u767c\u3002  \u99ac\u91cc\u862d\u5dde\u7f85\u514b\u7dad\u723e2025\u5e7410\u670829\u65e5 \/\u7f8e\u901a\u793e\/ -- \u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff0c\u4e0b\u7a31\u300c\u65b0\u6a4b\u751f\u7269\u300d\u6216\u300c\u516c\u53f8\u300d\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u516c\u53f8\u5df2\u5b8c\u6210\u540d\u7a31\u8b8a\u66f4\uff0c\u7531\u300cI-Mab\u300d\u6b63\u5f0f\u66f4\u540d\u70ba\u300c\u65b0\u6a4b\u751f\u7269\u300d\u3002\u6b64\u9805\u66f4\u540d\u6c7a\u8b70\u5df2\u7372\u5f97\u516c\u53f8\u65bc2025\u5e7410\u670824\u65e5\u53ec\u958b\u7684\u7279\u5225\u80a1\u6771\u5927\u6703\u9ad8\u7968\u901a\u904e\uff0c\u4e26\u7372\u8463\u4e8b\u6703\u6279\u51c6\u3002\u81ea2025\u5e7410\u670830\u65e5\u958b\u76e4\u8d77\uff0c\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u5c07\u6b63\u5f0f\u555f\u7528\u65b0\u516c\u53f8\u540d\u7a31\u53ca\u65b0\u80a1\u7968\u4ee3\u78bc\u300cNBP\u300d\uff08Nasdaq: NBP\uff09\uff0c\u53d6\u4ee3\u73fe\u6709\u4ee3\u78bc\u300cIMAB\u300d\uff08Nasdaq: IMAB\uff09\u3002 \u516c\u53f8\u540c\u6b65\u4e0a\u7dda\u5168\u65b0\u54c1\u724c\u53ca\u5b98\u7db2\uff08www.novabridge.com\uff09\uff0c\u6a19\u8a8c\u8457\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u6230\u7565\u8f49\u578b\u9081\u51fa\u95dc\u9375\u4e00\u6b65\uff0c\u6301\u7e8c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u7642\u6cd5\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002 \u95dc\u65bc\u6b64\u6b21\u540d\u7a31\u53ca\u80a1\u7968\u4ee3\u78bc\u8b8a\u66f4\uff0c\u73fe\u6709\u80a1\u6771\u7121\u9700\u9032\u884c\u4efb\u4f55\u884c\u52d5\uff0c\u516c\u53f8CUSIP\u865f\u78bc\u5c07\u4fdd\u6301\u4e0d\u8b8a\u3002\u5728\u90e8\u5206\u7b2c\u4e09\u65b9\u7db2\u7ad9\u6216\u61c9\u7528\u7a0b\u5e8f\u4e0a\uff0c\u82e5\u641c\u7d22\u300cNovaBridge Biosciences\u300d\u6216\u300cNBP\u300d\u6642\uff0c\u53ef\u80fd\u66ab\u6642\u7121\u6cd5\u67e5\u8a62\u5230\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u57282025\u5e7410\u670830\u65e5\u4e4b\u524d\u7684\u6b77\u53f2\u4ea4\u6613\u6578\u64da\u3002\u5982\u9047\u6b64\u7a2e\u60c5\u6cc1\uff0c\u76f8\u95dc\u6578\u64da\u53ef\u66ab\u6642\u901a\u904e\u641c\u7d22\u300cI-MAB\u300d\u6216\u300cIMAB\u300d\u9032\u884c\u67e5\u8a62\u3002 \u65b0\u6a4b\u751f\u7269Logo - \u76f8\u9023\u7684\u5206\u5b50\u7d50\u69cb\u7d44\u5408\u6210\u5b57\u6bcd\u300cN\u300d\uff0c\u5bd3\u610f\u516c\u53f8\u8207\u5408\u4f5c\u4f19\u4f34\u651c\u624b\u5171\u5efa\u66f4\u5065\u5eb7\u672a\u4f86\uff1b\u958b\u653e\u7684\u5713\u74b0\u8c61\u5fb5\u6301\u7e8c\u5275\u65b0\u8207\u63a2\u7d22\u7cbe\u795e\u3002 \u65b0\u6a4b\u751f\u7269\u57f7\u884c\u8463\u4e8b\u9577\u5085\u552f\u5148\u751f\u8868\u793a\uff1a\u300c\u5168\u65b0\u7684\u4f01\u696d\u54c1\u724c\u5f62\u8c61\u751f\u52d5\u9ad4\u73fe\u4e86\u6211\u5011\u65b0\u7684\u6230\u7565\u6838\u5fc3\u2014\u2014\u901a\u904e\u9ad8\u6548\u5354\u4f5c\u3001\u79d1\u5b78\u8f49\u5316\u8207\u5353\u8d8a\u57f7\u884c\uff0c\u52a0\u901f\u63a8\u9032\u8b8a\u9769\u6027\u7642\u6cd5\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u66f4\u5927\u50f9\u503c\u3002\u7f8e\u6e2f\u5169\u5730\u96d9\u91cd\u4e0a\u5e02\u662f\u516c\u53f8\u5168\u7403\u5316\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\uff0c\u9019\u5c07\u5e6b\u52a9\u6211\u5011\u62d3\u5bec\u6295\u8cc7\u8005\u7bc4\u570d\u3001\u63d0\u5347\u4ea4\u6613\u6d41\u52d5\u6027\u548c\u8cc7\u672c\u93c8\u63a5\u80fd\u529b\uff0c\u4e26\u5f37\u5316\u5728\u5feb\u901f\u589e\u9577\u7684\u4e9e\u6d32\u5e02\u5834\u7684\u5f71\u97ff\u529b\u3002\u300d \u65b0\u6a4b\u751f\u7269\u9996\u5e2d\u57f7\u884c\u5b98\u5085\u5e0c\u6e67\u535a\u58eb\u8868\u793a\uff1a\u300c\u65b0\u54c1\u724c\u5f62\u8c61\u8207\u6211\u5011\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u8f49\u578b\u7684\u6230\u7565\u9ad8\u5ea6\u4e00\u81f4\u3002\u8fd1\u671f\uff0c\u5728\u91dd\u5c0dgivastomig\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u80c3\u764c\u6cbb\u7642\u9818\u57df\u7684\u540c\u985e\u6700\u4f73 Claudin 18.2 \u9776\u5411\u7642\u6cd5\uff09\u7684\u300e\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300f\u4e0a\uff0c\u516c\u5e03\u4e86\u4ee4\u4eba\u632f\u596e\u7684I\u671f\u55ae\u85e5\u81e8\u5e8a\u6700\u65b0\u6578\u64da\uff1b\u540c\u6642\uff0c\u6211\u5011\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara \uff0c\u53ca\u5176\u8fd1\u671f\u6536\u8cfc\u7684 VIS\u2011101\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u4e0b\u4e00\u4ee3\u540c\u985e\u6700\u4f73\u7684\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff09\uff0c\u9032\u4e00\u6b65\u9a57\u8b49\u4e86\u65b0\u6230\u7565\u7684\u53ef\u884c\u6027\u3002\u6211\u5011\u6b63\u7a4d\u6975\u63a8\u9032 givastomig \u5168\u7403\u96a8\u6a5f\u5c0d\u7167 II \u671f\u7814\u7a76\uff0c\u9810\u8a08\u65bc\u202f2026\u202f\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5b8c\u6210\u9996\u4f8b\u60a3\u8005\u5165\u7d44\u3002\u6191\u501f\u65b0\u54c1\u724c\u5e36\u4f86\u7684\u7a4d\u6975\u52e2\u982d\uff0c\u5145\u5206\u91cb\u653e\u5275\u65b0\u85e5\u7269\u7684\u6f5b\u529b\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u50f9\u503c\u3002\u300d \u65b0\u6a4b\u751f\u7269\u7684\u5546\u696d\u6a21\u5f0f\u8207\u7522\u54c1\u7ba1\u7dda\u5e03\u5c40 \u516c\u53f8\u5c07\u8207\u5168\u7403\u9818\u5148\u5275\u65b0\u8005\u5408\u4f5c\uff0c\u7504\u9078\u4e26\u52a0\u901f\u9ad8\u6f5b\u529b\u85e5\u7269\u8cc7\u7522\u3002\u8a72\u6a21\u5f0f\u878d\u5408\u56b4\u8b39\u7684\u8cc7\u7522\u7504\u9078\u3001\u5b9a\u5236\u5316\u7684\u8f49\u5316\u7b56\u7565\u53ca\u9ad8\u6548\u81e8\u5e8a\u57f7\u884c\uff0c\u4e26\u4f9d\u6258\u5eb7\u6a4b\u8cc7\u672c\u6df1\u539a\u8cc7\u6e90\u8207\u5168\u7403\u80fd\u529b\uff0c\u5728\u591a\u6cbb\u7642\u9818\u57df\u63a8\u9032\u6700\u5177\u6f5b\u529b\u7684\u5275\u65b0\u85e5\u3002 \u516c\u53f8\u5c07\u63a1\u7528\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u6a21\u5f0f\uff0c\u901a\u904e\u8a2d\u7acb\u5c08\u6ce8\u7279\u5b9a\u6cbb\u7642\u9818\u57df\u6216\u8cc7\u7522\u7684\u885b\u661f\u5b50\u516c\u53f8\uff0c\u4fdd\u6301\u9ad8\u6548\u9748\u6d3b\u7684\u904b\u71df\u7d50\u69cb\uff0c\u5f9e\u800c\u5be6\u73fe\u98a8\u96aa\u53ef\u63a7\u8207\u50f9\u503c\u6700\u5927\u5316\u3002 \u7ba1\u7dda\u6982\u89bd   Givastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u76ee\u524d\u6b63\u5728\u958b\u5c551b\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u65e8\u5728\u7528\u65bc\u6cbb\u7642\u80c3\u764c\u53ca\u5176\u4ed6Claudin\u00a018.2\u967d\u6027\u7684\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u8a08\u5283\u555f\u52d5\u4e00\u9805\u5168\u7403\u96a8\u6a5f\u5c0d\u7167\u7684II\u671f\u7814\u7a76\uff0c\u76ee\u6a19\u65bc2026\u5e74\u7b2c\u4e00\u5b63\u5ea6\u62db\u52df\u9996\u4f4d\u60a3\u8005\u3002Givastomig\u6b63\u901a\u904e\u8207ABL\u00a0Bio\u7684\u5168\u7403\u5408\u4f5c\u9032\u884c\u806f\u5408\u958b\u767c\uff0c\u5176\u4e2d\u65b0\u6a4b\u751f\u7269\u4f5c\u70ba\u727d\u982d\u65b9\uff0c\u8207ABL\u00a0Bio\u5e73\u5206\u5168\u7403\u6b0a\u76ca\uff08\u5927\u4e2d\u83ef\u5340\u548c\u97d3\u570b\u9664\u5916\uff09\u3002  Ragistomig\u662f\u4e00\u6b3e\u6297PD-L1\u00d74-1BB\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\u3002\u57fa\u65bc\u4e00\u671f\u81e8\u5e8a\u6578\u64da\uff0c\u76ee\u524d\u958b\u5c55\u76841b\u671f\u7814\u7a76\u65e8\u5728\u64f4\u5927\u6cbb\u7642\u7a97\u53e3\uff0c\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u7522\u751f\u7d50\u679c\u3002\u8a72\u9805\u76ee\u6b63\u8207ABL Bio\u806f\u5408\u958b\u767c\u3002  Uliledlimab\uff08\u6297CD73\u55ae\u6297\uff09\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\uff0cCD73\u662f\u817a\u7518\u4ecb\u5c0e\u514d\u75ab\u6291\u5236\u7684\u9650\u901f\u9176\u3002\u76ee\u524d\u6b63\u5728\u958b\u5c55\u7684\u96a8\u6a5fII\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\uff0c\u5c07uliledlimab\u806f\u5408\u7279\u745e\u666e\u5229\u55ae\u6297\uff08toripalimab\uff09\u7684\u65b9\u6848\u8207\u5e15\u535a\u5229\u73e0\u55ae\u6297\uff08Pembrolizumab\uff09\u55ae\u85e5\u6216\u7279\u745e\u666e\u5229\u55ae\u6297\u55ae\u85e5\u5728\u7d93CD73\u7be9\u9078\u7684\u60a3\u8005\u4eba\u7fa4\u4e2d\u9032\u884c\u5c0d\u6bd4\uff0c\u5176\u7121\u9032\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u6578\u64da\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u516c\u5e03\u3002\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u5927\u4e2d\u83ef\u5340\u4ee5\u5916\u7684\u5168\u7403\u6b0a\u76ca\u3002  VIS-101\u7531\u65b0\u6a4b\u751f\u7269\u5728\u65b0\u5546\u696d\u6a21\u5f0f\u4e0b\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u6536\u8cfc\uff0c\u662f\u4e00\u6b3e\u9776\u5411VEGF-A\u548cANG2\u7684\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u76ee\u524d\u8655\u65bcII\u671f\u958b\u767c\u968e\u6bb5\u3002   VIS-101\u662f\u4e00\u6b3e\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff0c\u4e14\u5206\u5b50\u6d3b\u6027\u66f4\u5f37\uff0c\u76f8\u8f03\u65bc\u73fe\u6709\u6a19\u6e96\u7642\u6cd5\uff0c\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u3001\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u548c\u8996\u7db2\u819c\u975c\u8108\u963b\u585e\uff08RVO\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5b8c\u6210\u4e86\u521d\u6b65\u7684\u5b89\u5168\u6027\u548c\u5291\u91cf\u905e\u589e\u7814\u7a76\uff0c\u76ee\u524d\u6b63\u5728\u4e2d\u570b\u5b8c\u6210\u4e00\u9805\u96a8\u6a5f\u5291\u91cf\u7bc4\u570d\u7684II\u671f\u7814\u7a76\u3002VIS-101\u9810\u8a08\u5c07\u65bc2026\u5e74\u5177\u5099\u958b\u5c55III\u671f\u8a66\u9a57\u7684\u689d\u4ef6\u3002  \u6b64\u6b21\u6536\u8cfc\u5df2\u901a\u904e\u65b0\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u5b8c\u6210\u3002Visara\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u5236\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u540c\u985e\u6700\u4f73\u7684\u773c\u79d1\u7642\u6cd5\uff0c\u5176\u4f9d\u6258\u65b0\u6a4b\u751f\u7269\u7d043700\u842c\u7f8e\u5143\u7684\u6ce8\u8cc7\uff0c\u4ee5\u53ca\u4e00\u5bb6\u6230\u7565\u5408\u4f5c\u4f19\u4f34\u6240\u8ca2\u737b\u7684\u90e8\u5206\u76f8\u95dc\u6b0a\u76ca\u800c\u6210\u7acb\u3002\u65b0\u6a4b\u751f\u7269\u6210\u70ba Visara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002  Visara\u7531\u5176\u806f\u5408\u5275\u59cb\u4eba\u517c\u57f7\u884c\u8463\u4e8b\u9577Emmett\u00a0J.\u00a0Cunningham,\u00a0Jr.\u535a\u58eb\u9818\u5c0e\u3002Cunningham\u535a\u58eb\u5728\u904e\u53bb25\u5e74\u4e2d\u4e00\u76f4\u662f\u4e00\u4f4d\u91ab\u751f\u3001\u5275\u65b0\u8005\u3001\u4f01\u696d\u5bb6\u548c\u6295\u8cc7\u4eba\uff0c\u66fe\u4efb\u9ed1\u77f3\u96c6\u5718\u9ad8\u7d1a\u8463\u4e8b\u7e3d\u7d93\u7406\u4ee5\u53caClarus\u00a0Ventures\u8463\u4e8b\u7e3d\u7d93\u7406\u3002Cunningham\u535a\u58eb\u4e5f\u662f\u570b\u969b\u516c\u8a8d\u7684\u611f\u67d3\u6027\u548c\u708e\u75c7\u6027\u773c\u75c5\u5c08\u5bb6\uff0c\u5408\u4f5c\u767c\u8868\u4e86\u903e450\u7bc7\u5b78\u8853\u8ad6\u6587\u3002           1\uff1a\u300cAACR\u2013NCI\u2013EORTC \u5206\u5b50\u9776\u9ede\u8207\u764c\u75c7\u6cbb\u7642\u570b\u969b\u6703\u8b70\u300d\uff08AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics\uff09\u4e5f\u88ab\u7a31\u70ba\u300c\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300d\uff0c\u65bc 2025 \u5e74 10 \u6708 22 \u65e5\u81f3 26 \u65e5\u5728\u7f8e\u570b\u99ac\u85a9\u8af8\u585e\u5dde\u6ce2\u58eb\u9813\u8209\u884c\u3002         \u95dc\u65bc\u65b0\u6a4b\u751f\u7269 \u65b0\u6a4b\u751f\u7269\uff08\u66f4\u540d\u524d\u70baI-MAB\uff1b\u7d0d\u65af\u9054\u514b\u4ee3\u78bc\uff1aIMAB\uff0c\u81ea2025\u5e7410\u670830\u65e5\u8d77\u5c07\u66f4\u6539\u70ba\u300cNBP\u300d\uff09\u662f\u4e00\u5bb6\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u7684\u53ef\u53ca\u6027\u3002\u6211\u5011\u5c07\u5c08\u696d\u7684\u696d\u52d9\u62d3\u5c55\u80fd\u529b\u8207\u654f\u6377\u7684\u8f49\u5316\u81e8\u5e8a\u958b\u767c\u76f8\u7d50\u5408\uff0c\u4ee5\u767c\u73fe\u3001\u52a0\u901f\u4e26\u63a8\u9032\u7a81\u7834\u6027\u8cc7\u7522\u3002\u901a\u904e\u929c\u63a5\u79d1\u5b78\u3001\u6230\u7565\u548c\u57f7\u884c\uff0c\u65b0\u6a4b\u751f\u7269\u4f7f\u8b8a\u9769\u6027\u7642\u6cd5\u80fd\u5920\u5f9e\u767c\u73fe\u968e\u6bb5\u5feb\u901f\u63a8\u9032\u81f3\u6709\u9700\u6c42\u7684\u60a3\u8005\u3002 \u516c\u53f8\u7684\u5dee\u7570\u5316\u7ba1\u7dda\u4e3b\u8981\u7531givastomig\u548cVIS-101\u9818\u929c\u3002\u5176\u4e2d\uff0cgivastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff08Claudin 18.2\u00d74-1BB\uff09\uff1bVIS-101\u662f\u4e00\u6b3e\u540c\u985e\u7b2c\u4e8c\u4e14\u6709\u671b\u6210\u70ba\u540c\u985e\u6700\u4f73\u7684\u96d9\u529f\u80fd\u751f\u7269\u5236\u5291\uff0c\u9776\u5411VEGF-A\u548cANG2\u3002 Givastomig\u901a\u904e4-1BB\u4fe1\u865f\u901a\u8def\uff0c\u5728\u8868\u9054Claudin 18.2\u7684\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u689d\u4ef6\u6027\u6fc0\u6d3bT\u7d30\u80de\u3002givastomig\u6b63\u958b\u767c\u7528\u65bc\u6cbb\u7642Claudin 18.2\u967d\u6027\u7684\u80c3\u764c\u53ca\u5176\u4ed6\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u65b0\u6a4b\u751f\u7269\u9084\u8207\u5408\u4f5c\u4f19\u4f34ABL Bio\u5408\u4f5c\u958b\u767cragistomig\uff0c\u9019\u662f\u4e00\u6b3e\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u5728\u5be6\u9ad4\u7624\u4e2d\u5c07PD-L1\u4f5c\u70ba\u816b\u7624\u7d50\u5408\u9776\u9ede\u30014-1BB\u4f5c\u70ba\u689d\u4ef6\u6027T\u7d30\u80de\u6fc0\u6d3b\u5291\u3002\u6b64\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u4e2d\u570b\u4ee5\u5916\u5730\u5340\u7684\u5168\u7403\u6b0a\u76ca\u3002Uliledlimab\u662f\u4e00\u6b3e\u6297CD73\u6297\u9ad4\uff0c\u9776\u5411\u816b\u7624\u4e2d\u7531\u817a\u7518\u4ecb\u5c0e\u7684\u514d\u75ab\u6291\u5236\u3002 VIS-101\u9776\u5411VEGF-A\u548cANG2\uff0c\u53ef\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u5f37\u6709\u529b\u4e14\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u76ee\u524d\u6b63\u5728\u91dd\u5c0d\u6fd5\u6027AMD\u958b\u5c55\u4e00\u9805\u5927\u578b\u3001\u96a8\u6a5f\u3001\u5291\u91cf\u7bc4\u570d\u76842\u671f\u7814\u7a76\u3002\u65b0\u6a4b\u751f\u7269\u662fVisara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002 \u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f\uff1ahttps:\/\/www.novabridge.com\u00a0 \u516c\u53f8\u64ec\u5728\u7d0d\u65af\u9054\u514b\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u96d9\u91cd\u4e0a\u5e02 \u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u64ec\u8d74\u9999\u6e2fIPO\u4e26\u5728\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u4e0a\u5e02\u7684\u66f4\u591a\u4fe1\u606f\u5c07\u65bc\u65e5\u5f8c\u516c\u5e03\u3002 \u64ec\u8b70\u767c\u884c\u7684\u6642\u9593\u3001\u898f\u6a21\u3001\u7d50\u69cb\u548c\u5177\u9ad4\u689d\u6b3e\u5c1a\u672a\u78ba\u5b9a\uff0c\u4ecd\u53d6\u6c7a\u65bc\u5e02\u5834\u72c0\u6cc1\u4ee5\u53ca\u5305\u62ec\u9999\u6e2f\u806f\u4ea4\u6240\uff08\u53ca\u5176\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5728\u5167\u7684\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\u7684\u5be9\u6279\u3002\u5c0d\u65bc\u64ec\u8b70\u7684\u9999\u6e2f\u4e0a\u5e02\u662f\u5426\u6703\u5b8c\u6210\u3001\u4f55\u6642\u5b8c\u6210\u6216\u5c07\u5728\u4f55\u7a2e\u689d\u6b3e\u4e0b\u5b8c\u6210\uff0c\u7121\u6cd5\u63d0\u4f9b\u4efb\u4f55\u4fdd\u8b49\u3002 \u5728\u7372\u5f97\u76e3\u7ba1\u6a5f\u69cb\u548c\u516c\u53f8\u5fc5\u8981\u6279\u51c6\u7684\u524d\u63d0\u4e0b\uff0c\u516c\u53f8\u76ee\u524d\u9810\u8a08\u5c07\u7dad\u6301\u5176\u5728\u7d0d\u65af\u9054\u514b\u7684\u7f8e\u570b\u5b58\u6258\u80a1\uff08ADS\uff09\u4e0a\u5e02\u5730\u4f4d\uff0c\u4e26\u5c0b\u6c42\u5728\u7f8e\u570b\u548c\u9999\u6e2f\u5be6\u73fe\u96d9\u91cd\u4e0a\u5e02\u3002\u6700\u7d42\u6c7a\u5b9a\u5c07\u6839\u64da\u5e02\u5834\u72c0\u6cc1\u548c\u76e3\u7ba1\u53cd\u994b\u4f5c\u51fa\u3002 \u672c\u516c\u544a\u50c5\u70ba\u4fe1\u606f\u62ab\u9732\u4e4b\u7528\uff0c\u4e14\u4e0d\u69cb\u6210\u5c0d\u516c\u53f8\u4efb\u4f55\u8b49\u5238\u7684\u8a8d\u8cfc\u3001\u8cfc\u8cb7\u6216\u6536\u8cfc\u8981\u7d04\u6216\u9080\u8acb\u3002\u516c\u53f8\u80a1\u6771\u53ca\u6f5b\u5728\u6295\u8cc7\u8005\u5728\u6d89\u53ca\u516c\u53f8\u8b49\u5238\u7684\u4ea4\u6613\u6642\uff0c\u61c9\u8b39\u614e\u8a55\u4f30\u76f8\u95dc\u98a8\u96aa\u3002 \u524d\u77bb\u6027\u8072\u660e \u672c\u516c\u544a\u5305\u542b\u524d\u77bb\u6027\u8072\u660e\u3002\u9019\u4e9b\u8072\u660e\u4f9d\u64da1995\u5e74\u7f8e\u570b\u300a\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u7684\u300c\u5b89\u5168\u6e2f\u300d\u689d\u6b3e\u4f5c\u51fa\u3002\u53ef\u4ee5\u901a\u904e\u8853\u8a9e\u4f8b\u5982\u300c\u5c07\u300d\u3001\u300c\u9810\u8a08\u300d\u3001\u300c\u76f8\u4fe1\u300d\u3001\u300c\u65e8\u5728\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u3001\u300c\u6253\u7b97\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u4f30\u8a08\u300d\u3001\u300c\u6709\u4fe1\u5fc3\u300d\u7b49\u4ee5\u53ca\u985e\u4f3c\u8868\u8ff0\uff08\u6216\u5176\u53cd\u7fa9\u8868\u8ff0\uff09\u4f86\u8b58\u5225\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u3002\u65b0\u6a4b\u751f\u7269\u4e5f\u53ef\u80fd\u5728\u5176\u63d0\u4ea4\u7d66\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u7684\u5b9a\u671f\u5831\u544a\u3001\u5411\u80a1\u6771\u767c\u5e03\u7684\u5e74\u5ea6\u5831\u544a\u3001\u65b0\u805e\u7a3f\u53ca\u5176\u4ed6\u66f8\u9762\u6750\u6599\u4e2d\uff0c\u4ee5\u53ca\u516c\u53f8\u9ad8\u7ba1\u3001\u8463\u4e8b\u6216\u54e1\u5de5\u5411\u7b2c\u4e09\u65b9\u6240\u4f5c\u7684\u53e3\u982d\u9673\u8ff0\u4e2d\u4f5c\u51fa\u66f8\u9762\u6216\u53e3\u982d\u7684\u524d\u77bb\u6027\u8072\u660e\u3002\u51e1\u4e0d\u5c6c\u65bc\u6b77\u53f2\u4e8b\u5be6\u7684\u9673\u8ff0\uff08\u5305\u62ec\u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u7684\u4fe1\u5ff5\u548c\u9810\u671f\u7684\u9673\u8ff0\uff09\u5747\u70ba\u524d\u77bb\u6027\u8072\u660e\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u7684\u524d\u77bb\u6027\u8072\u660e\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u5167\u5bb9\uff1a\u65b0\u7684\u516c\u53f8\u6230\u7565\u53ef\u80fd\u5e36\u4f86\u7684\u6f5b\u5728\u76ca\u8655\uff1b\u516c\u53f8\u4ee5\u65b0\u540d\u7a31\u548c\u80a1\u7968\u4ee3\u78bc\u5728\u7d0d\u65af\u9054\u514b\u4ea4\u6613\u7684\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u64ec\u63a8\u9032\u9999\u6e2f IPO\uff0c\u9032\u800c\u5be6\u73fe\u64ec\u5728\u7d0d\u65af\u9054\u514b\u5168\u7403\u5e02\u5834\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\u7684\u8a08\u5283\uff1bgivastomig\u3001VIS-101\u53ca\u516c\u53f8\u5176\u4ed6\u5019\u9078\u85e5\u7269\u7684\u6230\u7565\u3001\u81e8\u5e8a\u958b\u767c\u3001\u8a08\u5283\u3001\u7d50\u679c\u3001\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\uff08\u5305\u62ec givastomig \u548c VIS-101\uff09\u7684\u6230\u7565\u8207\u81e8\u5e8a\u958b\u767c\uff1b\u9810\u671f\u7684\u81e8\u5e8a\u91cc\u7a0b\u7891\u548c\u7d50\u679c\u53ca\u76f8\u95dc\u6642\u9593\uff1b\u516c\u53f8\u7684\u9810\u671f\u8cc7\u91d1\u53ef\u7dad\u6301\u904b\u71df\u7684\u5468\u671f\u3002\u524d\u77bb\u6027\u8072\u660e\u6d89\u53ca\u7684\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u4e2d\u5305\u542b\u7684\u7d50\u679c\u5b58\u5728\u91cd\u5927\u5dee\u7570\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u56e0\u7d20\uff1a\u65b0\u6a4b\u751f\u7269\u8b49\u660e\u5176\u5019\u9078\u85e5\u7269\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7684\u80fd\u529b\uff1b\u516c\u53f8\u7372\u5f97\u8b49\u5238\u76e3\u7ba1\u6a5f\u69cb\u53ca\u4ea4\u6613\u6240\u5fc5\u8981\u6279\u51c6\u7684\u80fd\u529b\uff1b\u5019\u9078\u85e5\u7269\u7684\u81e8\u5e8a\u7d50\u679c\uff08\u53ef\u80fd\u652f\u6301\u4e5f\u53ef\u80fd\u4e0d\u652f\u6301\u9032\u4e00\u6b65\u958b\u767c\u6216\u65b0\u85e5\u7533\u8acb\/\u751f\u7269\u5236\u54c1\u8a31\u53ef\u7533\u8acb\uff08NDA\/BLA\uff09\u7684\u6279\u51c6\uff09\uff1b\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\uff08\u5305\u62ec\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\u4ee5\u53ca\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5c31\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\u76e3\u7ba1\u5be9\u6279\u6240\u4f5c\u6c7a\u5b9a\u7684\u5167\u5bb9\u548c\u6642\u9593\uff1b\u65b0\u6a4b\u751f\u7269\u5728\u5019\u9078\u85e5\u7269\u7372\u6279\u5f8c\u7684\u5546\u696d\u6210\u529f\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u4e26\u7dad\u8b77\u5176\u6280\u8853\u548c\u85e5\u7269\u77e5\u8b58\u7522\u6b0a\u4fdd\u8b77\u7684\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u5c0d\u7b2c\u4e09\u65b9\u958b\u5c55\u85e5\u7269\u958b\u767c\u3001\u751f\u7522\u5236\u9020\u53ca\u5176\u4ed6\u670d\u52d9\u7684\u4f9d\u8cf4\uff1b\u65b0\u6a4b\u751f\u7269\u6709\u9650\u7684\u904b\u71df\u6b77\u53f2\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u984d\u5916\u904b\u71df\u8cc7\u91d1\u4e26\u5b8c\u6210\u5176\u5019\u9078\u85e5\u7269\u958b\u767c\u548c\u5546\u696d\u5316\u7684\u80fd\u529b\uff1b\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u5df2\u65bc2025\u5e744\u67083\u65e5\u5411\u7f8e\u570bSEC\u63d0\u4ea4\u768420-F\u5e74\u5ea6\u5831\u544a\u4e2d\u300c\u98a8\u96aa\u56e0\u7d20\u300d\u90e8\u5206\u66f4\u5168\u9762\u8a0e\u8ad6\u7684\u98a8\u96aa\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u96a8\u5f8c\u5411SEC\u63d0\u4ea4\u7684\u6587\u4ef6\u4e2d\u8a0e\u8ad6\u7684\u6f5b\u5728\u98a8\u96aa\u3001\u4e0d\u78ba\u5b9a\u6027\u548c\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u3002\u6240\u6709\u524d\u77bb\u6027\u8072\u660e\u5747\u57fa\u65bc\u65b0\u6a4b\u751f\u7269\u7576\u524d\u53ef\u7372\u5f97\u7684\u4fe1\u606f\u3002\u9664\u6cd5\u5f8b\u8981\u6c42\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u4e0d\u627f\u64d4\u56e0\u7372\u5f97\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u6216\u4fee\u8a02\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u7684\u7fa9\u52d9\u3002 \u65b0\u6a4b\u751f\u7269\u6295\u8cc7\u8005\u53ca\u5a92\u9ad4\u806f\u7e6b\u4ebaPJ Kelleher \u2013 LifeSci Advisors+1-617-430-7579pkelleher@lifesciadvisors.com \u96f7\u9cf4\uff08Kyler Lei\uff09\u2013 \u65b0\u6a4b\u751f\u7269+1-240-745-6330kyler.lei@imabbio.comIR@imabbio.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pingtungtimes.com.tw\/?p=376800","og_locale":"zh_TW","og_type":"article","og_title":"I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","og_description":"\u5168\u65b0\u4f01\u696d\u54c1\u724c\u6a19\u8a8c\u8457\u516c\u53f8\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u7684\u6230\u7565\u8f49\u578b\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002  \u516c\u53f8\u64ec\u5728\u9999\u6e2f\u9032\u884c\u9996\u6b21\u516c\u958b\u52df\u80a1\uff08IPO\uff09\uff0c\u4e26\u901a\u904e\u5728\u7f8e\u570b\u7d0d\u65af\u9054\u514b\uff08NASDAQ\uff09\u548c\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\uff0c\u64f4\u5927\u5c0d\u5168\u7403\u8cc7\u672c\u548c\u5275\u65b0\u8cc7\u6e90\u7684\u93c8\u63a5\u3002  \u57fa\u65bc\u5168\u65b0\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u696d\u52d9\u6a21\u5f0f\uff0c\u516c\u53f8\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara Inc. (Visara)\uff0c\u4e26\u5df2\u6536\u8cfc\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50VIS-101\uff08\u9776\u5411 VEGF-A\/ANG2\uff09\u3002\u76f8\u8f03\u73fe\u884c\u6a19\u6e96\u7642\u6cd5\uff0cVIS-101\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u3001\u66f4\u6709\u6548\u7684\u6cbb\u7642\u9078\u64c7\u3002  \u516c\u53f8\u6838\u5fc3\u8cc7\u7522givastomig\uff08\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff09\uff0c\u6b63\u6309\u7167\u6b64\u524d\u516c\u5e03\u7684\u6295\u8cc7\u8a08\u5283\u6301\u7e8c\u63a8\u9032\u7814\u767c\u3002  \u99ac\u91cc\u862d\u5dde\u7f85\u514b\u7dad\u723e2025\u5e7410\u670829\u65e5 \/\u7f8e\u901a\u793e\/ -- \u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff0c\u4e0b\u7a31\u300c\u65b0\u6a4b\u751f\u7269\u300d\u6216\u300c\u516c\u53f8\u300d\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u516c\u53f8\u5df2\u5b8c\u6210\u540d\u7a31\u8b8a\u66f4\uff0c\u7531\u300cI-Mab\u300d\u6b63\u5f0f\u66f4\u540d\u70ba\u300c\u65b0\u6a4b\u751f\u7269\u300d\u3002\u6b64\u9805\u66f4\u540d\u6c7a\u8b70\u5df2\u7372\u5f97\u516c\u53f8\u65bc2025\u5e7410\u670824\u65e5\u53ec\u958b\u7684\u7279\u5225\u80a1\u6771\u5927\u6703\u9ad8\u7968\u901a\u904e\uff0c\u4e26\u7372\u8463\u4e8b\u6703\u6279\u51c6\u3002\u81ea2025\u5e7410\u670830\u65e5\u958b\u76e4\u8d77\uff0c\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u5c07\u6b63\u5f0f\u555f\u7528\u65b0\u516c\u53f8\u540d\u7a31\u53ca\u65b0\u80a1\u7968\u4ee3\u78bc\u300cNBP\u300d\uff08Nasdaq: NBP\uff09\uff0c\u53d6\u4ee3\u73fe\u6709\u4ee3\u78bc\u300cIMAB\u300d\uff08Nasdaq: IMAB\uff09\u3002 \u516c\u53f8\u540c\u6b65\u4e0a\u7dda\u5168\u65b0\u54c1\u724c\u53ca\u5b98\u7db2\uff08www.novabridge.com\uff09\uff0c\u6a19\u8a8c\u8457\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u6230\u7565\u8f49\u578b\u9081\u51fa\u95dc\u9375\u4e00\u6b65\uff0c\u6301\u7e8c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u7642\u6cd5\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002 \u95dc\u65bc\u6b64\u6b21\u540d\u7a31\u53ca\u80a1\u7968\u4ee3\u78bc\u8b8a\u66f4\uff0c\u73fe\u6709\u80a1\u6771\u7121\u9700\u9032\u884c\u4efb\u4f55\u884c\u52d5\uff0c\u516c\u53f8CUSIP\u865f\u78bc\u5c07\u4fdd\u6301\u4e0d\u8b8a\u3002\u5728\u90e8\u5206\u7b2c\u4e09\u65b9\u7db2\u7ad9\u6216\u61c9\u7528\u7a0b\u5e8f\u4e0a\uff0c\u82e5\u641c\u7d22\u300cNovaBridge Biosciences\u300d\u6216\u300cNBP\u300d\u6642\uff0c\u53ef\u80fd\u66ab\u6642\u7121\u6cd5\u67e5\u8a62\u5230\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u57282025\u5e7410\u670830\u65e5\u4e4b\u524d\u7684\u6b77\u53f2\u4ea4\u6613\u6578\u64da\u3002\u5982\u9047\u6b64\u7a2e\u60c5\u6cc1\uff0c\u76f8\u95dc\u6578\u64da\u53ef\u66ab\u6642\u901a\u904e\u641c\u7d22\u300cI-MAB\u300d\u6216\u300cIMAB\u300d\u9032\u884c\u67e5\u8a62\u3002 \u65b0\u6a4b\u751f\u7269Logo - \u76f8\u9023\u7684\u5206\u5b50\u7d50\u69cb\u7d44\u5408\u6210\u5b57\u6bcd\u300cN\u300d\uff0c\u5bd3\u610f\u516c\u53f8\u8207\u5408\u4f5c\u4f19\u4f34\u651c\u624b\u5171\u5efa\u66f4\u5065\u5eb7\u672a\u4f86\uff1b\u958b\u653e\u7684\u5713\u74b0\u8c61\u5fb5\u6301\u7e8c\u5275\u65b0\u8207\u63a2\u7d22\u7cbe\u795e\u3002 \u65b0\u6a4b\u751f\u7269\u57f7\u884c\u8463\u4e8b\u9577\u5085\u552f\u5148\u751f\u8868\u793a\uff1a\u300c\u5168\u65b0\u7684\u4f01\u696d\u54c1\u724c\u5f62\u8c61\u751f\u52d5\u9ad4\u73fe\u4e86\u6211\u5011\u65b0\u7684\u6230\u7565\u6838\u5fc3\u2014\u2014\u901a\u904e\u9ad8\u6548\u5354\u4f5c\u3001\u79d1\u5b78\u8f49\u5316\u8207\u5353\u8d8a\u57f7\u884c\uff0c\u52a0\u901f\u63a8\u9032\u8b8a\u9769\u6027\u7642\u6cd5\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u66f4\u5927\u50f9\u503c\u3002\u7f8e\u6e2f\u5169\u5730\u96d9\u91cd\u4e0a\u5e02\u662f\u516c\u53f8\u5168\u7403\u5316\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\uff0c\u9019\u5c07\u5e6b\u52a9\u6211\u5011\u62d3\u5bec\u6295\u8cc7\u8005\u7bc4\u570d\u3001\u63d0\u5347\u4ea4\u6613\u6d41\u52d5\u6027\u548c\u8cc7\u672c\u93c8\u63a5\u80fd\u529b\uff0c\u4e26\u5f37\u5316\u5728\u5feb\u901f\u589e\u9577\u7684\u4e9e\u6d32\u5e02\u5834\u7684\u5f71\u97ff\u529b\u3002\u300d \u65b0\u6a4b\u751f\u7269\u9996\u5e2d\u57f7\u884c\u5b98\u5085\u5e0c\u6e67\u535a\u58eb\u8868\u793a\uff1a\u300c\u65b0\u54c1\u724c\u5f62\u8c61\u8207\u6211\u5011\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u8f49\u578b\u7684\u6230\u7565\u9ad8\u5ea6\u4e00\u81f4\u3002\u8fd1\u671f\uff0c\u5728\u91dd\u5c0dgivastomig\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u80c3\u764c\u6cbb\u7642\u9818\u57df\u7684\u540c\u985e\u6700\u4f73 Claudin 18.2 \u9776\u5411\u7642\u6cd5\uff09\u7684\u300e\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300f\u4e0a\uff0c\u516c\u5e03\u4e86\u4ee4\u4eba\u632f\u596e\u7684I\u671f\u55ae\u85e5\u81e8\u5e8a\u6700\u65b0\u6578\u64da\uff1b\u540c\u6642\uff0c\u6211\u5011\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara \uff0c\u53ca\u5176\u8fd1\u671f\u6536\u8cfc\u7684 VIS\u2011101\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u4e0b\u4e00\u4ee3\u540c\u985e\u6700\u4f73\u7684\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff09\uff0c\u9032\u4e00\u6b65\u9a57\u8b49\u4e86\u65b0\u6230\u7565\u7684\u53ef\u884c\u6027\u3002\u6211\u5011\u6b63\u7a4d\u6975\u63a8\u9032 givastomig \u5168\u7403\u96a8\u6a5f\u5c0d\u7167 II \u671f\u7814\u7a76\uff0c\u9810\u8a08\u65bc\u202f2026\u202f\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5b8c\u6210\u9996\u4f8b\u60a3\u8005\u5165\u7d44\u3002\u6191\u501f\u65b0\u54c1\u724c\u5e36\u4f86\u7684\u7a4d\u6975\u52e2\u982d\uff0c\u5145\u5206\u91cb\u653e\u5275\u65b0\u85e5\u7269\u7684\u6f5b\u529b\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u50f9\u503c\u3002\u300d \u65b0\u6a4b\u751f\u7269\u7684\u5546\u696d\u6a21\u5f0f\u8207\u7522\u54c1\u7ba1\u7dda\u5e03\u5c40 \u516c\u53f8\u5c07\u8207\u5168\u7403\u9818\u5148\u5275\u65b0\u8005\u5408\u4f5c\uff0c\u7504\u9078\u4e26\u52a0\u901f\u9ad8\u6f5b\u529b\u85e5\u7269\u8cc7\u7522\u3002\u8a72\u6a21\u5f0f\u878d\u5408\u56b4\u8b39\u7684\u8cc7\u7522\u7504\u9078\u3001\u5b9a\u5236\u5316\u7684\u8f49\u5316\u7b56\u7565\u53ca\u9ad8\u6548\u81e8\u5e8a\u57f7\u884c\uff0c\u4e26\u4f9d\u6258\u5eb7\u6a4b\u8cc7\u672c\u6df1\u539a\u8cc7\u6e90\u8207\u5168\u7403\u80fd\u529b\uff0c\u5728\u591a\u6cbb\u7642\u9818\u57df\u63a8\u9032\u6700\u5177\u6f5b\u529b\u7684\u5275\u65b0\u85e5\u3002 \u516c\u53f8\u5c07\u63a1\u7528\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u6a21\u5f0f\uff0c\u901a\u904e\u8a2d\u7acb\u5c08\u6ce8\u7279\u5b9a\u6cbb\u7642\u9818\u57df\u6216\u8cc7\u7522\u7684\u885b\u661f\u5b50\u516c\u53f8\uff0c\u4fdd\u6301\u9ad8\u6548\u9748\u6d3b\u7684\u904b\u71df\u7d50\u69cb\uff0c\u5f9e\u800c\u5be6\u73fe\u98a8\u96aa\u53ef\u63a7\u8207\u50f9\u503c\u6700\u5927\u5316\u3002 \u7ba1\u7dda\u6982\u89bd   Givastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u76ee\u524d\u6b63\u5728\u958b\u5c551b\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u65e8\u5728\u7528\u65bc\u6cbb\u7642\u80c3\u764c\u53ca\u5176\u4ed6Claudin\u00a018.2\u967d\u6027\u7684\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u8a08\u5283\u555f\u52d5\u4e00\u9805\u5168\u7403\u96a8\u6a5f\u5c0d\u7167\u7684II\u671f\u7814\u7a76\uff0c\u76ee\u6a19\u65bc2026\u5e74\u7b2c\u4e00\u5b63\u5ea6\u62db\u52df\u9996\u4f4d\u60a3\u8005\u3002Givastomig\u6b63\u901a\u904e\u8207ABL\u00a0Bio\u7684\u5168\u7403\u5408\u4f5c\u9032\u884c\u806f\u5408\u958b\u767c\uff0c\u5176\u4e2d\u65b0\u6a4b\u751f\u7269\u4f5c\u70ba\u727d\u982d\u65b9\uff0c\u8207ABL\u00a0Bio\u5e73\u5206\u5168\u7403\u6b0a\u76ca\uff08\u5927\u4e2d\u83ef\u5340\u548c\u97d3\u570b\u9664\u5916\uff09\u3002  Ragistomig\u662f\u4e00\u6b3e\u6297PD-L1\u00d74-1BB\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\u3002\u57fa\u65bc\u4e00\u671f\u81e8\u5e8a\u6578\u64da\uff0c\u76ee\u524d\u958b\u5c55\u76841b\u671f\u7814\u7a76\u65e8\u5728\u64f4\u5927\u6cbb\u7642\u7a97\u53e3\uff0c\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u7522\u751f\u7d50\u679c\u3002\u8a72\u9805\u76ee\u6b63\u8207ABL Bio\u806f\u5408\u958b\u767c\u3002  Uliledlimab\uff08\u6297CD73\u55ae\u6297\uff09\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\uff0cCD73\u662f\u817a\u7518\u4ecb\u5c0e\u514d\u75ab\u6291\u5236\u7684\u9650\u901f\u9176\u3002\u76ee\u524d\u6b63\u5728\u958b\u5c55\u7684\u96a8\u6a5fII\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\uff0c\u5c07uliledlimab\u806f\u5408\u7279\u745e\u666e\u5229\u55ae\u6297\uff08toripalimab\uff09\u7684\u65b9\u6848\u8207\u5e15\u535a\u5229\u73e0\u55ae\u6297\uff08Pembrolizumab\uff09\u55ae\u85e5\u6216\u7279\u745e\u666e\u5229\u55ae\u6297\u55ae\u85e5\u5728\u7d93CD73\u7be9\u9078\u7684\u60a3\u8005\u4eba\u7fa4\u4e2d\u9032\u884c\u5c0d\u6bd4\uff0c\u5176\u7121\u9032\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u6578\u64da\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u516c\u5e03\u3002\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u5927\u4e2d\u83ef\u5340\u4ee5\u5916\u7684\u5168\u7403\u6b0a\u76ca\u3002  VIS-101\u7531\u65b0\u6a4b\u751f\u7269\u5728\u65b0\u5546\u696d\u6a21\u5f0f\u4e0b\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u6536\u8cfc\uff0c\u662f\u4e00\u6b3e\u9776\u5411VEGF-A\u548cANG2\u7684\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u76ee\u524d\u8655\u65bcII\u671f\u958b\u767c\u968e\u6bb5\u3002   VIS-101\u662f\u4e00\u6b3e\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff0c\u4e14\u5206\u5b50\u6d3b\u6027\u66f4\u5f37\uff0c\u76f8\u8f03\u65bc\u73fe\u6709\u6a19\u6e96\u7642\u6cd5\uff0c\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u3001\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u548c\u8996\u7db2\u819c\u975c\u8108\u963b\u585e\uff08RVO\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5b8c\u6210\u4e86\u521d\u6b65\u7684\u5b89\u5168\u6027\u548c\u5291\u91cf\u905e\u589e\u7814\u7a76\uff0c\u76ee\u524d\u6b63\u5728\u4e2d\u570b\u5b8c\u6210\u4e00\u9805\u96a8\u6a5f\u5291\u91cf\u7bc4\u570d\u7684II\u671f\u7814\u7a76\u3002VIS-101\u9810\u8a08\u5c07\u65bc2026\u5e74\u5177\u5099\u958b\u5c55III\u671f\u8a66\u9a57\u7684\u689d\u4ef6\u3002  \u6b64\u6b21\u6536\u8cfc\u5df2\u901a\u904e\u65b0\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u5b8c\u6210\u3002Visara\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u5236\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u540c\u985e\u6700\u4f73\u7684\u773c\u79d1\u7642\u6cd5\uff0c\u5176\u4f9d\u6258\u65b0\u6a4b\u751f\u7269\u7d043700\u842c\u7f8e\u5143\u7684\u6ce8\u8cc7\uff0c\u4ee5\u53ca\u4e00\u5bb6\u6230\u7565\u5408\u4f5c\u4f19\u4f34\u6240\u8ca2\u737b\u7684\u90e8\u5206\u76f8\u95dc\u6b0a\u76ca\u800c\u6210\u7acb\u3002\u65b0\u6a4b\u751f\u7269\u6210\u70ba Visara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002  Visara\u7531\u5176\u806f\u5408\u5275\u59cb\u4eba\u517c\u57f7\u884c\u8463\u4e8b\u9577Emmett\u00a0J.\u00a0Cunningham,\u00a0Jr.\u535a\u58eb\u9818\u5c0e\u3002Cunningham\u535a\u58eb\u5728\u904e\u53bb25\u5e74\u4e2d\u4e00\u76f4\u662f\u4e00\u4f4d\u91ab\u751f\u3001\u5275\u65b0\u8005\u3001\u4f01\u696d\u5bb6\u548c\u6295\u8cc7\u4eba\uff0c\u66fe\u4efb\u9ed1\u77f3\u96c6\u5718\u9ad8\u7d1a\u8463\u4e8b\u7e3d\u7d93\u7406\u4ee5\u53caClarus\u00a0Ventures\u8463\u4e8b\u7e3d\u7d93\u7406\u3002Cunningham\u535a\u58eb\u4e5f\u662f\u570b\u969b\u516c\u8a8d\u7684\u611f\u67d3\u6027\u548c\u708e\u75c7\u6027\u773c\u75c5\u5c08\u5bb6\uff0c\u5408\u4f5c\u767c\u8868\u4e86\u903e450\u7bc7\u5b78\u8853\u8ad6\u6587\u3002           1\uff1a\u300cAACR\u2013NCI\u2013EORTC \u5206\u5b50\u9776\u9ede\u8207\u764c\u75c7\u6cbb\u7642\u570b\u969b\u6703\u8b70\u300d\uff08AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics\uff09\u4e5f\u88ab\u7a31\u70ba\u300c\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300d\uff0c\u65bc 2025 \u5e74 10 \u6708 22 \u65e5\u81f3 26 \u65e5\u5728\u7f8e\u570b\u99ac\u85a9\u8af8\u585e\u5dde\u6ce2\u58eb\u9813\u8209\u884c\u3002         \u95dc\u65bc\u65b0\u6a4b\u751f\u7269 \u65b0\u6a4b\u751f\u7269\uff08\u66f4\u540d\u524d\u70baI-MAB\uff1b\u7d0d\u65af\u9054\u514b\u4ee3\u78bc\uff1aIMAB\uff0c\u81ea2025\u5e7410\u670830\u65e5\u8d77\u5c07\u66f4\u6539\u70ba\u300cNBP\u300d\uff09\u662f\u4e00\u5bb6\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u7684\u53ef\u53ca\u6027\u3002\u6211\u5011\u5c07\u5c08\u696d\u7684\u696d\u52d9\u62d3\u5c55\u80fd\u529b\u8207\u654f\u6377\u7684\u8f49\u5316\u81e8\u5e8a\u958b\u767c\u76f8\u7d50\u5408\uff0c\u4ee5\u767c\u73fe\u3001\u52a0\u901f\u4e26\u63a8\u9032\u7a81\u7834\u6027\u8cc7\u7522\u3002\u901a\u904e\u929c\u63a5\u79d1\u5b78\u3001\u6230\u7565\u548c\u57f7\u884c\uff0c\u65b0\u6a4b\u751f\u7269\u4f7f\u8b8a\u9769\u6027\u7642\u6cd5\u80fd\u5920\u5f9e\u767c\u73fe\u968e\u6bb5\u5feb\u901f\u63a8\u9032\u81f3\u6709\u9700\u6c42\u7684\u60a3\u8005\u3002 \u516c\u53f8\u7684\u5dee\u7570\u5316\u7ba1\u7dda\u4e3b\u8981\u7531givastomig\u548cVIS-101\u9818\u929c\u3002\u5176\u4e2d\uff0cgivastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff08Claudin 18.2\u00d74-1BB\uff09\uff1bVIS-101\u662f\u4e00\u6b3e\u540c\u985e\u7b2c\u4e8c\u4e14\u6709\u671b\u6210\u70ba\u540c\u985e\u6700\u4f73\u7684\u96d9\u529f\u80fd\u751f\u7269\u5236\u5291\uff0c\u9776\u5411VEGF-A\u548cANG2\u3002 Givastomig\u901a\u904e4-1BB\u4fe1\u865f\u901a\u8def\uff0c\u5728\u8868\u9054Claudin 18.2\u7684\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u689d\u4ef6\u6027\u6fc0\u6d3bT\u7d30\u80de\u3002givastomig\u6b63\u958b\u767c\u7528\u65bc\u6cbb\u7642Claudin 18.2\u967d\u6027\u7684\u80c3\u764c\u53ca\u5176\u4ed6\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u65b0\u6a4b\u751f\u7269\u9084\u8207\u5408\u4f5c\u4f19\u4f34ABL Bio\u5408\u4f5c\u958b\u767cragistomig\uff0c\u9019\u662f\u4e00\u6b3e\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u5728\u5be6\u9ad4\u7624\u4e2d\u5c07PD-L1\u4f5c\u70ba\u816b\u7624\u7d50\u5408\u9776\u9ede\u30014-1BB\u4f5c\u70ba\u689d\u4ef6\u6027T\u7d30\u80de\u6fc0\u6d3b\u5291\u3002\u6b64\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u4e2d\u570b\u4ee5\u5916\u5730\u5340\u7684\u5168\u7403\u6b0a\u76ca\u3002Uliledlimab\u662f\u4e00\u6b3e\u6297CD73\u6297\u9ad4\uff0c\u9776\u5411\u816b\u7624\u4e2d\u7531\u817a\u7518\u4ecb\u5c0e\u7684\u514d\u75ab\u6291\u5236\u3002 VIS-101\u9776\u5411VEGF-A\u548cANG2\uff0c\u53ef\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u5f37\u6709\u529b\u4e14\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u76ee\u524d\u6b63\u5728\u91dd\u5c0d\u6fd5\u6027AMD\u958b\u5c55\u4e00\u9805\u5927\u578b\u3001\u96a8\u6a5f\u3001\u5291\u91cf\u7bc4\u570d\u76842\u671f\u7814\u7a76\u3002\u65b0\u6a4b\u751f\u7269\u662fVisara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002 \u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f\uff1ahttps:\/\/www.novabridge.com\u00a0 \u516c\u53f8\u64ec\u5728\u7d0d\u65af\u9054\u514b\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u96d9\u91cd\u4e0a\u5e02 \u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u64ec\u8d74\u9999\u6e2fIPO\u4e26\u5728\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u4e0a\u5e02\u7684\u66f4\u591a\u4fe1\u606f\u5c07\u65bc\u65e5\u5f8c\u516c\u5e03\u3002 \u64ec\u8b70\u767c\u884c\u7684\u6642\u9593\u3001\u898f\u6a21\u3001\u7d50\u69cb\u548c\u5177\u9ad4\u689d\u6b3e\u5c1a\u672a\u78ba\u5b9a\uff0c\u4ecd\u53d6\u6c7a\u65bc\u5e02\u5834\u72c0\u6cc1\u4ee5\u53ca\u5305\u62ec\u9999\u6e2f\u806f\u4ea4\u6240\uff08\u53ca\u5176\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5728\u5167\u7684\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\u7684\u5be9\u6279\u3002\u5c0d\u65bc\u64ec\u8b70\u7684\u9999\u6e2f\u4e0a\u5e02\u662f\u5426\u6703\u5b8c\u6210\u3001\u4f55\u6642\u5b8c\u6210\u6216\u5c07\u5728\u4f55\u7a2e\u689d\u6b3e\u4e0b\u5b8c\u6210\uff0c\u7121\u6cd5\u63d0\u4f9b\u4efb\u4f55\u4fdd\u8b49\u3002 \u5728\u7372\u5f97\u76e3\u7ba1\u6a5f\u69cb\u548c\u516c\u53f8\u5fc5\u8981\u6279\u51c6\u7684\u524d\u63d0\u4e0b\uff0c\u516c\u53f8\u76ee\u524d\u9810\u8a08\u5c07\u7dad\u6301\u5176\u5728\u7d0d\u65af\u9054\u514b\u7684\u7f8e\u570b\u5b58\u6258\u80a1\uff08ADS\uff09\u4e0a\u5e02\u5730\u4f4d\uff0c\u4e26\u5c0b\u6c42\u5728\u7f8e\u570b\u548c\u9999\u6e2f\u5be6\u73fe\u96d9\u91cd\u4e0a\u5e02\u3002\u6700\u7d42\u6c7a\u5b9a\u5c07\u6839\u64da\u5e02\u5834\u72c0\u6cc1\u548c\u76e3\u7ba1\u53cd\u994b\u4f5c\u51fa\u3002 \u672c\u516c\u544a\u50c5\u70ba\u4fe1\u606f\u62ab\u9732\u4e4b\u7528\uff0c\u4e14\u4e0d\u69cb\u6210\u5c0d\u516c\u53f8\u4efb\u4f55\u8b49\u5238\u7684\u8a8d\u8cfc\u3001\u8cfc\u8cb7\u6216\u6536\u8cfc\u8981\u7d04\u6216\u9080\u8acb\u3002\u516c\u53f8\u80a1\u6771\u53ca\u6f5b\u5728\u6295\u8cc7\u8005\u5728\u6d89\u53ca\u516c\u53f8\u8b49\u5238\u7684\u4ea4\u6613\u6642\uff0c\u61c9\u8b39\u614e\u8a55\u4f30\u76f8\u95dc\u98a8\u96aa\u3002 \u524d\u77bb\u6027\u8072\u660e \u672c\u516c\u544a\u5305\u542b\u524d\u77bb\u6027\u8072\u660e\u3002\u9019\u4e9b\u8072\u660e\u4f9d\u64da1995\u5e74\u7f8e\u570b\u300a\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u7684\u300c\u5b89\u5168\u6e2f\u300d\u689d\u6b3e\u4f5c\u51fa\u3002\u53ef\u4ee5\u901a\u904e\u8853\u8a9e\u4f8b\u5982\u300c\u5c07\u300d\u3001\u300c\u9810\u8a08\u300d\u3001\u300c\u76f8\u4fe1\u300d\u3001\u300c\u65e8\u5728\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u3001\u300c\u6253\u7b97\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u4f30\u8a08\u300d\u3001\u300c\u6709\u4fe1\u5fc3\u300d\u7b49\u4ee5\u53ca\u985e\u4f3c\u8868\u8ff0\uff08\u6216\u5176\u53cd\u7fa9\u8868\u8ff0\uff09\u4f86\u8b58\u5225\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u3002\u65b0\u6a4b\u751f\u7269\u4e5f\u53ef\u80fd\u5728\u5176\u63d0\u4ea4\u7d66\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u7684\u5b9a\u671f\u5831\u544a\u3001\u5411\u80a1\u6771\u767c\u5e03\u7684\u5e74\u5ea6\u5831\u544a\u3001\u65b0\u805e\u7a3f\u53ca\u5176\u4ed6\u66f8\u9762\u6750\u6599\u4e2d\uff0c\u4ee5\u53ca\u516c\u53f8\u9ad8\u7ba1\u3001\u8463\u4e8b\u6216\u54e1\u5de5\u5411\u7b2c\u4e09\u65b9\u6240\u4f5c\u7684\u53e3\u982d\u9673\u8ff0\u4e2d\u4f5c\u51fa\u66f8\u9762\u6216\u53e3\u982d\u7684\u524d\u77bb\u6027\u8072\u660e\u3002\u51e1\u4e0d\u5c6c\u65bc\u6b77\u53f2\u4e8b\u5be6\u7684\u9673\u8ff0\uff08\u5305\u62ec\u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u7684\u4fe1\u5ff5\u548c\u9810\u671f\u7684\u9673\u8ff0\uff09\u5747\u70ba\u524d\u77bb\u6027\u8072\u660e\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u7684\u524d\u77bb\u6027\u8072\u660e\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u5167\u5bb9\uff1a\u65b0\u7684\u516c\u53f8\u6230\u7565\u53ef\u80fd\u5e36\u4f86\u7684\u6f5b\u5728\u76ca\u8655\uff1b\u516c\u53f8\u4ee5\u65b0\u540d\u7a31\u548c\u80a1\u7968\u4ee3\u78bc\u5728\u7d0d\u65af\u9054\u514b\u4ea4\u6613\u7684\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u64ec\u63a8\u9032\u9999\u6e2f IPO\uff0c\u9032\u800c\u5be6\u73fe\u64ec\u5728\u7d0d\u65af\u9054\u514b\u5168\u7403\u5e02\u5834\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\u7684\u8a08\u5283\uff1bgivastomig\u3001VIS-101\u53ca\u516c\u53f8\u5176\u4ed6\u5019\u9078\u85e5\u7269\u7684\u6230\u7565\u3001\u81e8\u5e8a\u958b\u767c\u3001\u8a08\u5283\u3001\u7d50\u679c\u3001\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\uff08\u5305\u62ec givastomig \u548c VIS-101\uff09\u7684\u6230\u7565\u8207\u81e8\u5e8a\u958b\u767c\uff1b\u9810\u671f\u7684\u81e8\u5e8a\u91cc\u7a0b\u7891\u548c\u7d50\u679c\u53ca\u76f8\u95dc\u6642\u9593\uff1b\u516c\u53f8\u7684\u9810\u671f\u8cc7\u91d1\u53ef\u7dad\u6301\u904b\u71df\u7684\u5468\u671f\u3002\u524d\u77bb\u6027\u8072\u660e\u6d89\u53ca\u7684\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u4e2d\u5305\u542b\u7684\u7d50\u679c\u5b58\u5728\u91cd\u5927\u5dee\u7570\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u56e0\u7d20\uff1a\u65b0\u6a4b\u751f\u7269\u8b49\u660e\u5176\u5019\u9078\u85e5\u7269\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7684\u80fd\u529b\uff1b\u516c\u53f8\u7372\u5f97\u8b49\u5238\u76e3\u7ba1\u6a5f\u69cb\u53ca\u4ea4\u6613\u6240\u5fc5\u8981\u6279\u51c6\u7684\u80fd\u529b\uff1b\u5019\u9078\u85e5\u7269\u7684\u81e8\u5e8a\u7d50\u679c\uff08\u53ef\u80fd\u652f\u6301\u4e5f\u53ef\u80fd\u4e0d\u652f\u6301\u9032\u4e00\u6b65\u958b\u767c\u6216\u65b0\u85e5\u7533\u8acb\/\u751f\u7269\u5236\u54c1\u8a31\u53ef\u7533\u8acb\uff08NDA\/BLA\uff09\u7684\u6279\u51c6\uff09\uff1b\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\uff08\u5305\u62ec\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\u4ee5\u53ca\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5c31\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\u76e3\u7ba1\u5be9\u6279\u6240\u4f5c\u6c7a\u5b9a\u7684\u5167\u5bb9\u548c\u6642\u9593\uff1b\u65b0\u6a4b\u751f\u7269\u5728\u5019\u9078\u85e5\u7269\u7372\u6279\u5f8c\u7684\u5546\u696d\u6210\u529f\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u4e26\u7dad\u8b77\u5176\u6280\u8853\u548c\u85e5\u7269\u77e5\u8b58\u7522\u6b0a\u4fdd\u8b77\u7684\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u5c0d\u7b2c\u4e09\u65b9\u958b\u5c55\u85e5\u7269\u958b\u767c\u3001\u751f\u7522\u5236\u9020\u53ca\u5176\u4ed6\u670d\u52d9\u7684\u4f9d\u8cf4\uff1b\u65b0\u6a4b\u751f\u7269\u6709\u9650\u7684\u904b\u71df\u6b77\u53f2\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u984d\u5916\u904b\u71df\u8cc7\u91d1\u4e26\u5b8c\u6210\u5176\u5019\u9078\u85e5\u7269\u958b\u767c\u548c\u5546\u696d\u5316\u7684\u80fd\u529b\uff1b\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u5df2\u65bc2025\u5e744\u67083\u65e5\u5411\u7f8e\u570bSEC\u63d0\u4ea4\u768420-F\u5e74\u5ea6\u5831\u544a\u4e2d\u300c\u98a8\u96aa\u56e0\u7d20\u300d\u90e8\u5206\u66f4\u5168\u9762\u8a0e\u8ad6\u7684\u98a8\u96aa\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u96a8\u5f8c\u5411SEC\u63d0\u4ea4\u7684\u6587\u4ef6\u4e2d\u8a0e\u8ad6\u7684\u6f5b\u5728\u98a8\u96aa\u3001\u4e0d\u78ba\u5b9a\u6027\u548c\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u3002\u6240\u6709\u524d\u77bb\u6027\u8072\u660e\u5747\u57fa\u65bc\u65b0\u6a4b\u751f\u7269\u7576\u524d\u53ef\u7372\u5f97\u7684\u4fe1\u606f\u3002\u9664\u6cd5\u5f8b\u8981\u6c42\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u4e0d\u627f\u64d4\u56e0\u7372\u5f97\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u6216\u4fee\u8a02\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u7684\u7fa9\u52d9\u3002 \u65b0\u6a4b\u751f\u7269\u6295\u8cc7\u8005\u53ca\u5a92\u9ad4\u806f\u7e6b\u4ebaPJ Kelleher \u2013 LifeSci Advisors+1-617-430-7579pkelleher@lifesciadvisors.com \u96f7\u9cf4\uff08Kyler Lei\uff09\u2013 \u65b0\u6a4b\u751f\u7269+1-240-745-6330kyler.lei@imabbio.comIR@imabbio.com","og_url":"https:\/\/pingtungtimes.com.tw\/?p=376800","og_site_name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","article_publisher":"https:\/\/www.facebook.com\/pingtungnews","article_published_time":"2025-10-29T15:09:00+00:00","og_image":[{"width":1706,"height":960,"url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","type":"image\/jpeg"}],"author":"\u7f8e\u901a\u793e","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005:":"\u7f8e\u901a\u793e","\u9810\u4f30\u95b1\u8b80\u6642\u9593":"1 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/pingtungtimes.com.tw\/?p=376800#article","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=376800"},"author":{"name":"\u7f8e\u901a\u793e","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3"},"headline":"I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002","datePublished":"2025-10-29T15:09:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=376800"},"wordCount":215,"publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=376800#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/image_5053990_46034728.jpg","articleSection":["\u7f8e\u901a\u793e"],"inLanguage":"zh-TW"},{"@type":"WebPage","@id":"https:\/\/pingtungtimes.com.tw\/?p=376800","url":"https:\/\/pingtungtimes.com.tw\/?p=376800","name":"I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=376800#primaryimage"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=376800#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/image_5053990_46034728.jpg","datePublished":"2025-10-29T15:09:00+00:00","description":"\u5168\u65b0\u4f01\u696d\u54c1\u724c\u6a19\u8a8c\u8457\u516c\u53f8\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u7684\u6230\u7565\u8f49\u578b\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002 \u516c\u53f8\u64ec\u5728\u9999\u6e2f\u9032\u884c\u9996\u6b21\u516c\u958b\u52df\u80a1\uff08IPO\uff09\uff0c\u4e26\u901a\u904e\u5728\u7f8e\u570b\u7d0d\u65af\u9054\u514b\uff08NASDAQ\uff09\u548c\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\uff0c\u64f4\u5927\u5c0d\u5168\u7403\u8cc7\u672c\u548c\u5275\u65b0\u8cc7\u6e90\u7684\u93c8\u63a5\u3002 \u57fa\u65bc\u5168\u65b0\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u696d\u52d9\u6a21\u5f0f\uff0c\u516c\u53f8\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara Inc. (Visara)\uff0c\u4e26\u5df2\u6536\u8cfc\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50VIS-101\uff08\u9776\u5411 VEGF-A\/ANG2\uff09\u3002\u76f8\u8f03\u73fe\u884c\u6a19\u6e96\u7642\u6cd5\uff0cVIS-101\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u3001\u66f4\u6709\u6548\u7684\u6cbb\u7642\u9078\u64c7\u3002 \u516c\u53f8\u6838\u5fc3\u8cc7\u7522givastomig\uff08\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff09\uff0c\u6b63\u6309\u7167\u6b64\u524d\u516c\u5e03\u7684\u6295\u8cc7\u8a08\u5283\u6301\u7e8c\u63a8\u9032\u7814\u767c\u3002 \u99ac\u91cc\u862d\u5dde\u7f85\u514b\u7dad\u723e2025\u5e7410\u670829\u65e5 \/\u7f8e\u901a\u793e\/ -- \u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff0c\u4e0b\u7a31\u300c\u65b0\u6a4b\u751f\u7269\u300d\u6216\u300c\u516c\u53f8\u300d\uff09\u4eca\u65e5\u5ba3\u5e03\uff0c\u516c\u53f8\u5df2\u5b8c\u6210\u540d\u7a31\u8b8a\u66f4\uff0c\u7531\u300cI-Mab\u300d\u6b63\u5f0f\u66f4\u540d\u70ba\u300c\u65b0\u6a4b\u751f\u7269\u300d\u3002\u6b64\u9805\u66f4\u540d\u6c7a\u8b70\u5df2\u7372\u5f97\u516c\u53f8\u65bc2025\u5e7410\u670824\u65e5\u53ec\u958b\u7684\u7279\u5225\u80a1\u6771\u5927\u6703\u9ad8\u7968\u901a\u904e\uff0c\u4e26\u7372\u8463\u4e8b\u6703\u6279\u51c6\u3002\u81ea2025\u5e7410\u670830\u65e5\u958b\u76e4\u8d77\uff0c\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u5c07\u6b63\u5f0f\u555f\u7528\u65b0\u516c\u53f8\u540d\u7a31\u53ca\u65b0\u80a1\u7968\u4ee3\u78bc\u300cNBP\u300d\uff08Nasdaq: NBP\uff09\uff0c\u53d6\u4ee3\u73fe\u6709\u4ee3\u78bc\u300cIMAB\u300d\uff08Nasdaq: IMAB\uff09\u3002 \u516c\u53f8\u540c\u6b65\u4e0a\u7dda\u5168\u65b0\u54c1\u724c\u53ca\u5b98\u7db2\uff08www.novabridge.com\uff09\uff0c\u6a19\u8a8c\u8457\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u6230\u7565\u8f49\u578b\u9081\u51fa\u95dc\u9375\u4e00\u6b65\uff0c\u6301\u7e8c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u7642\u6cd5\u60e0\u53ca\u5168\u7403\u60a3\u8005\u3002 \u95dc\u65bc\u6b64\u6b21\u540d\u7a31\u53ca\u80a1\u7968\u4ee3\u78bc\u8b8a\u66f4\uff0c\u73fe\u6709\u80a1\u6771\u7121\u9700\u9032\u884c\u4efb\u4f55\u884c\u52d5\uff0c\u516c\u53f8CUSIP\u865f\u78bc\u5c07\u4fdd\u6301\u4e0d\u8b8a\u3002\u5728\u90e8\u5206\u7b2c\u4e09\u65b9\u7db2\u7ad9\u6216\u61c9\u7528\u7a0b\u5e8f\u4e0a\uff0c\u82e5\u641c\u7d22\u300cNovaBridge Biosciences\u300d\u6216\u300cNBP\u300d\u6642\uff0c\u53ef\u80fd\u66ab\u6642\u7121\u6cd5\u67e5\u8a62\u5230\u516c\u53f8\u7f8e\u570b\u5b58\u6258\u80a1\u4efd\uff08ADS\uff09\u57282025\u5e7410\u670830\u65e5\u4e4b\u524d\u7684\u6b77\u53f2\u4ea4\u6613\u6578\u64da\u3002\u5982\u9047\u6b64\u7a2e\u60c5\u6cc1\uff0c\u76f8\u95dc\u6578\u64da\u53ef\u66ab\u6642\u901a\u904e\u641c\u7d22\u300cI-MAB\u300d\u6216\u300cIMAB\u300d\u9032\u884c\u67e5\u8a62\u3002 \u65b0\u6a4b\u751f\u7269Logo - \u76f8\u9023\u7684\u5206\u5b50\u7d50\u69cb\u7d44\u5408\u6210\u5b57\u6bcd\u300cN\u300d\uff0c\u5bd3\u610f\u516c\u53f8\u8207\u5408\u4f5c\u4f19\u4f34\u651c\u624b\u5171\u5efa\u66f4\u5065\u5eb7\u672a\u4f86\uff1b\u958b\u653e\u7684\u5713\u74b0\u8c61\u5fb5\u6301\u7e8c\u5275\u65b0\u8207\u63a2\u7d22\u7cbe\u795e\u3002 \u65b0\u6a4b\u751f\u7269\u57f7\u884c\u8463\u4e8b\u9577\u5085\u552f\u5148\u751f\u8868\u793a\uff1a\u300c\u5168\u65b0\u7684\u4f01\u696d\u54c1\u724c\u5f62\u8c61\u751f\u52d5\u9ad4\u73fe\u4e86\u6211\u5011\u65b0\u7684\u6230\u7565\u6838\u5fc3\u2014\u2014\u901a\u904e\u9ad8\u6548\u5354\u4f5c\u3001\u79d1\u5b78\u8f49\u5316\u8207\u5353\u8d8a\u57f7\u884c\uff0c\u52a0\u901f\u63a8\u9032\u8b8a\u9769\u6027\u7642\u6cd5\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u66f4\u5927\u50f9\u503c\u3002\u7f8e\u6e2f\u5169\u5730\u96d9\u91cd\u4e0a\u5e02\u662f\u516c\u53f8\u5168\u7403\u5316\u6230\u7565\u7684\u95dc\u9375\u4e00\u6b65\uff0c\u9019\u5c07\u5e6b\u52a9\u6211\u5011\u62d3\u5bec\u6295\u8cc7\u8005\u7bc4\u570d\u3001\u63d0\u5347\u4ea4\u6613\u6d41\u52d5\u6027\u548c\u8cc7\u672c\u93c8\u63a5\u80fd\u529b\uff0c\u4e26\u5f37\u5316\u5728\u5feb\u901f\u589e\u9577\u7684\u4e9e\u6d32\u5e02\u5834\u7684\u5f71\u97ff\u529b\u3002\u300d \u65b0\u6a4b\u751f\u7269\u9996\u5e2d\u57f7\u884c\u5b98\u5085\u5e0c\u6e67\u535a\u58eb\u8868\u793a\uff1a\u300c\u65b0\u54c1\u724c\u5f62\u8c61\u8207\u6211\u5011\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u8f49\u578b\u7684\u6230\u7565\u9ad8\u5ea6\u4e00\u81f4\u3002\u8fd1\u671f\uff0c\u5728\u91dd\u5c0dgivastomig\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u80c3\u764c\u6cbb\u7642\u9818\u57df\u7684\u540c\u985e\u6700\u4f73 Claudin 18.2 \u9776\u5411\u7642\u6cd5\uff09\u7684\u300e\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300f\u4e0a\uff0c\u516c\u5e03\u4e86\u4ee4\u4eba\u632f\u596e\u7684I\u671f\u55ae\u85e5\u81e8\u5e8a\u6700\u65b0\u6578\u64da\uff1b\u540c\u6642\uff0c\u6211\u5011\u5df2\u6210\u7acb\u5b50\u516c\u53f8 Visara \uff0c\u53ca\u5176\u8fd1\u671f\u6536\u8cfc\u7684 VIS\u2011101\uff08\u4e00\u6b3e\u6709\u671b\u6210\u70ba\u4e0b\u4e00\u4ee3\u540c\u985e\u6700\u4f73\u7684\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff09\uff0c\u9032\u4e00\u6b65\u9a57\u8b49\u4e86\u65b0\u6230\u7565\u7684\u53ef\u884c\u6027\u3002\u6211\u5011\u6b63\u7a4d\u6975\u63a8\u9032 givastomig \u5168\u7403\u96a8\u6a5f\u5c0d\u7167 II \u671f\u7814\u7a76\uff0c\u9810\u8a08\u65bc\u202f2026\u202f\u5e74\u7b2c\u4e00\u5b63\u5ea6\u5b8c\u6210\u9996\u4f8b\u60a3\u8005\u5165\u7d44\u3002\u6191\u501f\u65b0\u54c1\u724c\u5e36\u4f86\u7684\u7a4d\u6975\u52e2\u982d\uff0c\u5145\u5206\u91cb\u653e\u5275\u65b0\u85e5\u7269\u7684\u6f5b\u529b\uff0c\u70ba\u60a3\u8005\u548c\u6295\u8cc7\u8005\u5275\u9020\u50f9\u503c\u3002\u300d \u65b0\u6a4b\u751f\u7269\u7684\u5546\u696d\u6a21\u5f0f\u8207\u7522\u54c1\u7ba1\u7dda\u5e03\u5c40 \u516c\u53f8\u5c07\u8207\u5168\u7403\u9818\u5148\u5275\u65b0\u8005\u5408\u4f5c\uff0c\u7504\u9078\u4e26\u52a0\u901f\u9ad8\u6f5b\u529b\u85e5\u7269\u8cc7\u7522\u3002\u8a72\u6a21\u5f0f\u878d\u5408\u56b4\u8b39\u7684\u8cc7\u7522\u7504\u9078\u3001\u5b9a\u5236\u5316\u7684\u8f49\u5316\u7b56\u7565\u53ca\u9ad8\u6548\u81e8\u5e8a\u57f7\u884c\uff0c\u4e26\u4f9d\u6258\u5eb7\u6a4b\u8cc7\u672c\u6df1\u539a\u8cc7\u6e90\u8207\u5168\u7403\u80fd\u529b\uff0c\u5728\u591a\u6cbb\u7642\u9818\u57df\u63a8\u9032\u6700\u5177\u6f5b\u529b\u7684\u5275\u65b0\u85e5\u3002 \u516c\u53f8\u5c07\u63a1\u7528\u300c\u4e2d\u5fc3-\u8f3b\u5c04\uff08hub-and-spoke\uff09\u300d\u6a21\u5f0f\uff0c\u901a\u904e\u8a2d\u7acb\u5c08\u6ce8\u7279\u5b9a\u6cbb\u7642\u9818\u57df\u6216\u8cc7\u7522\u7684\u885b\u661f\u5b50\u516c\u53f8\uff0c\u4fdd\u6301\u9ad8\u6548\u9748\u6d3b\u7684\u904b\u71df\u7d50\u69cb\uff0c\u5f9e\u800c\u5be6\u73fe\u98a8\u96aa\u53ef\u63a7\u8207\u50f9\u503c\u6700\u5927\u5316\u3002 \u7ba1\u7dda\u6982\u89bd Givastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u5730\u4f4d\u7684Claudin 18.2\u00d74-1BB\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u76ee\u524d\u6b63\u5728\u958b\u5c551b\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u65e8\u5728\u7528\u65bc\u6cbb\u7642\u80c3\u764c\u53ca\u5176\u4ed6Claudin\u00a018.2\u967d\u6027\u7684\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u8a08\u5283\u555f\u52d5\u4e00\u9805\u5168\u7403\u96a8\u6a5f\u5c0d\u7167\u7684II\u671f\u7814\u7a76\uff0c\u76ee\u6a19\u65bc2026\u5e74\u7b2c\u4e00\u5b63\u5ea6\u62db\u52df\u9996\u4f4d\u60a3\u8005\u3002Givastomig\u6b63\u901a\u904e\u8207ABL\u00a0Bio\u7684\u5168\u7403\u5408\u4f5c\u9032\u884c\u806f\u5408\u958b\u767c\uff0c\u5176\u4e2d\u65b0\u6a4b\u751f\u7269\u4f5c\u70ba\u727d\u982d\u65b9\uff0c\u8207ABL\u00a0Bio\u5e73\u5206\u5168\u7403\u6b0a\u76ca\uff08\u5927\u4e2d\u83ef\u5340\u548c\u97d3\u570b\u9664\u5916\uff09\u3002 Ragistomig\u662f\u4e00\u6b3e\u6297PD-L1\u00d74-1BB\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\u3002\u57fa\u65bc\u4e00\u671f\u81e8\u5e8a\u6578\u64da\uff0c\u76ee\u524d\u958b\u5c55\u76841b\u671f\u7814\u7a76\u65e8\u5728\u64f4\u5927\u6cbb\u7642\u7a97\u53e3\uff0c\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u7522\u751f\u7d50\u679c\u3002\u8a72\u9805\u76ee\u6b63\u8207ABL Bio\u806f\u5408\u958b\u767c\u3002 Uliledlimab\uff08\u6297CD73\u55ae\u6297\uff09\u5728\u816b\u7624\u5fae\u74b0\u5883\u4e2d\uff0cCD73\u662f\u817a\u7518\u4ecb\u5c0e\u514d\u75ab\u6291\u5236\u7684\u9650\u901f\u9176\u3002\u76ee\u524d\u6b63\u5728\u958b\u5c55\u7684\u96a8\u6a5fII\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\uff0c\u5c07uliledlimab\u806f\u5408\u7279\u745e\u666e\u5229\u55ae\u6297\uff08toripalimab\uff09\u7684\u65b9\u6848\u8207\u5e15\u535a\u5229\u73e0\u55ae\u6297\uff08Pembrolizumab\uff09\u55ae\u85e5\u6216\u7279\u745e\u666e\u5229\u55ae\u6297\u55ae\u85e5\u5728\u7d93CD73\u7be9\u9078\u7684\u60a3\u8005\u4eba\u7fa4\u4e2d\u9032\u884c\u5c0d\u6bd4\uff0c\u5176\u7121\u9032\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u6578\u64da\u9810\u8a08\u5c07\u57282026\u5e74\u4e0b\u534a\u5e74\u516c\u5e03\u3002\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u5927\u4e2d\u83ef\u5340\u4ee5\u5916\u7684\u5168\u7403\u6b0a\u76ca\u3002 VIS-101\u7531\u65b0\u6a4b\u751f\u7269\u5728\u65b0\u5546\u696d\u6a21\u5f0f\u4e0b\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u6536\u8cfc\uff0c\u662f\u4e00\u6b3e\u9776\u5411VEGF-A\u548cANG2\u7684\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u76ee\u524d\u8655\u65bcII\u671f\u958b\u767c\u968e\u6bb5\u3002 VIS-101\u662f\u4e00\u6b3e\u65b0\u578b\u96d9\u7279\u7570\u6027\u751f\u7269\u5206\u5b50\uff0c\u9776\u5411VEGF-A\u548cANG2\uff0c\u4e14\u5206\u5b50\u6d3b\u6027\u66f4\u5f37\uff0c\u76f8\u8f03\u65bc\u73fe\u6709\u6a19\u6e96\u7642\u6cd5\uff0c\u6709\u671b\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u3001\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u548c\u8996\u7db2\u819c\u975c\u8108\u963b\u585e\uff08RVO\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5b8c\u6210\u4e86\u521d\u6b65\u7684\u5b89\u5168\u6027\u548c\u5291\u91cf\u905e\u589e\u7814\u7a76\uff0c\u76ee\u524d\u6b63\u5728\u4e2d\u570b\u5b8c\u6210\u4e00\u9805\u96a8\u6a5f\u5291\u91cf\u7bc4\u570d\u7684II\u671f\u7814\u7a76\u3002VIS-101\u9810\u8a08\u5c07\u65bc2026\u5e74\u5177\u5099\u958b\u5c55III\u671f\u8a66\u9a57\u7684\u689d\u4ef6\u3002 \u6b64\u6b21\u6536\u8cfc\u5df2\u901a\u904e\u65b0\u6210\u7acb\u7684\u5b50\u516c\u53f8Visara\u5b8c\u6210\u3002Visara\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u5236\u85e5\u516c\u53f8\uff0c\u5c08\u6ce8\u65bc\u958b\u767c\u540c\u985e\u6700\u4f73\u7684\u773c\u79d1\u7642\u6cd5\uff0c\u5176\u4f9d\u6258\u65b0\u6a4b\u751f\u7269\u7d043700\u842c\u7f8e\u5143\u7684\u6ce8\u8cc7\uff0c\u4ee5\u53ca\u4e00\u5bb6\u6230\u7565\u5408\u4f5c\u4f19\u4f34\u6240\u8ca2\u737b\u7684\u90e8\u5206\u76f8\u95dc\u6b0a\u76ca\u800c\u6210\u7acb\u3002\u65b0\u6a4b\u751f\u7269\u6210\u70ba Visara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002 Visara\u7531\u5176\u806f\u5408\u5275\u59cb\u4eba\u517c\u57f7\u884c\u8463\u4e8b\u9577Emmett\u00a0J.\u00a0Cunningham,\u00a0Jr.\u535a\u58eb\u9818\u5c0e\u3002Cunningham\u535a\u58eb\u5728\u904e\u53bb25\u5e74\u4e2d\u4e00\u76f4\u662f\u4e00\u4f4d\u91ab\u751f\u3001\u5275\u65b0\u8005\u3001\u4f01\u696d\u5bb6\u548c\u6295\u8cc7\u4eba\uff0c\u66fe\u4efb\u9ed1\u77f3\u96c6\u5718\u9ad8\u7d1a\u8463\u4e8b\u7e3d\u7d93\u7406\u4ee5\u53caClarus\u00a0Ventures\u8463\u4e8b\u7e3d\u7d93\u7406\u3002Cunningham\u535a\u58eb\u4e5f\u662f\u570b\u969b\u516c\u8a8d\u7684\u611f\u67d3\u6027\u548c\u708e\u75c7\u6027\u773c\u75c5\u5c08\u5bb6\uff0c\u5408\u4f5c\u767c\u8868\u4e86\u903e450\u7bc7\u5b78\u8853\u8ad6\u6587\u3002 1\uff1a\u300cAACR\u2013NCI\u2013EORTC \u5206\u5b50\u9776\u9ede\u8207\u764c\u75c7\u6cbb\u7642\u570b\u969b\u6703\u8b70\u300d\uff08AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics\uff09\u4e5f\u88ab\u7a31\u70ba\u300c\u4e09\u806f\u6703\u8b70\uff08Triple Meeting\uff09\u300d\uff0c\u65bc 2025 \u5e74 10 \u6708 22 \u65e5\u81f3 26 \u65e5\u5728\u7f8e\u570b\u99ac\u85a9\u8af8\u585e\u5dde\u6ce2\u58eb\u9813\u8209\u884c\u3002 \u95dc\u65bc\u65b0\u6a4b\u751f\u7269 \u65b0\u6a4b\u751f\u7269\uff08\u66f4\u540d\u524d\u70baI-MAB\uff1b\u7d0d\u65af\u9054\u514b\u4ee3\u78bc\uff1aIMAB\uff0c\u81ea2025\u5e7410\u670830\u65e5\u8d77\u5c07\u66f4\u6539\u70ba\u300cNBP\u300d\uff09\u662f\u4e00\u5bb6\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u516c\u53f8\uff0c\u81f4\u529b\u65bc\u52a0\u901f\u5275\u65b0\u85e5\u7269\u7684\u53ef\u53ca\u6027\u3002\u6211\u5011\u5c07\u5c08\u696d\u7684\u696d\u52d9\u62d3\u5c55\u80fd\u529b\u8207\u654f\u6377\u7684\u8f49\u5316\u81e8\u5e8a\u958b\u767c\u76f8\u7d50\u5408\uff0c\u4ee5\u767c\u73fe\u3001\u52a0\u901f\u4e26\u63a8\u9032\u7a81\u7834\u6027\u8cc7\u7522\u3002\u901a\u904e\u929c\u63a5\u79d1\u5b78\u3001\u6230\u7565\u548c\u57f7\u884c\uff0c\u65b0\u6a4b\u751f\u7269\u4f7f\u8b8a\u9769\u6027\u7642\u6cd5\u80fd\u5920\u5f9e\u767c\u73fe\u968e\u6bb5\u5feb\u901f\u63a8\u9032\u81f3\u6709\u9700\u6c42\u7684\u60a3\u8005\u3002 \u516c\u53f8\u7684\u5dee\u7570\u5316\u7ba1\u7dda\u4e3b\u8981\u7531givastomig\u548cVIS-101\u9818\u929c\u3002\u5176\u4e2d\uff0cgivastomig\u662f\u4e00\u6b3e\u6f5b\u5728\u540c\u985e\u6700\u4f73\u7684\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff08Claudin 18.2\u00d74-1BB\uff09\uff1bVIS-101\u662f\u4e00\u6b3e\u540c\u985e\u7b2c\u4e8c\u4e14\u6709\u671b\u6210\u70ba\u540c\u985e\u6700\u4f73\u7684\u96d9\u529f\u80fd\u751f\u7269\u5236\u5291\uff0c\u9776\u5411VEGF-A\u548cANG2\u3002 Givastomig\u901a\u904e4-1BB\u4fe1\u865f\u901a\u8def\uff0c\u5728\u8868\u9054Claudin 18.2\u7684\u816b\u7624\u5fae\u74b0\u5883\u4e2d\u689d\u4ef6\u6027\u6fc0\u6d3bT\u7d30\u80de\u3002givastomig\u6b63\u958b\u767c\u7528\u65bc\u6cbb\u7642Claudin 18.2\u967d\u6027\u7684\u80c3\u764c\u53ca\u5176\u4ed6\u80c3\u8178\u9053\u60e1\u6027\u816b\u7624\u3002\u65b0\u6a4b\u751f\u7269\u9084\u8207\u5408\u4f5c\u4f19\u4f34ABL Bio\u5408\u4f5c\u958b\u767cragistomig\uff0c\u9019\u662f\u4e00\u6b3e\u96d9\u7279\u7570\u6027\u6297\u9ad4\uff0c\u5728\u5be6\u9ad4\u7624\u4e2d\u5c07PD-L1\u4f5c\u70ba\u816b\u7624\u7d50\u5408\u9776\u9ede\u30014-1BB\u4f5c\u70ba\u689d\u4ef6\u6027T\u7d30\u80de\u6fc0\u6d3b\u5291\u3002\u6b64\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u64c1\u6709uliledlimab\u5728\u4e2d\u570b\u4ee5\u5916\u5730\u5340\u7684\u5168\u7403\u6b0a\u76ca\u3002Uliledlimab\u662f\u4e00\u6b3e\u6297CD73\u6297\u9ad4\uff0c\u9776\u5411\u816b\u7624\u4e2d\u7531\u817a\u7518\u4ecb\u5c0e\u7684\u514d\u75ab\u6291\u5236\u3002 VIS-101\u9776\u5411VEGF-A\u548cANG2\uff0c\u53ef\u70ba\u6fd5\u6027\u5e74\u9f61\u76f8\u95dc\u6027\u9ec3\u6591\u8b8a\u6027\uff08wet AMD\uff09\u548c\u7cd6\u5c3f\u75c5\u6027\u9ec3\u6591\u6c34\u816b\uff08DME\uff09\u60a3\u8005\u63d0\u4f9b\u66f4\u5f37\u6709\u529b\u4e14\u6301\u4e45\u7684\u7642\u6548\u3002VIS-101\u76ee\u524d\u6b63\u5728\u91dd\u5c0d\u6fd5\u6027AMD\u958b\u5c55\u4e00\u9805\u5927\u578b\u3001\u96a8\u6a5f\u3001\u5291\u91cf\u7bc4\u570d\u76842\u671f\u7814\u7a76\u3002\u65b0\u6a4b\u751f\u7269\u662fVisara \u7684\u63a7\u80a1\u80a1\u6771\uff0c\u4e26\u64c1\u6709VIS-101\u7684\u5168\u7403\u6b0a\u76ca\u3002 \u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f\uff1ahttps:\/\/www.novabridge.com\u00a0 \u516c\u53f8\u64ec\u5728\u7d0d\u65af\u9054\u514b\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u96d9\u91cd\u4e0a\u5e02 \u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u64ec\u8d74\u9999\u6e2fIPO\u4e26\u5728\u9999\u6e2f\u806f\u4ea4\u6240\uff08HKEX\uff09\u4e0a\u5e02\u7684\u66f4\u591a\u4fe1\u606f\u5c07\u65bc\u65e5\u5f8c\u516c\u5e03\u3002 \u64ec\u8b70\u767c\u884c\u7684\u6642\u9593\u3001\u898f\u6a21\u3001\u7d50\u69cb\u548c\u5177\u9ad4\u689d\u6b3e\u5c1a\u672a\u78ba\u5b9a\uff0c\u4ecd\u53d6\u6c7a\u65bc\u5e02\u5834\u72c0\u6cc1\u4ee5\u53ca\u5305\u62ec\u9999\u6e2f\u806f\u4ea4\u6240\uff08\u53ca\u5176\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5728\u5167\u7684\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\u7684\u5be9\u6279\u3002\u5c0d\u65bc\u64ec\u8b70\u7684\u9999\u6e2f\u4e0a\u5e02\u662f\u5426\u6703\u5b8c\u6210\u3001\u4f55\u6642\u5b8c\u6210\u6216\u5c07\u5728\u4f55\u7a2e\u689d\u6b3e\u4e0b\u5b8c\u6210\uff0c\u7121\u6cd5\u63d0\u4f9b\u4efb\u4f55\u4fdd\u8b49\u3002 \u5728\u7372\u5f97\u76e3\u7ba1\u6a5f\u69cb\u548c\u516c\u53f8\u5fc5\u8981\u6279\u51c6\u7684\u524d\u63d0\u4e0b\uff0c\u516c\u53f8\u76ee\u524d\u9810\u8a08\u5c07\u7dad\u6301\u5176\u5728\u7d0d\u65af\u9054\u514b\u7684\u7f8e\u570b\u5b58\u6258\u80a1\uff08ADS\uff09\u4e0a\u5e02\u5730\u4f4d\uff0c\u4e26\u5c0b\u6c42\u5728\u7f8e\u570b\u548c\u9999\u6e2f\u5be6\u73fe\u96d9\u91cd\u4e0a\u5e02\u3002\u6700\u7d42\u6c7a\u5b9a\u5c07\u6839\u64da\u5e02\u5834\u72c0\u6cc1\u548c\u76e3\u7ba1\u53cd\u994b\u4f5c\u51fa\u3002 \u672c\u516c\u544a\u50c5\u70ba\u4fe1\u606f\u62ab\u9732\u4e4b\u7528\uff0c\u4e14\u4e0d\u69cb\u6210\u5c0d\u516c\u53f8\u4efb\u4f55\u8b49\u5238\u7684\u8a8d\u8cfc\u3001\u8cfc\u8cb7\u6216\u6536\u8cfc\u8981\u7d04\u6216\u9080\u8acb\u3002\u516c\u53f8\u80a1\u6771\u53ca\u6f5b\u5728\u6295\u8cc7\u8005\u5728\u6d89\u53ca\u516c\u53f8\u8b49\u5238\u7684\u4ea4\u6613\u6642\uff0c\u61c9\u8b39\u614e\u8a55\u4f30\u76f8\u95dc\u98a8\u96aa\u3002 \u524d\u77bb\u6027\u8072\u660e \u672c\u516c\u544a\u5305\u542b\u524d\u77bb\u6027\u8072\u660e\u3002\u9019\u4e9b\u8072\u660e\u4f9d\u64da1995\u5e74\u7f8e\u570b\u300a\u79c1\u4eba\u8b49\u5238\u8a34\u8a1f\u6539\u9769\u6cd5\u6848\u300b\u7684\u300c\u5b89\u5168\u6e2f\u300d\u689d\u6b3e\u4f5c\u51fa\u3002\u53ef\u4ee5\u901a\u904e\u8853\u8a9e\u4f8b\u5982\u300c\u5c07\u300d\u3001\u300c\u9810\u8a08\u300d\u3001\u300c\u76f8\u4fe1\u300d\u3001\u300c\u65e8\u5728\u300d\u3001\u300c\u9810\u671f\u300d\u3001\u300c\u672a\u4f86\u300d\u3001\u300c\u6253\u7b97\u300d\u3001\u300c\u8a08\u5283\u300d\u3001\u300c\u6f5b\u5728\u300d\u3001\u300c\u4f30\u8a08\u300d\u3001\u300c\u6709\u4fe1\u5fc3\u300d\u7b49\u4ee5\u53ca\u985e\u4f3c\u8868\u8ff0\uff08\u6216\u5176\u53cd\u7fa9\u8868\u8ff0\uff09\u4f86\u8b58\u5225\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u3002\u65b0\u6a4b\u751f\u7269\u4e5f\u53ef\u80fd\u5728\u5176\u63d0\u4ea4\u7d66\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\uff08SEC\uff09\u7684\u5b9a\u671f\u5831\u544a\u3001\u5411\u80a1\u6771\u767c\u5e03\u7684\u5e74\u5ea6\u5831\u544a\u3001\u65b0\u805e\u7a3f\u53ca\u5176\u4ed6\u66f8\u9762\u6750\u6599\u4e2d\uff0c\u4ee5\u53ca\u516c\u53f8\u9ad8\u7ba1\u3001\u8463\u4e8b\u6216\u54e1\u5de5\u5411\u7b2c\u4e09\u65b9\u6240\u4f5c\u7684\u53e3\u982d\u9673\u8ff0\u4e2d\u4f5c\u51fa\u66f8\u9762\u6216\u53e3\u982d\u7684\u524d\u77bb\u6027\u8072\u660e\u3002\u51e1\u4e0d\u5c6c\u65bc\u6b77\u53f2\u4e8b\u5be6\u7684\u9673\u8ff0\uff08\u5305\u62ec\u95dc\u65bc\u65b0\u6a4b\u751f\u7269\u7684\u4fe1\u5ff5\u548c\u9810\u671f\u7684\u9673\u8ff0\uff09\u5747\u70ba\u524d\u77bb\u6027\u8072\u660e\u3002\u672c\u65b0\u805e\u7a3f\u4e2d\u7684\u524d\u77bb\u6027\u8072\u660e\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u5167\u5bb9\uff1a\u65b0\u7684\u516c\u53f8\u6230\u7565\u53ef\u80fd\u5e36\u4f86\u7684\u6f5b\u5728\u76ca\u8655\uff1b\u516c\u53f8\u4ee5\u65b0\u540d\u7a31\u548c\u80a1\u7968\u4ee3\u78bc\u5728\u7d0d\u65af\u9054\u514b\u4ea4\u6613\u7684\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u64ec\u63a8\u9032\u9999\u6e2f IPO\uff0c\u9032\u800c\u5be6\u73fe\u64ec\u5728\u7d0d\u65af\u9054\u514b\u5168\u7403\u5e02\u5834\u8207\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\uff08HKEX\uff09\u96d9\u91cd\u4e0a\u5e02\u7684\u8a08\u5283\uff1bgivastomig\u3001VIS-101\u53ca\u516c\u53f8\u5176\u4ed6\u5019\u9078\u85e5\u7269\u7684\u6230\u7565\u3001\u81e8\u5e8a\u958b\u767c\u3001\u8a08\u5283\u3001\u7d50\u679c\u3001\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff1b\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\uff08\u5305\u62ec givastomig \u548c VIS-101\uff09\u7684\u6230\u7565\u8207\u81e8\u5e8a\u958b\u767c\uff1b\u9810\u671f\u7684\u81e8\u5e8a\u91cc\u7a0b\u7891\u548c\u7d50\u679c\u53ca\u76f8\u95dc\u6642\u9593\uff1b\u516c\u53f8\u7684\u9810\u671f\u8cc7\u91d1\u53ef\u7dad\u6301\u904b\u71df\u7684\u5468\u671f\u3002\u524d\u77bb\u6027\u8072\u660e\u6d89\u53ca\u7684\u98a8\u96aa\u548c\u4e0d\u78ba\u5b9a\u6027\u53ef\u80fd\u5c0e\u81f4\u5be6\u969b\u7d50\u679c\u8207\u9019\u4e9b\u524d\u77bb\u6027\u8072\u660e\u4e2d\u5305\u542b\u7684\u7d50\u679c\u5b58\u5728\u91cd\u5927\u5dee\u7570\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u65bc\u4ee5\u4e0b\u56e0\u7d20\uff1a\u65b0\u6a4b\u751f\u7269\u8b49\u660e\u5176\u5019\u9078\u85e5\u7269\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u7684\u80fd\u529b\uff1b\u516c\u53f8\u7372\u5f97\u8b49\u5238\u76e3\u7ba1\u6a5f\u69cb\u53ca\u4ea4\u6613\u6240\u5fc5\u8981\u6279\u51c6\u7684\u80fd\u529b\uff1b\u5019\u9078\u85e5\u7269\u7684\u81e8\u5e8a\u7d50\u679c\uff08\u53ef\u80fd\u652f\u6301\u4e5f\u53ef\u80fd\u4e0d\u652f\u6301\u9032\u4e00\u6b65\u958b\u767c\u6216\u65b0\u85e5\u7533\u8acb\/\u751f\u7269\u5236\u54c1\u8a31\u53ef\u7533\u8acb\uff08NDA\/BLA\uff09\u7684\u6279\u51c6\uff09\uff1b\u76f8\u95dc\u76e3\u7ba1\u6a5f\u69cb\uff08\u5305\u62ec\u7f8e\u570b\u8b49\u5238\u4ea4\u6613\u59d4\u54e1\u6703\u4ee5\u53ca\u9999\u6e2f\u806f\u5408\u4ea4\u6613\u6240\u4e0a\u5e02\u59d4\u54e1\u6703\uff09\u5c31\u65b0\u6a4b\u751f\u7269\u5019\u9078\u85e5\u7269\u76e3\u7ba1\u5be9\u6279\u6240\u4f5c\u6c7a\u5b9a\u7684\u5167\u5bb9\u548c\u6642\u9593\uff1b\u65b0\u6a4b\u751f\u7269\u5728\u5019\u9078\u85e5\u7269\u7372\u6279\u5f8c\u7684\u5546\u696d\u6210\u529f\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u4e26\u7dad\u8b77\u5176\u6280\u8853\u548c\u85e5\u7269\u77e5\u8b58\u7522\u6b0a\u4fdd\u8b77\u7684\u80fd\u529b\uff1b\u65b0\u6a4b\u751f\u7269\u5c0d\u7b2c\u4e09\u65b9\u958b\u5c55\u85e5\u7269\u958b\u767c\u3001\u751f\u7522\u5236\u9020\u53ca\u5176\u4ed6\u670d\u52d9\u7684\u4f9d\u8cf4\uff1b\u65b0\u6a4b\u751f\u7269\u6709\u9650\u7684\u904b\u71df\u6b77\u53f2\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u7372\u5f97\u984d\u5916\u904b\u71df\u8cc7\u91d1\u4e26\u5b8c\u6210\u5176\u5019\u9078\u85e5\u7269\u958b\u767c\u548c\u5546\u696d\u5316\u7684\u80fd\u529b\uff1b\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u5df2\u65bc2025\u5e744\u67083\u65e5\u5411\u7f8e\u570bSEC\u63d0\u4ea4\u768420-F\u5e74\u5ea6\u5831\u544a\u4e2d\u300c\u98a8\u96aa\u56e0\u7d20\u300d\u90e8\u5206\u66f4\u5168\u9762\u8a0e\u8ad6\u7684\u98a8\u96aa\uff0c\u4ee5\u53ca\u65b0\u6a4b\u751f\u7269\u96a8\u5f8c\u5411SEC\u63d0\u4ea4\u7684\u6587\u4ef6\u4e2d\u8a0e\u8ad6\u7684\u6f5b\u5728\u98a8\u96aa\u3001\u4e0d\u78ba\u5b9a\u6027\u548c\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u3002\u6240\u6709\u524d\u77bb\u6027\u8072\u660e\u5747\u57fa\u65bc\u65b0\u6a4b\u751f\u7269\u7576\u524d\u53ef\u7372\u5f97\u7684\u4fe1\u606f\u3002\u9664\u6cd5\u5f8b\u8981\u6c42\u5916\uff0c\u65b0\u6a4b\u751f\u7269\u4e0d\u627f\u64d4\u56e0\u7372\u5f97\u65b0\u4fe1\u606f\u3001\u672a\u4f86\u4e8b\u4ef6\u6216\u5176\u4ed6\u539f\u56e0\u800c\u516c\u958b\u66f4\u65b0\u6216\u4fee\u8a02\u4efb\u4f55\u524d\u77bb\u6027\u8072\u660e\u7684\u7fa9\u52d9\u3002 \u65b0\u6a4b\u751f\u7269\u6295\u8cc7\u8005\u53ca\u5a92\u9ad4\u806f\u7e6b\u4ebaPJ Kelleher \u2013 LifeSci Advisors+1-617-430-7579pkelleher@lifesciadvisors.com \u96f7\u9cf4\uff08Kyler Lei\uff09\u2013 \u65b0\u6a4b\u751f\u7269+1-240-745-6330kyler.lei@imabbio.comIR@imabbio.com","breadcrumb":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=376800#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pingtungtimes.com.tw\/?p=376800"]}]},{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/?p=376800#primaryimage","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/image_5053990_46034728.jpg","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/image_5053990_46034728.jpg","width":400,"height":282},{"@type":"BreadcrumbList","@id":"https:\/\/pingtungtimes.com.tw\/?p=376800#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/pingtungtimes.com.tw\/"},{"@type":"ListItem","position":2,"name":"I-MAB (Nasdaq: IMAB)\u6b63\u5f0f\u66f4\u540d\u70ba\u65b0\u6a4b\u751f\u7269\uff08NovaBridge Biosciences\uff1bNasdaq: NBP\uff09\uff0c\u80a1\u7968\u4ea4\u6613\u5c07\u65bc 2025 \u5e74 10 \u6708 30 \u65e5\u6b63\u5f0f\u751f\u6548\uff0c\u65b0\u54c1\u724c\u6a19\u8a8c\u8457\u5176\u5411\u5168\u7403\u751f\u7269\u79d1\u6280\u5e73\u53f0\u578b\u516c\u53f8\u7684\u6230\u7565\u8f49\u578b\u3002"}]},{"@type":"WebSite","@id":"https:\/\/pingtungtimes.com.tw\/#website","url":"https:\/\/pingtungtimes.com.tw\/","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4","publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pingtungtimes.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"},{"@type":"Organization","@id":"https:\/\/pingtungtimes.com.tw\/#organization","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","url":"https:\/\/pingtungtimes.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","width":150,"height":150,"caption":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pingtungnews"]},{"@type":"Person","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3","name":"\u7f8e\u901a\u793e","image":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","caption":"\u7f8e\u901a\u793e"},"url":"https:\/\/pingtungtimes.com.tw\/?author=16"}]}},"_links":{"self":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/376800","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=376800"}],"version-history":[{"count":0,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/376800\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/media\/376801"}],"wp:attachment":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=376800"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=376800"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=376800"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}